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Abstract
Background
Complex regional pain syndrome (CRPS) is a painful and disabling condition that usually manifests in 
response to trauma or surgery. When it occurs, it is associated with significant pain and disability. It is thought 
to arise and persist as a consequence of a maladaptive pro-inflammatory response and disturbances in 
sympathetically-mediated vasomotor control, together with maladaptive peripheral and central neuronal 
plasticity. CRPS can be classified into two types: type I (CRPS I) in which a specific nerve lesion has not been 
identified, and type II (CRPS II) where there is an identifiable nerve lesion. Guidelines recommend the 
inclusion of a variety of physiotherapy interventions as part of the multimodal treatment of people with CRPS, 
although their effectiveness is not known.
Objectives
To determine the effectiveness of physiotherapy interventions for treating the pain and disability associated 
with CRPS types I and II.
Search methods
We searched the following databases from inception up to 12 February 2015: CENTRAL (the Cochrane 
Library), MEDLINE, EMBASE, CINAHL, PsycINFO, LILACS, PEDro, Web of Science, DARE and Health 
Technology Assessments, without language restrictions, for randomised controlled trials (RCTs) of 
physiotherapy interventions for treating pain and disability in people CRPS. We also searched additional online 
sources for unpublished trials and trials in progress.
Selection criteria
We included RCTs of physiotherapy interventions (including manual therapy, therapeutic exercise, 
electrotherapy, physiotherapist-administered education and cortically directed sensory-motor rehabilitation 
strategies) employed in either a stand-alone fashion or in combination, compared with placebo, no treatment, 
another intervention or usual care, or of varying physiotherapy interventions compared with each other in 
adults with CRPS I and II. Our primary outcomes of interest were patient-centred outcomes of pain intensity 
and functional disability.
Data collection and analysis
Two review authors independently evaluated those studies identified through the electronic searches for 
eligibility and subsequently extracted all relevant data from the included RCTs. Two review authors 
independently performed 'Risk of bias' assessments and rated the quality of the body of evidence for the main 
outcomes using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) 
approach.
Main results
We included 18 RCTs (739 participants) that tested the effectiveness of a broad range of physiotherapy-based 
interventions. Overall, there was a paucity of high quality evidence concerning physiotherapy treatment for 
pain and disability in people with CRPS I. Most included trials were at 'high' risk of bias (15 trials) and the 
remainder were at 'unclear' risk of bias (three trials). The quality of the evidence was very low or low for all 
comparisons, according to the GRADE approach.
We found very low quality evidence that graded motor imagery (GMI; two trials, 49 participants) may be useful 
for improving pain (0 to 100 VAS) (mean difference (MD) − 21.00, 95% CI − 31.17 to − 10.83) and functional 
disability (11-point numerical rating scale) (MD 2.30, 95% CI 1.12 to 3.48), at long-term (six months) follow-up, 
in people with CRPS I compared to usual care plus physiotherapy; very low quality evidence that multimodal 
physiotherapy (one trial, 135 participants) may be useful for improving 'impairment' at long-term (12 month) 
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follow-up compared to a minimal 'social work' intervention; and very low quality evidence that mirror therapy 
(two trials, 72 participants) provides clinically meaningful improvements in pain (0 to 10 VAS) (MD 3.4, 95% CI 
− 4.71 to − 2.09) and function (0 to 5 functional ability subscale of the Wolf Motor Function Test) (MD − 2.3, 
95% CI − 2.88 to − 1.72) at long-term (six month) follow-up in people with CRPS I post stroke compared to 
placebo (covered mirror).
There was low to very low quality evidence that tactile discrimination training, stellate ganglion block via 
ultrasound and pulsed electromagnetic field therapy compared to placebo, and manual lymphatic drainage 
combined with and compared to either anti-inflammatories and physical therapy or exercise are not effective 
for treating pain in the short-term in people with CRPS I. Laser therapy may provide small clinically 
insignificant, short-term, improvements in pain compared to interferential current therapy in people with CRPS 
I.
Adverse events were only rarely reported in the included trials. No trials including participants with CRPS II 
met the inclusion criteria of this review.
Authors' conclusions
The best available data show that GMI and mirror therapy may provide clinically meaningful improvements in 
pain and function in people with CRPS I although the quality of the supporting evidence is very low. Evidence 
of the effectiveness of multimodal physiotherapy, electrotherapy and manual lymphatic drainage for treating 
people with CRPS types I and II is generally absent or unclear. Large scale, high quality RCTs are required to 
test the effectiveness of physiotherapy-based interventions for treating pain and disability of people with CRPS 
I and II. Implications for clinical practice and future research are considered.
Plain language summary
Physiotherapy for pain and disability in adults with complex regional pain 
syndrome (CRPS) types I and II
 
Background
Complex regional pain syndrome (CRPS) is a painful and disabling condition. Most commonly it affects a 
person's arm and hand or leg and foot and may occur after a traumatic injury. There are two types of CRPS: 
CRPS I in which there is no nerve injury, and CRPS II in which there is a nerve injury. Guidelines recommend 
physiotherapy, which could include different kinds of exercise therapy or electrotherapy for instance, along with 
other medical treatments for treating the pain and disability associated with CRPS. However, we do not know 
how well these treatments work.
Review question
Which types of physiotherapy treatment are effective for reducing the pain and disability associated with CRPS 
in adults?
Study characteristics
We searched for clinical trials of physiotherapy up to 12 February 2015. We included 18 trials that had 739 
participants with CRPS I. In most of these trials the participants had CRPS I of the arm and hand. We did not 
find any clinical trials that included participants with CRPS II.
Key results
Overall we did not find any good quality clinical trials of physiotherapy aimed at reducing the pain and disability 
of CRPS I in adults. Most included trials were not well designed and contained only small numbers of patients. 
We did find some low quality trials suggesting that two broadly similar types of rehabilitation training, known as 
'graded motor imagery' (GMI) and 'mirror therapy', might be useful for reducing the pain and disability 
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associated with CRPS I after traumatic events or surgery or a stroke. From the limited evidence available it 
appears that some types of electrotherapy, such as ultrasound and pulsed electromagnetic field therapy, as 
well as a type of massage therapy known as manual lymphatic drainage, are not effective. Most studies did not 
report on adverse events and so we do not know if these treatments have any harmful side-effects.
On the whole, because of the limited number and low quality of available trials for the various physiotherapy 
treatments, we cannot be sure if any of the physiotherapy treatments we evaluated are effective for treating 
the pain and disability of CRPS I in adults. It is possible that some treatments, such as GMI or mirror therapy, 
might be effective. Further high quality clinical trials of physiotherapy are needed in order to find out if any of 
the different types of physiotherapy treatment are effective at improving pain and disability in people with 
CRPS.
Background
Description of the condition
Complex regional pain syndrome (CRPS) is a persistent, painful and disabling condition that usually, but not 
exclusively, manifests in response to acute trauma or surgery (Goebel 2011; Shipton 2009). The International 
Association for the Study of Pain (IASP) introduced the diagnostic label 'CRPS' in the 1990s in order to 
standardise inconsistencies in terminology and diagnostic criteria (Merskey 1994). Two sub-categories of 
CRPS have been described: CRPS type I (CRPS I) (formerly and variously referred to as reflex sympathetic 
dystrophy (RSD), algodystrophy, Sudek's atrophy) in which no nerve lesion is present and CRPS type II 
(CRPS II) (formerly referred to as causalgia, algoneurodystrophy), in which a co-existing nerve lesion (as 
determined by nerve conduction studies or surgical inspection for example) is present (Coderre 2011; 
Todorova 2013).
CRPS is characterised by symptoms and signs typically confined to a body region or limb, but which may 
become more widespread (van Rijn 2011). The diagnostic criteria for CRPS originally proposed by the IASP 
(Merskey 1994) have since been revised in response to their low specificity and potential to over-diagnose 
cases of CRPS. The Budapest criteria proposed by Harden 2010 have enhanced diagnostic accuracy and are 
now widely accepted (Goebel 2011). The diagnosis of CRPS is clinical (Goebel 2011) and the cardinal 
features include:
1. continuing pain disproportionate to any inciting event;
2. the presence of clusters of various symptoms and signs reflecting sensory (e.g. hyperaesthesia, 
allodynia), vasomotor (e.g. asymmetries of temperature or skin colour, or both), sudomotor (e.g. oedema 
or altered sweating or both), motor (e.g. reduced range of motion, tremor) or trophic (e.g. altered hair or 
nails, or both) disturbances; and
3. the absence of any other medical diagnosis that might better account for an individual's symptoms and 
signs.
The pathophysiological mechanisms underlying CRPS are not fully understood (Harden 2010). Current 
understanding implicates multiple mechanisms including complex contributions from a maladaptive 
pro-inflammatory response and a disturbance in sympathetically mediated vasomotor control, together with 
maladaptive peripheral and central neuronal plasticity (Bruehl 2010; Bruehl 2015; Marinus 2011; 
Parkitny 2013). Furthermore, mechanisms, and in consequence symptoms and signs, may vary between 
individuals and within individuals over the time course of the disorder, thus heightening the complexity 
(Marinus 2011).
The incidence of CRPS is not accurately known but population estimates indicate an incidence of somewhere 
between five and 26 cases per 100,000 person-years (Marinus 2011). A likely conservative 11-year period 
prevalence rate for CRPS of 20.57 per 100,000 people has been reported (Sandroni 2003). CRPS is three to 
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four times more likely to occur in women than in men, and although it may occur at any time throughout the 
lifespan it tends to occur more frequently with increasing age (Shipton 2009). Genetic susceptibility may serve 
as an aetiological risk factor for the development of CRPS (de Rooij 2009). In individuals who develop CRPS 
after a fracture, intra-articular fracture, fracture-dislocation, pre-existing rheumatoid arthritis, pre-existing 
musculoskeletal co-morbidities (e.g. low-back pain, arthrosis) (Beerthuizen 2012) and limb immobilisation 
(Marinus 2011) may increase the risk of its development. Psychological traits, such as depression, anxiety, 
neuroticism and anger, have so far been discounted as risk factors for the development of CRPS (Beerthuizen 
2009: Lohnberg 2013), although further prospective studies are required to substantiate this assertion (Harden 
2013).
People with CRPS experience significant suffering and disability (Bruehl 2010; Lohnberg 2013). Preliminary 
data suggest that interference with activities of daily living, sleep, work and recreation is common and further 
contributes to a diminished quality of life (Galer 2000; Geertzen 1998; Kemler 2000; Sharma 2009).
Studies into the course of CRPS present contradictory findings. Whilst some studies have reported complete 
and partial symptom resolution within one year (Sandroni 2003; Zyluk 1998), other studies have indicated 
more protracted symptoms and impairments lasting from three to nine years (de Mos 2009; Geertzen 1998; 
Vaneker 2006). In addition, emerging evidence suggests that people with CRPS of an upper limb (which 
develops less often in response to a fracture) and whose affected limb is colder than the contralateral limb, 
may experience significantly longer disease duration than people with CRPS of a lower limb (which occurs 
more commonly after fracture) and whose affected limb is warmer than the contralateral limb (de Mos 2009).
Although guidelines for the treatment of CRPS recommend an interdisciplinary multimodal approach, 
comprising pharmacological and interventional pain management strategies together with rehabilitation, 
psychological therapy and educational strategies (Goebel 2012; Harden 2013; Perez 2010; 
Stanton-Hicks 2002), determining the optimal approach to therapy remains clinically challenging 
(Cossins 2013; O'Connell 2013).
Description of the intervention
Guidelines recommend the inclusion of a variety of physiotherapy interventions as part of the multimodal 
treatment of CRPS (Goebel 2012; Perez 2010; Stanton-Hicks 2002) but their effectiveness is not known. 
Physiotherapy has been defined as "the treatment of disorders with physical agents and methods" (Anderson 
2002) and for CRPS could include any of the following interventions employed either as stand-alone 
interventions or in combination: manual therapy (e.g. mobilisation, manipulation, massage, desensitisation); 
therapeutic exercise and progressive loading regimens (including hydrotherapy); electrotherapy (e.g. 
transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, interferential, shortwave 
diathermy, laser); physiotherapist-administered education (e.g. pain neuroscience education); as well as 
cortically directed sensory-motor rehabilitation strategies (e.g. graded motor imagery (GMI), mirror therapy, 
sensory motor retuning, tactile discrimination training).
How the intervention might work
The precise mechanisms of action through which various physiotherapy interventions are purported to relieve 
the pain and disability associated with CRPS are not fully understood. Theories underpinning the use of 
manual therapies to relieve pain include the induction of peripheral or central nervous system-mediated 
analgesia, or both (Bialosky 2009; Goats 1994). Therapeutic exercise may induce analgesia, via 
endorphin-mediated inhibition (Nijs 2012), and improve function, and by extension disability, by restoring 
range of movement at affected joints and improving neuromuscular function (Kisner 2002). Theories 
underlying the use of electrotherapy modalities for pain relief variously include spinal cord-mediated 
electro-analgesia, heat- or cold-mediated analgesia and anti-inflammatory effects (Atamaz 2012; Robertson 
2006). Pain neuroscience education may reduce pain and disability by helping individuals to better understand 
the biological processes underlying their pain in a way that positively changes pain perceptions and attitudes 
(Louw 2011). Other rehabilitation strategies, such GMI or mirror therapy, may provide pain relief or increase 
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mobility, or both, by ameliorating maladaptive somatosensory and motor cortex reorganisation (Moseley 2005; 
Moseley 2012).
Why it is important to do this review
A number of systematic reviews suggest that physiotherapy interventions (e.g. exercise, GMI, TENS) 
employed in combination with medical management may be beneficial in reducing the pain and disability 
associated with CRPS (Daly 2009; Smith 2005). However, the inclusion of non-randomised clinical trials and 
case series designs, together with the exclusion of studies involving people with CRPS type II as well as those 
published in a language other than English, may have biased these conclusions. Furthermore, the 
methodologies used for conducting systematic reviews have been substantially revised in recent years, such 
as those recommended within the Grading of Recommendations Assessment, Development and Evaluation 
(GRADE) approach for describing the strength of the evidence (Balshem 2011), which has not been utilised in 
previous reviews. Given the limitations of existing systematic reviews, together with the availability of 
potentially numerous physiotherapy treatment strategies for CRPS, an up-to-date systematic review of the 
evidence from randomised clinical trials for the effectiveness of these interventions may assist clinicians in 
their treatment choices and inform future clinical guidelines that may be of use to policymakers and those who 
commission health care for people with CRPS.
Objectives
To determine the effectiveness of physiotherapy interventions for treating pain and disability associated with 
CRPS types I and II.
Methods
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) (including those of parallel, cluster-randomised and 
cross-over design) published in any language. Translators identified by the Managing Editor of the Cochrane 
Pain, Palliative and Supportive Care Group evaluated studies published in a language other than English. We 
excluded studies in which participants were not randomised to intervention groups.
Types of participants
We included trials of adults, aged 18 years or older, diagnosed with CRPS I or II, or with an alternative 
diagnostic label for these conditions (e.g. RSD, causalgia). We grouped trials according to diagnosis (i.e. 
CRPS types I and II, or mixed). Since the use of formal diagnostic criteria for CRPS is inconsistent across 
studies (Reinders 2002), we included trials that used established or validated diagnostic criteria, including the 
Veldman criteria (Veldman 1993), the International Association for the Study of Pain (IASP) criteria (Merskey 
1994), Bruehl criteria (Bruehl 1999), Budapest criteria (Harden 2010) and Atkins criteria (Atkins 2010), as well 
as studies that either predate these criteria or use non-standard diagnostic criteria.
Types of interventions
We included all randomised controlled comparisons of physiotherapy interventions, employed in either a 
stand-alone fashion or in combination, compared with placebo, no treatment, another intervention or usual 
care, or of varying physiotherapy interventions compared with each other, which were aimed at treating pain or 
disability, or both, associated with CRPS. We included trials in which non-physiotherapists (e.g. occupational 
therapists) delivered such physiotherapy interventions, as defined in 'Description of the intervention', and 
reported the professional discipline of the clinician delivering the intervention. After the publication of our 
Cochrane protocol, (Smart 2013) we decided to exclude studies that evaluated non-physiotherapy based 
interventions (e.g. pharmacological) in which all arms received the same physiotherapy intervention (differing 
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only in the application of the non-physiotherapy component) as they are unlikely to offer any insight into the 
value of physiotherapy management (see Differences between protocol and review).
Types of outcome measures
Primary outcomes
1. Changes in pain severity/intensity as measured using a visual analogue scale (VAS), numerical rating 
scale (NRS), verbal rating scale or Likert scale;
2. changes in disability as measured by validated self-report questionnaires/scales or functional testing 
protocols.
We presented and analysed primary outcomes as change on a continuous scale or in a dichotomised format 
as the proportion of participants in each group who attained a predetermined threshold of improvement. For 
example, we judged cut-points from which to interpret the likely clinical importance of (pooled) effect sizes 
according to provisional criteria proposed in the Initiative on Methods, Measurement, and Pain Assessment in 
Clinical Trials (IMMPACT) consensus statement (Dworkin 2008). Specifically, reductions in pain intensity 
compared with baseline were judged as follows:
1. less than 15%: 'no important change';
2. 15% or more: 'minimally important change';
3. 30% or more: 'moderately important change';
4. 50% or more: 'substantially important change'.
We planned to use the cut-points for 'minimally', 'moderately' and 'substantially  important changes to generate 
dichotomous outcomes, the effect size for which we would have expressed as the risk ratio (or relative risk 
(RR)) but a lack of data did not permit any such analyses.
Secondary outcomes
We planned to analyse the following secondary outcome measures where such data were available:
1. changes in composite scores for CRPS symptoms;
2. changes in health-related quality of life (HRQoL) using any validated tool;
3. changes in patient global impression of change (PGIC) scales;
4. incidence/nature of adverse effects.
We planned to analyse and present secondary outcomes as change on a continuous scale or in a 
dichotomised format but a lack of data did not permit any such analyses. For example, equivalent measures of 
treatment effect with respect to PGIC have been defined as: 'much' or 'very much' improved (moderate benefit) 
and very much' improved (substantial benefit) (Dworkin 2008). Future updates may allow such analyses where 
relevant data are available.
Search methods for identification of studies
Electronic searches
We identified relevant RCTs by electronically searching the following databases:
1. Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library, Issue 1 of 12, 2015;
2. Database of Abstracts of Reviews of Effects in the Cochrane Library, Issue 1 of 4 2015;
3. Health Technology Assessments in the Cochrane Library, Issue 1 of 4 2015;
4. MEDLINE (OVID) (1966 to 11 February 2015);
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5. EMBASE (OVID) (1974 to 11 February 2015);
6. CINAHL (EBSCO) (1982 to 11 February 2015);
7. PsycINFO (OVID) (1806 to 11 February 2015);
8. LILACS; (1982 to 15 February 2015);
9. PEDro; (1929 to 15 February 2015);
10. Web of Science (ISI);(1945 to 15 February 2015).
The Trials Search Co-ordinator of the Cochrane Pain, Palliative and Supportive Care Group devised the 
search strategies. She and the review authors ran these searches. We used a combination of controlled 
vocabulary, i.e. medical subject headings (MeSH) and free-text terms. The search strategies are in Appendix 
1.
Searching other resources
Reference lists
On completion of the electronic searches we searched the reference lists of all eligible studies in order to 
identify additional relevant studies. In addition we screened the reference lists of key physiotherapy textbooks 
and previous systematic reviews.
External experts
We sent the list of included trials to a content expert to help identify any additional relevant studies.
Unpublished data
In order to minimise the impact of publication bias we searched the following registers and databases to 
identify unpublished research as well as research in progress:
1. OpenGrey (System for Information on Grey Literature in Europe);
2. Dissertation Abstracts (ProQuest);
3. National Research Register Archive;
4. Health Services Research Projects in Progress;
5. Current Controlled Trials Register (incorporating the meta-register of controlled trials and the International 
Standard Randomised Controlled Trial Number);
6. ClinicalTrials.gov;
7. International Clinical Trials Registry Platform;
8. Pan African Clinical Trials Registry;
9. EU Clinical Trials Register.
Data collection and analysis
Selection of studies
Two review authors (KMS and BMW) independently assessed the titles and abstracts of studies we identified 
by the search strategy for eligibility. If the eligibility of a trial was unclear from the title and abstract, we 
assessed the full-text article. We excluded trials that did not match the inclusion criteria (see the 'Criteria for 
considering studies for this review' section). We resolved any disagreements between review authors 
regarding a study's inclusion by discussion. If we could not resolve disagreements, a third review author (NEO) 
assessed relevant studies and we made a majority decision. Trials were not anonymised prior to assessment. 
We obtained potentially relevant studies identified in the first round of screening in full text and independently 
assessed these for inclusion using the same process outlined above. We did not apply any language 
restrictions.
Physiotherapy for pain and disability in adults with complex regional pain syndrome...26-Feb-2016
Review Manager 5.2 9
Data extraction and management
Two review authors (KMS and BMW) independently extracted data from all included trials. We extracted data 
using a standardised and piloted form. We resolved any discrepancies and disagreements by consensus. In 
cases where we could not achieve consensus, a third review author (NEO) assessed the trial and we took a 
majority decision. We extracted the following data from each included trial:
1. country of origin;
2. study design;
3. study population (including diagnosis, diagnostic criteria used, symptom duration, age range, gender 
split);
4. type of noxious initiating event: surgery, fracture, crush injury, projectile, stab injury, other or no event;
5. type of tissue injured: nerve, soft tissue, bone;
6. presence of medicolegal factors (that may influence the experience of pain and the outcomes of 
therapeutic interventions);
7. concomitant treatments that may affect outcome: medication, procedures etc.;
8. sample size: active and control/comparator groups;
9. intervention (including type, parameters (e.g. frequency, dose, duration), setting and professional 
discipline of the clinician delivering the therapy);
10. type of placebo/comparator intervention;
11. outcomes (primary and secondary) and time points assessed;
12. adverse effects;
13. author conflict of interest statements;
14. assessment of risk of bias.
Assessment of risk of bias in included studies
We assessed the overall risk of bias for each included trial on the basis of an evaluation of key domains using 
a modified version of the Cochrane 'Risk of bias' assessment tool. We classified risk of bias as either 'low' (low 
risk of bias for all key domains), 'unclear' (unclear risk of bias for one or more key domains) or 'high' (high risk 
of bias for one or more key domains), as outlined in the Cochrane Handbook for Systematic Reviews of 
Interventions (Higgins 2011a). We also considered experimental design-specific (e.g. cross-over study 
designs) 'Risk of bias' issues where appropriate (Higgins 2011b). We assessed the following key domains of 
risks of bias for each included trial using either 'yes', 'no' or 'unclear' judgements:
1. random sequence generation (checking for possible selection bias). We assessed the method used to 
generate the allocation sequence as either: low risk of bias (any truly random process, e.g. random 
number table; computer random number generator); unclear risk of bias (method used to generate 
sequence not clearly stated); or high risk of bias (studies using a quasi/non-random process (e.g. odd or 
even date of birth; hospital or clinic record number);
2. allocation concealment (checking for possible selection bias). The method used to conceal allocation to 
group prior to assignment determines whether intervention allocation could have been foreseen in 
advance of, or during recruitment, or changed after assignment. We assessed the methods used as: low 
risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); 
unclear risk of bias (method not clearly stated); or high risk of bias (studies that do not conceal allocation 
(e.g. open list));
3. blinding of study participants and personnel (checking for possible performance bias). We assessed the 
methods used to blind participants and care providers as either: low risk of bias (participants and care 
providers blinded to allocated intervention and unlikely that blinding broken; or no/incomplete blinding but 
judged that both intervention arms reflect active interventions of relatively equal credibility delivered with 
equal enthusiasm); unclear risk of bias (insufficient information provided to permit a judgement of 
low/high risk of bias); or high risk of bias (participants and care providers not blinded to the allocated 
intervention and interventions are clearly identifiable as control and experimental; or participants and care 
Physiotherapy for pain and disability in adults with complex regional pain syndrome...26-Feb-2016
Review Manager 5.2 10
providers blinded to the allocated intervention but likely that blinding was broken);
4. blinding of outcome assessment (self reported outcomes) (checking for possible detection bias). We 
assessed the methods used to blind study participants self-reporting outcomes (e.g. pain severity) from 
knowledge of which intervention a participant received. We assessed the methods as either: low risk of 
bias (participants blinded to allocated intervention and unlikely that blinding broken; or no/incomplete 
blinding but judged that both intervention arms reflect active interventions of relatively equal credibility 
delivered with equal enthusiasm); unclear risk of bias (insufficient information provided to permit a 
judgement of low/high risk of bias); or high risk of bias (participants not blinded to the allocated 
intervention and interventions are clearly identifiable as control and experimental; or participants blinded 
to the allocated intervention but likely that blinding was broken);
5. blinding of outcome assessment (investigator-administered outcomes) (checking for possible detection 
bias). We assessed the methods used to blind researchers undertaking outcome assessments (e.g. 
functional testing protocols) from knowledge of which intervention a participant received. We assessed 
the methods as at either: low risk of bias (researchers blinded to allocated intervention and unlikely that 
blinding broken); unclear risk of bias (insufficient information provided to permit a judgement of low/high 
risk of bias); high risk of bias (researchers not blinded to the allocated intervention; or researcher blinded 
to the allocated intervention but likely that blinding was broken);
6. incomplete outcome data (drop out) (checking for possible attrition bias). We first assessed for risk of 
attrition bias by evaluating participant drop out rates according to judgements based on the following 
criteria: low risk of bias (less than 20% drop out and appears not to be systematic, with numbers for each 
group and reasons for drop out reported); unclear risk of bias (less than 20% drop out but appears to be 
systematic or numbers per group and reasons for drop out not reported); high risk of bias (greater than or 
equal to 20% drop out);
7. incomplete outcome data (method of analysis) (participants analysed in the group to which they were 
allocated) (checking for possible attrition bias). We further assessed for risk of attrition bias by separately 
evaluating the appropriateness of the method of analysis employed, using the following criteria: low risk 
of bias (participants analysed in the group to which they were allocated (intention-to-treat (ITT) or as an 
available case analysis); unclear risk of bias (insufficient information provided to determine if analysis 
was based on the principle of ITT or per protocol); or high risk of bias (if per protocol analysis used or 
where available data is not analysed or participant s data were included in group to which they were not 
originally assigned to);
8. selective reporting (checking for possible reporting bias). We assessed studies for selective outcome 
reporting using the following judgements: low risk of bias (study protocol available and all pre-specified 
primary outcomes of interest adequately reported or study protocol not available but all expected primary 
outcomes of interest adequately reported or all primary outcomes numerically reported with point 
estimates and measures of variance for all time points); unclear risk of bias (insufficient information 
provided to permit a judgement of low/high risk of bias); or high risk of bias (incomplete reporting of 
pre-specified primary outcomes or point estimates and measures of variance for one or more primary 
outcome not reported numerically (e.g. graphically only) or one or more primary outcomes reported using 
measurements, analysis methods or subsets of data that were not pre-specified or one or more reported 
primary outcomes were not pre-specified or results for a primary outcome expected to have been 
reported were excluded);
9. other bias. We assessed studies for other potential sources of bias. We determined judgements 
regarding low/unclear/high risk of bias according to the potential confounding influence of identified 
factors, for example: low risk of bias (appears free of other potentially serious sources of bias e.g. no 
serious study protocol violations identified); unclear risk of bias (other sources of bias may be present but 
there is either insufficient information to assess whether an important risk of bias exists or insufficient 
rationale or evidence regarding whether an identified problem will introduce bias); or high risk of bias 
(results may have been confounded by at least one potentially serious risk of bias, e.g. a significant 
baseline imbalance between groups; a serious protocol violation; use of 'last observation carried forward' 
when dealing with missing data).
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We also evaluated included trials for the additional sources of bias associated with:
1. sample size; and
2. duration of follow-up, as recommended by Moore 2010.
Small studies are more prone to bias because of their inherent imprecision and due to the effects of publication 
biases (Dechartres 2013; Moore 2012; Nüesch 2010). Inadequate length of follow-up may produce an overly 
positive view of the true clinical effectiveness of interventions, particularly in persistent conditions (Moore 
2010). These additional criteria were not considered 'key domains' and therefore did not inform judgements of 
a trial's overall risk of bias. We assessed these trials according to the following criteria:
1. sample size (checking for possible biases confounded by small sample size): we assessed trials as being 
at low risk of bias (greater than or equal to 200 participants per treatment arm); unclear risk of bias (50 to 
199 participants per treatment arm); high risk of bias (less than 50 participants per treatment arm);
2. duration of follow-up (checking for possible biases confounded by a short duration of follow-up): we 
assessed trials as being at low risk of bias (follow-up of greater than or equal to eight weeks); unclear risk 
of bias (follow-up of two to seven weeks); or high risk of bias (follow-up of less than two weeks).
Two review authors (KMS and BMW) independently undertook the 'Risk of bias' assessments, and resolved 
any disagreements by discussion. If they could not reach an agreement, a third review author (NEO) 
undertook a 'Risk of bias' assessment and we took a majority decision.
Measures of treatment effect
We presented treatment effect sizes using appropriate metrics. We calculated the risk ratio (RR) with 95% 
confidence intervals (CIs) for dichotomised outcome measures, and the number needed to treat (NNT) as an 
absolute measure of treatment effect where possible.
We expressed the size of treatment effect on pain intensity, as measured with a VAS or NRS, using the mean 
difference (MD) (where all studies utilised the same measurement scale) or the standardised mean difference 
(SMD) (where studies used different scales). In order to aid interpretation of the pooled effect size we planned 
to back-transform the SMD value to a 0 to 100 mm VAS format on the basis of the mean standard deviation 
(SD) from trials using a 0 to 100 mm VAS where possible.
We analysed the data using Review Manager (RevMan) (RevMan 2014). We plotted the results of each RCT 
with available data as point estimates with corresponding 95% CIs and displayed them using forest plots. If 
included trials demonstrated clinical homogeneity we performed a meta-analysis to quantify the pooled 
treatment effect sizes using a random-effects model. We did not perform a meta-analysis when clinical 
heterogeneity was present. Similarly we presented secondary outcomes, though we did not consider them for 
meta-analysis.
Unit of analysis issues
All included trials randomised participants at the individual participant level. We planned to meta-analyse 
estimates of treatment effect (and their standard errors (SE)) from cluster-RCTs employing appropriate 
statistical analyses using the generic inverse-variance method in RevMan (RevMan 
2014), as suggested in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011b). 
Where we considered such trials to have employed inappropriate analyses, we planned to utilise methods for 
'approximately correct analysis' where possible (Higgins 2011b). In addition, we planned to enter cross-over 
trials into a meta-analysis when it was clear that data were free from carry-over effects, and to combine the 
results of cross-over trials with those of parallel trials by imputing the post-treatment between-condition 
correlation coefficient from an included trial that presented individual participant data and use this to calculate 
the SE of the SMD. These data may be entered into a meta-analysis using the generic inverse-variance 
method (Higgins 2011b). Issues concerning cluster-RCTs and crossover trials did not arise as we did not 
identify any cluster-RCTs that met the inclusion criteria of this review and we did not conduct any quantitative 
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analyses on the one included crossover trial. We may include such analyses where relevant data are available 
in future updates of this Cochrane review.
Dealing with missing data
We attempted to contact the authors of included trials when numerical data were unreported or incomplete. If 
trial authors only presented data in graphical form, we did not attempt to extract the data from the figures. If SD 
values were missing from follow-up assessments but were available at baseline, we used these values as 
estimates of variance in the follow-up analyses.
Assessment of heterogeneity
We evaluated the included trials for clinical homogeneity regarding study population, treatment procedure, 
control intervention, timing of follow-up and outcome measurement. For trials that were sufficiently clinically 
homogenous to pool, we formally explored heterogeneity using the Chi² test to investigate the statistical 
significance of any heterogeneity, and the l² statistic to estimate the amount of heterogeneity. Where 
significant heterogeneity (P value < 0.1) was present, we planned to explore subgroup analyses (see the 
'Differences between protocol and review' section).
Assessment of reporting biases
We planned to test for the possible influence of publication bias on trials that utilised dichotomised outcomes 
by estimating the number of participants in trials with zero effect required to change the NNT to an 
unacceptably high level (defined as an NNT of 10), as outlined by Moore 2008. An absence of relevant data 
meant that we did not undertake any analyses. Instead, we considered the possible influence of small 
study/publication biases on review findings as part of our 'Risk of bias' assessment (see the 'Assessment of 
risk of bias in included studies' section) and as part of our Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) assessments (Guyatt 2011a) of the quality of evidence (see the 'Data 
synthesis' section). We may include such analyses in future updates of this Cochrane review where relevant 
data are available.
Data synthesis
Where possible, we grouped extracted data according to diagnosis (CRPS types I or II, or mixed), intervention, 
outcome (i.e. pain, disability) and duration of follow-up (short-term: zero to less than two weeks 
postintervention; mid-term: two to seven weeks postintervention; and long-term: eight or more weeks 
postintervention). Regarding intervention, we planned to pool data from trials that investigated the same single 
therapy separately for each therapy. We planned to pool trials of multimodal physiotherapy programmes 
together.
For all analyses, we report the outcome of the 'Risk of bias' assessments. Where we found inadequate data to 
support statistical pooling, we performed a narrative synthesis of the evidence. We were only able to combine 
trials through meta-analysis for one type of intervention (graded motor imagery (GMI)) because of insufficient 
data and clinical heterogeneity. We conducted a qualitative analysis of all trial findings and used the GRADE 
approach to assess the quality of evidence (Guyatt 2011a; Guyatt 2011b).
To ensure consistency of GRADE judgements we applied the following criteria to each domain equally for all 
key comparisons of the primary outcome:
1. limitations of studies: we downgraded once if more than 25% of the participants were from trials we 
classified as being at high risk of bias;
2. inconsistency: we downgraded once if heterogeneity was statistically significant and the I² statistic value 
was greater than 40%. When a meta-analysis was not performed we downgraded once if the trials did not 
show effects in the same direction;
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3. indirectness: we downgraded once if more than 50% of the participants were outside the target group;
4. imprecision: we downgraded once if there were fewer than 400 participants for continuous data and fewer 
than 300 events for dichotomous data;
5. publication bias: we downgraded once where there was direct evidence of publication bias or if estimates 
of effect based on small scale, industry sponsored studies raised a high index of suspicion of publication 
bias.
Two review authors (KS and NO) made the judgement of whether these factors were present or not. We 
considered single trials to be inconsistent and imprecise, unless more than 400 participants were randomised 
for continuous outcomes or more than 300 for dichotomous outcomes. We applied the following definitions of 
the quality of the evidence (Balshem 2011):
1. high quality: we are very confident that the true effect lies close to that of the estimate of the effect;
2. moderate quality: we are moderately confident in the effect estimate. The true effect is likely to be close 
to the estimate of the effect, but there is a possibility that it is substantially different;
3. low quality: our confidence in the effect estimate is limited. The true effect may be substantially different 
from the estimate of the effect;
4. very low quality: we have very little confidence in the effect estimate. The true effect is likely to be 
substantially different from the estimate of effect.
Subgroup analysis and investigation of heterogeneity
We planned to perform subgroup analyses based on the type of CRPS (i.e. I, II or mixed) and its temporal 
characteristics (i.e. acute (defined as symptoms and signs of CRPS of zero to 12 weeks duration) and chronic 
(symptoms and signs of CRPS lasting 13 weeks). However, we did not undertake them due to the insufficient 
number of included trials.
Sensitivity analysis
We planned to perform sensitivity analyses on risk of bias (investigating the influence of excluding studies 
classified at high risk of bias) and choice of meta-analysis model (investigating the influence of using a 
fixed-effect analysis). We did not perform them as insufficient data were available (see the 'Differences 
between protocol and review' section).
Results
Description of studies
See the 'Characteristics of included studies' and 'Characteristics of excluded studies' sections.
Results of the search
We conducted the literature search up to 12 February 2015 and identified 990 papers that comprised original 
research studies, reviews and poster abstracts, of which 744 remained after we removed duplicates. After we 
screened titles and abstracts, we discarded 702 records because they did not meet the inclusion criteria of this 
Cochrane review. We retrieved 42 records for full-text screening. We deemed 21 trial reports from 18 original 
trials for inclusion (Askin 2014; Aydemir 2006; Cacchio 2009a; Cacchio 2009b; Dimitrijevic 2014; Duman 
2009; Durmus 2004; Hazneci 2005; Jeon 2014; Li 2012; Moseley 2004; Moseley 2005; Moseley 2006; 
Moseley 2009; Mucha 1992; Oerlemans 1999; Schreuders 2014; Severens 1999; Uher 2000). Four published 
trial manuscripts reported data pertaining to a single included trial (Oerlemans 1999).
One additional trial is awaiting submission for publication (ISRCTN39729827), one trial is available only as a 
conference abstract (Mete-Topcuoglu 2010) and we were unable to contact the authors of one registered trial 
(NCT00625976). These three trials are awaiting classification (see the 'Characteristics of studies awaiting 
classification' table).
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In addition, we identified five ongoing trials (see the 'Characteristics of ongoing studies' section). We have 
presented a flow diagram outlining the trial screening and selection process (Figure 1). Two review authors 
(KMS and BMW) reported study details in the 'Characteristics of included studies' and 'Risk of bias' tables for 
two papers published in the Turkish language (Aydemir 2006; Hazneci 2005) based on an English translation 
of the original trial report; and one review author (BMW) reported study details in the 'Characteristics of 
included studies' and 'Risk of bias' tables for two papers published in the German language (Mucha 1992; 
Uher 2000).
Included studies
We have provided the details of all included trials in the 'Characteristics of included studies' tables. We 
extracted relevant data from eight included trials (Askin 2014; Aydemir 2006; Cacchio 2009a; Dimitrijevic 
2014; Duman 2009; Durmus 2004; Hazneci 2005; Li 2012). We contacted or attempted to contact the 
corresponding authors of 10 trials on three occasions in order to obtain missing outcomes data 
(Cacchio 2009b; Jeon 2014; Moseley 2004; Moseley 2005; Moseley 2006; Moseley 2009; Mucha 1992; 
Oerlemans 1999; Schreuders 2014; Uher 2000). One trial author responded and supplied data for an outcome 
measure of 'impairment' but we were unable to extract outcome data linked to 'pain intensity' from the supplied 
data (Oerlemans 1999); one trial author responded stating that they were unable to supply the relevant data 
(Schreuders 2014); and there was no response from the other trial authors we had contacted.
Design
All included trials were RCTs, and 17 essentially used a parallel-group design. Whilst the selected participants 
in three trials crossed over from comparator to intervention groups (Cacchio 2009b; Moseley 2004; 
Mucha 1992), none employed a true randomised crossover design and we analysed them up to the point of 
crossover as parallel group-designs. One trial employed a within-subject randomised crossover design 
(Moseley 2009). Twelve trials included two intervention arms (Cacchio 2009a; Dimitrijevic 2014; Duman 
2009; Durmus 2004; Hazneci 2005; Jeon 2014; Li 2012; Moseley 2004; Moseley 2006; Mucha 1992; 
Schreuders 2014; Uher 2000), five trials included three arms (Askin 2014; Aydemir 2006; Cacchio 2009b; 
Moseley 2005; Oerlemans 1999) and one study used four arms (Moseley 2009). No cluster-RCTs met the 
inclusion criteria of this Cochrane review.
Participants
The 18 trials included a total of 739 participants and the total number of participants per trial ranged from 10 to 
135. All 18 trials included participants with CRPS I using a range of diagnostic criteria, most commonly using 
those of Bruehl 1999. There were no trials that included participants with CRPS II. Fourteen trials included 
participants with CRPS I of the upper limb (Askin 2014; Aydemir 2006; Cacchio 2009a; Cacchio 2009b; 
Duman 2009; Durmus 2004; Hazneci 2005; Li 2012; Moseley 2004; Moseley 2005; Moseley 2009; Mucha 
1992; Oerlemans 1999; Schreuders 2014), two with either upper or lower limb CRPS I (Dimitrijevic 2014; 
Moseley 2006), one with CRPS I of the lower limb (Uher 2000) and one trial included participants with either 
upper, lower, multi-limb or whole body CRPS I (Jeon 2014). Participants developed CRPS I linked to a range 
of aetiologies including onset post fracture, soft-tissue injuries, stroke, surgery, carpal tunnel syndrome as well 
as of idiopathic onset. Participants had acute symptoms (less than or equal to three months) of CRPS I in six 
trials (Cacchio 2009a; Dimitrijevic 2014; Durmus 2004; Hazneci 2005; Li 2012; Mucha 1992), chronic 
symptoms (greater than three months) in seven trials (Duman 2009; Jeon 2014; Moseley 2004; Moseley 
2005; Moseley 2006; Moseley 2009; Schreuders 2014), a mix of acute and chronic symptoms in two trials 
(Askin 2014; Oerlemans 1999), and three trials did not report the duration of symptoms (Aydemir 2006; 
Cacchio 2009b; Uher 2000). Trials were undertaken across a range of geographical locations including: 
Turkey (N = 5); Australia (N = 4); Italy, Germany, the Netherlands (N = 2 each); China, Serbia, and South 
Korea (N = 1 each).
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Interventions
We have provided a detailed description of the interventions delivered in each included trial in the 
'Characteristics of included studies' table. The types of physiotherapy interventions delivered were 
heterogenous across the included trials and included various electrotherapy modalities (ultrasound, TENS, 
laser, interferential therapy, pulsed electromagnetic field therapy), cortically-directed sensory-motor 
rehabilitation strategies (GMI, mirror therapy, virtual body swapping, tactile sensory discrimination training), 
exercise (active, active-assisted, passive, stretching, strengthening, mobilising, functional; supervised and 
unsupervised), manual lymphatic drainage (MLD) and pain management advice. Five trials directly compared 
an active and placebo intervention (Askin 2014; Aydemir 2006; Cacchio 2009a; Cacchio 2009b; Durmus 
2004). Six trials evaluated electrotherapy modalities (Askin 2014; Aydemir 2006; Dimitrijevic 2014; Durmus 
2004; Hazneci 2005; Mucha 1992), eight trials evaluated cortically-directed sensory-motor rehabilitation 
strategies (Cacchio 2009a; Cacchio 2009b; Jeon 2014; Moseley 2004; Moseley 2005; Moseley 2006; 
Moseley 2009; Schreuders 2014), two trials evaluated MLD (Duman 2009; Uher 2000) and two trials 
evaluated general rehabilitation therapies (Li 2012; Oerlemans 1999).
Excluded studies
We have listed the details regarding the 13 trial reports that we excluded in the 'Characteristics of excluded 
studies' table. The main reasons for exclusion were that the studies were either not RCTs (N = 8), investigated 
clinically irrelevant outcome measures (N = 2), tested interventions that fell outside the scope of physiotherapy 
(N = 2) or included participants with mixed aetiologies with only one participant with CRPS I in each of the two 
arms of the trial (N = 1).
Risk of bias in included studies
We presented a summary of the 'Risk of bias' assessments for all included trials in Figure 2 and Figure 3. We 
judged the overall risk of bias as being 'high' for 15 trials (Askin 2014; Cacchio 2009a; Cacchio 2009b; 
Dimitrijevic 2014; Duman 2009; Jeon 2014; Li 2012; Moseley 2004; Moseley 2005; Moseley 2006; Moseley 
2009; Mucha 1992; Oerlemans 1999; Schreuders 2014; Uher 2000) and 'unclear' for three trials 
(Aydemir 2006; Durmus 2004; Hazneci 2005). We did not judge any of the included trials as having an overall 
'low' risk of bias.
Allocation (selection bias)
Only seven out of the 18 trials reported using, or were judged to have used, adequate methods to generate a 
random sequence and conceal allocation (Aydemir 2006; Dimitrijevic 2014; Li 2012; Moseley 2004; Moseley 
2005; Moseley 2006; Schreuders 2014) and as such we judged them as being of 'low' risk of selection bias. 
The risk of selection bias was 'unclear' in 10 trials (Cacchio 2009a; Cacchio 2009b; Duman 2009; 
Durmus 2004; Hazneci 2005; Jeon 2014; Moseley 2009; Mucha 1992; Oerlemans 1999; Uher 2000) where 
the methods used to generate the allocation sequence or where the method of allocation concealment were 
not adequately reported enough in order to allow a judgement of 'high' or 'low' risk of bias. One trial, 
Askin 2014, used a quasi-randomisation method and we judged it as having a 'high' risk of selection bias.
Blinding (performance bias and detection bias)
We judged six trials to have a 'low' risk of performance bias (Askin 2014; Aydemir 2006; Dimitrijevic 2014; 
Durmus 2004; Hazneci 2005; Moseley 2005), where participants were adequately blinded to their intervention 
or where we considered a lack of blinding to have been unlikely to have biased trial outcomes. Eight trials were 
at 'high' risk of performance bias and consequently detection biases because of inadequate or a lack of 
blinding (Duman 2009; Li 2012; Moseley 2004; Moseley 2006; Mucha 1992; Oerlemans 1999; Schreuders 
2014; Uher 2000). We judged three trials, all of which tested the efficacy of electrotherapy-based modalities, 
as at 'low' risk of detection bias because they successfully blinded participants and outcome assessors (Askin 
2014; Aydemir 2006; Durmus 2004).
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Incomplete outcome data (attrition bias)
Twelve trials either had no drop-outs or a drop-out rate of less than 20% and as such we judged them as 
having a 'low' risk of attrition bias secondary to drop-outs (Askin 2014; Cacchio 2009b; Duman 2009; Durmus 
2004; Jeon 2014; Li 2012; Moseley 2004; Moseley 2005; Moseley 2006; Moseley 2009; Mucha 1992; Uher 
2000). In five trials the risk of attrition bias was 'unclear' either because the drop-out rate was not reported 
(Aydemir 2006; Hazneci 2005) or the drop-out rate between groups was unequal and the effect of which was 
uncertain (Cacchio 2009a; Dimitrijevic 2014; Oerlemans 1999). One trial, with an overall drop-out rate of 44%, 
had a 'high' risk of attrition bias (Schreuders 2014). We judged 11 trials (Cacchio 2009a; Cacchio 2009b; 
Duman 2009; Durmus 2004; Jeon 2014; Li 2012; Moseley 2004; Moseley 2006; Moseley 2009; Mucha 1992; 
Oerlemans 1999), two trials (Aydemir 2006; Hazneci 2005) and five trials (Askin 2014; Dimitrijevic 2014; 
Moseley 2005; Schreuders 2014; Uher 2000) respectively as being at 'low', 'unclear' and 'high' risk of attrition 
bias as a consequence of their adopted method of analysis.
Selective reporting (reporting bias)
We judged a total of nine trials as being of 'high' risk of reporting bias; three trials because of inadequate or 
incomplete reporting of primary outcomes, or both (Jeon 2014; Oerlemans 1999; Uher 2000) and six trials 
because the trial authors presented data in graphical format only, i.e. point estimates with measures of 
variation were not reported (Cacchio 2009b; Moseley 2004; Moseley 2005; Moseley 2009; Mucha 1992; 
Schreuders 2014). The other nine trials adequately reported outcome data and we judged them as being at 
'low' risk of reporting bias (Askin 2014; Aydemir 2006; Cacchio 2009a; Dimitrijevic 2014; Duman 2009; 
Durmus 2004; Hazneci 2005; Li 2012; Moseley 2006).
Other potential sources of bias
We considered three trials to be at 'high' risk of other potential sources of bias; one trial because it was 
published as a 'Letter to the Editor' and not as a full trial report (Cacchio 2009b); one trial because violations of 
the random sequence generation were permitted (Oerlemans 1999); and one trial because it did not report the 
baseline data of three participants excluded from the analysis and because of a likely highly significant 
baseline imbalance in duration of symptoms between groups (Schreuders 2014). The 15 other trials appeared 
to be free of other potential sources of bias.
Sample size
None of the included trials had intervention arms with 200 or more participants per treatment arm. One trial 
randomised 60 participants to each trial arm and we judged it as being at 'unclear' risk of bias (Li 2012). The 
remaining 17 trials had less than 50 participants per trial arm and we judged them as being at 'high' risk of bias 
based on this criterion.
Duration of follow-up
Nine trials employed a follow-up period of less than two weeks and we judged them as being at 'high' risk of 
bias based on this criterion (Askin 2014; Cacchio 2009b; Dimitrijevic 2014; Durmus 2004; Hazneci 2005; Jeon 
2014; Moseley 2009; Mucha 1992; Uher 2000). Six trials employed a follow-up period of eight or more weeks 
and we judged them as being at 'low' risk of bias (Cacchio 2009a; Duman 2009; Li 2012; Moseley 2005; 
Moseley 2006; Oerlemans 1999). Three trials reported a follow-up period of two to seven weeks and we 
judged them as being at 'unclear' risk of bias (Aydemir 2006; Moseley 2004; Schreuders 2014).
Effects of interventions
Multimodal physiotherapy
One three-arm trial, Oerlemans 1999, (135 participants), which we judged as being at 'high' risk of bias based 
on a number of criteria, compared a physiotherapy programme (pain management advice, relaxation 
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exercises, connective tissue massage, TENS and exercise) plus medical treatment according to a fixed 
pre-established protocol, to an occupational therapy (OT) programme (splinting, de-sensitisation, functional 
rehabilitation) plus medical management and to a control intervention, described as 'social work' (SW), 
(attention, advice) plus medical management in participants with CRPS I of the upper limb secondary to mixed 
aetiologies. The trial authors did not adequately report details regarding the nature of the interventions and did 
not standardise the number of treatment sessions given with the intensity and frequency of treatment adjusted 
to the individual needs of participants. The trial authors did not report the overall duration of the treatment 
periods for each trial group.
According to the trial authors, adjuvant physiotherapy, and to a lesser extent, OT were superior to SW for 
reducing pain according to all four measures of pain intensity at three months post-recruitment, and for 
reducing pain from effort of use of the affected extremity at six months. However, there were no significant 
between-group differences for any measure of pain intensity at 12 months follow-up. Numerical data (i.e. group 
means and standard deviations (SD) for each time-point) for the four self-reported measures of pain intensity 
(current pain, pain from effort of use of the affected extremity, least and worst pain experienced in the 
preceding week) were not reported, and the trial authors have not provided these data. Consequently, no 
further analyses of these measures were possible and we could not determine effect sizes.
Physiotherapy demonstrated a small but statistically significant between-group improvement in impairment at 
12 months compared to SW (impairment level sum score, five to 50 scale; mean difference (MD) 3.7, 95% (CI) 
− 7.13 to − 0.27, P = 0.03; but not OT.
The trial authors did not report numerical data from other outcomes of interest, including measures of function 
(Radboud Skills Questionnaire, modified Greentest, Radboud Dexterity Test), HRQoL (Sickness Impact 
Profile) and adverse events although Oerlemans 1999 state that there were no between-group differences in 
function or well-being at 12 months follow-up.
Quality of the evidence
There is very low quality evidence (RCT evidence: high, downgraded once for methodological limitations, once 
for imprecision and once for inconsistency) that physiotherapy plus medical treatment may be more effective at 
reducing pain at short- (three months) but not long-term follow-up (12 months) compared to a control 
intervention of SW and that physiotherapy plus medical treatment may be more effective at reducing 
impairment compared to SW at long-term follow-up in the treatment of CRPS I of the upper limb.
Cortically directed sensory-motor rehabilitation strategies
Graded Motor Imagery
We included four separate trials of GMI, all of which were small trials (13 to 37 participants) judged to be at 
'high' risk of bias. Two trials compared the same GMI protocol to control interventions of standard care 
(Moseley 2004; Moseley 2006); one compared a different GMI protocol plus conventional treatment 
(occupational and therapy physiotherapy) to conventional treatment alone (Schreuders 2014); and one 
compared three different GMI protocols to each another (Moseley 2005).
Moseley 2004 (N = 13) compared a six-week GMI programme (consisting of two weeks of limb laterality 
recognition followed by two weeks of imagined movements followed by two weeks of mirror-box therapy) to 12 
weeks of ongoing medical management (predominantly physiotherapy) in participants with longstanding CRPS 
I of the upper limb post wrist fracture. Moseley 2006 compared the same GMI programme to physical therapy 
and usual care in a combined cohort of 14 participants with phantom-limb pain and 37 participants with CRPS I 
of the upper or lower limb of mixed aetiologies. Schreuders 2014 (N = 18) compared a six-week GMI 
programme (consisting of one week of limb laterality recognition, followed by one week of imagined 
movements, followed by four weeks of mirror-box therapy) plus conventional care (physiotherapy and OT) to 
conventional care alone in participants with longstanding CRPS I of the upper limb (aetiology not reported).
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Moseley 2004 reported a statistically significant improvement in pain, as measured by the Neuropathic Pain 
Scale (NPS) at six weeks post-treatment, in participants that received GMI compared to ongoing medical 
management. Moseley 2004 reported a NNT to obtain a 50% reduction in the NPS (total score) of three (95% 
CI 1.4 to 10.1). Moseley 2006 reported statistically significant improvements in pain, as measured by a 0 to 
100 VAS, and function, as measured by an 11-point NRS, immediately postintervention and at six months 
post-treatment for the combined cohort of participants with CRPS I and phantom limb pain. At six weeks 
post-treatment Schreuders 2014 found no statistically significant differences between groups on any measure 
of pain intensity or function. None of these trials reported any data about adverse events and did not measure 
other outcomes of interest, such as composite scoring of symptoms, HRQoL and PGIC.
Moseley 2004, Moseley 2006 and Schreuders 2014 presented data for changes in pain and function in 
participants specifically with CRPS I graphically only and did not report numerical data (i.e. group means and 
SD values at each time-point) for measures of pain intensity or function, or both. However, 0 to 100 VAS pain 
and function data were available from Moseley 2004 and the CRPS I participants in Moseley 2006 from a 
previous overview of systematic reviews of interventions for CRPS (O'Connell 2013). We used these data in 
this Cochrane review with the authors' permission. Pooling of these results gave an effect size (weighted mean 
difference) of − 14.45 (95% CI − 23.02 to − 5.87, P = 0.001, 49 participants, two trials; Analysis 1.1) with no 
significant heterogeneity. We expressed this data as a percentage of the mean baseline pain levels in the 
larger trial (58 out of 100), which equated to a 25% (95% CI 10 to 40) reduction in pain intensity at the end of 
the treatment period. Moseley 2004 presented outcomes at medium-term follow-up (six weeks post-treatment, 
N = 13, MD − 20.00, 95% CI − 7.97 to − 32.13, P = 0.001). This equated to an improvement of 34% (95% CI 14 
to 55) of the baseline VAS pain level in the Moseley 2006 trial (average baseline data for pain VAS was not 
available from the Moseley 2004 trial report). At long-term follow-up (six months post-treatment (N = 36)) in 
Moseley 2006, the MD was − 21.00, 95% CI − 10.83 to − 31.17, P < 0.001, which equates to an improvement 
of 36% (95% CI 19% to 54%). The immediate post-treatment effect was below the threshold for a moderately 
clinically important difference but exceeded the threshold for a minimally clinically important difference. The 
medium- and long-term effects met the threshold for a moderately important benefit. We were unable to obtain 
numerical data from Schreuders 2014.
We pooled the data on function from two trials (Moseley 2004 and Moseley 2006; data on CRPS I participants 
only), which returned a MD of: 1.87 (95% CI 1.03 to 2.71, 49 participants, two trials; P < 0.001; Analysis 1.2) at 
the end of treatment; 2.26 (95% CI 1.42 to 3.10, P < 0.001) at medium-term follow-up (Moseley 2004, N = 13); 
and 2.30 (95% CI 1.12 to 3.48, P < 0.001) at long-term follow-up (Moseley 2006, N = 36). This represented a 
large improvement in function from the baseline function score (0.5) in the control group of the larger trial 
(Moseley 2006).
In a three-arm trial, Moseley 2005 (N = 20) compared a six-week GMI programme with its three components 
delivered in the 'correct  order (i.e. two weeks of laterality recognition followed by two weeks of imagined 
movements followed by two weeks of mirror-box therapy) to two other GMI programmes with selected 
components delivered in different orders at odds with its hypothesised mechanism of action, in participants 
with longstanding CRPS I of the upper limb post wrist fracture. We found statistically significant improvements 
in pain and function in the correctly ordered GMI group compared to both comparison groups, as measured by 
the NPS and an 11-point NRS respectively at 12 weeks post-treatment. Moseley 2005 reported that at 
12-week follow-up, the mean reduction in NPS score for the correctly ordered GMI group was approximately 
seven and 18 points greater than the mean reductions in the other two groups respectively. The trial did not 
report numerical data for measures of pain intensity and function, and we have been unable to obtain these 
data from the trial author. Consequently we were unable to perform any further analyses of these measures 
and we could not determine the effect sizes. The trial did not report any data concerning adverse events and 
did not measure other outcomes of interest, such as composite scoring of symptoms, HRQoL and PGIC.
Quality of the evidence
There is very low quality evidence (RCT evidence: high, downgraded once for methodological limitations, once 
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for imprecision and once for inconsistency) that GMI plus medical management may be more effective at 
reducing pain and improving function than conventional physiotherapy plus medical management in the 
treatment of CRPS I of the upper limb. There is very low quality evidence (RCT evidence: high, downgraded 
once for methodological limitations, once for imprecision and once for inconsistency) that appropriately 
ordered GMI was more effective at reducing pain and improving function than inappropriately ordered GMI.
Mirror therapy
We included two trials of mirror therapy (Cacchio 2009a; Cacchio 2009b). Cacchio 2009a (N = 48) compared 
four weeks of mirror therapy plus conventional stroke rehabilitation to placebo mirror therapy (covered mirror) 
plus conventional stroke rehabilitation in participants with CRPS I of the upper limb post-stroke. In a trial 
judged to be at 'unclear' risk of bias, Cacchio 2009a reported statistically significant improvements in pain and 
function, at all post-treatment time-points, in the mirror therapy group compared to the placebo group. 
Specifically, Cacchio 2009a reported a mean between-group difference following treatment in pain at rest (0 to 
10 VAS) of − 2.9 (95% CI − 4.23 to − 1.57, P < 0.001) and in pain on movement (shoulder flexion) of − 3.10 
(95% CI − 4.28 to − 1.92, P < 0.001). At six-month follow-up the differences were still present, − 3.4 (95% CI 
− 4.71 to − 2.09, P < 0.001) for pain at rest, and − 3.8 (95% CI − 4.96 to − 2.64, P < 0.001) for pain on 
movement. The post-treatment and six-months follow-up mean differences for pain at rest equated to a 38% 
(95% CI 21 to 56%) and 45% (95% CI 28 to 62%) reduction in the average baseline pain level respectively, 
whist the post-treatment and six-months follow-up mean differences for pain on movement equated to a 36% 
(95% CI 23 to 50%) and 45% (95% CI 31 to 58%) reduction in the average baseline pain level respectively, 
consistent with a moderately important benefit.
Regarding disability, Cacchio 2009a also reported significant mean between-group differences in functional 
limitation, as measured by the functional ability subscale of the Wolf Motor Function Test (WMFT, zero to five 
score range) of − 1.9 (95% CI − 2.36 to − 1.44, P < 0.001) at the end of treatment and of − 2.3 (95% CI − 2.88 
to − 1.72, P < 0.001) at six-months follow-up.
In a separate three-arm trial, judged to be at 'high' risk of bias, Cacchio 2009b (N = 24) compared four weeks 
of mirror therapy to either placebo mirror therapy (covered mirror) or mental imagery training in participants 
with CRPS I of the upper limb post stroke. Cacchio 2009b reported that seven out of eight participants in the 
mirror therapy group reported reduced pain (median change in zero to 100 VAS of − 51 mm, range − 70 to 
− 18) compared with one of eight participants in the covered mirror therapy group and two of eight participants 
in the mental imagery group; the median change was not reported for either the covered mirror or mental 
imagery groups. At the end of the treatment period, pain scores were significantly lower in the mirror therapy 
group compared to the other two groups. However, the trial authors did not report any further between-group 
data and we have been unable to obtain these data from the trial authors. Consequently we were unable to 
perform any further analyses of these measures and we could not determine the effect size. The trial authors 
did not report data from other outcomes of interest, including measures of function and adverse events, while 
they did not measure outcomes, such as composite scoring of symptoms, HRQoL and PGIC.
Quality of the evidence
There was very low quality evidence (RCT evidence: high, downgraded once for methodological limitations, 
once for imprecision, once for indirectness) that mirror therapy reduced pain and improved upper limb function 
in participants with post stroke CRPS I of the upper limb compared with covered mirror therapy.
Virtual body swapping
We included one trial of virtual body swapping with mental rehearsal compared to virtual body swapping alone (
Jeon 2014) (N = 10) in participants with CRPS I of either the upper or lower limbs, multiple limbs or the whole 
body, the aetiology of which was not reported. Participants underwent a single session of their allocated 
intervention with follow-up immediately post-treatment only. Jeon 2014 reported that there was no difference 
between the groups regarding pain intensity, as measured by an 11-point Likert rating scale ranging from zero 
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(no pain) to 10 (severe pain) immediately post-treatment. The trial authors did not report numerical data for 
measures of pain intensity, and we have been unable to obtain these data from the trial authors. As a result, 
we could not conduct any further analyses and we could not determine the effect size. We rated the trial as at 
'unclear' risk of bias for random sequence generation and allocation concealment, and at 'high' risk of bias for 
selective outcome reporting. The trial authors did not report any data concerning adverse events and did not 
measure other outcomes of interest, such as measures of function, composite scoring of symptoms, HRQoL 
and PGIC.
Quality of the evidence
There was very low quality evidence (RCT evidence: high, downgraded once for methodological limitations, 
once for imprecision and once for inconsistency) that virtual body swapping with mental rehearsal does not 
reduce pain in people with CRPS I in the short-term.
Tactile discrimination training
We included one trial, Moseley 2009, that compared four tactile discrimination training (TDT) protocols with 
one another (N = 10) in participants with CRPS I of the upper limb from mixed aetiologies. Moseley 2009 
reported no significant differences in self-reported pain intensity (0 to 100 VAS) at two day follow-up. The trial 
authors did not report numerical data for measures of pain intensity, and they have not supplied us with these 
data. Thus we were unable to perform any further analyses and we could not determine the effect size. We 
rated the trial at 'high' risk of bias for selective outcome reporting, sample size and duration of follow-up. 
Regarding adverse events, three participants reported that the pressure stimuli associated with the TDT 
occasionally hurt but that this was not enough to necessitate modification or cessation of the TDT training. The 
trial authors did not measure other outcomes of interest, such as function, composite scoring of symptoms, 
HRQoL and PGIC.
Quality of the evidence
There was very low quality evidence (RCT evidence: high, downgraded once for methodological limitations, 
once for imprecision and once for inconsistency) that TDT does not reduce the pain associated with CRPS I at 
short-term follow-up.
Electrotherapy interventions
Ultrasound of the stellate ganglion versus placebo
Two trials, Askin 2014 and Aydemir 2006, investigated the effectiveness of applying ultrasound directed to the 
stellate ganglion versus placebo. Both trials were small, with fewer than 50 participants, and were at 'high' or 
'unclear' risk of bias based on a number of criteria. Askin 2014 (N = 45) compared two doses (3.0 watts and 
0.5 watts intensity) of high frequency ultrasound to placebo ultrasound. All trial groups also received 
multimodal conventional treatment that included a course of medication (including vitamin C, gabapentin and 
prednisolone) and physiotherapy (including TENS, contrast baths, active and passive range of motion 
exercises and stretching, resistance and mirror box exercises). The participants received treatments daily for 
20 days. Aydemir 2006 (N = 25) compared stellate ganglion block with ultrasound to blocks with lidocaine and 
placebo conditions for both interventions. All trial groups received exercises, TENS, contrast baths, 
compression and oral paracetamol. While only one trial, Aydemir 2006, provided data in an extractable format 
for meta-analysis, both trials demonstrated no statistically significant difference of ultrasound over placebo for 
pain. Regarding assessment of function, Askin 2014 used the DASH score to measure function. While Askin 
2014 did not present data in a format extractable for meta-analysis, they reported no statistically significant 
effect of ultrasound. Aydemir 2006 measured hand function using a Functional Hand Scale (0 to 19 scale, with 
lower scores indicating better function) and reported statistically significant improvements in all three trial 
groups post-treatment and at one month follow-up. According to our analyses there were significantly greater 
improvements in the placebo group post-treatment (MD 7.86, 95% CI 1.93 to 13.79, P = 0.009) and at one 
month follow-up (MD 6.79, 95% CI 0.85 to 12.73, P = 0.02). The trial authors did not present any data 
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concerning adverse events and did not measure other outcomes of interest, such as composite scoring of 
symptoms, HRQoL and PGIC.
Quality of the evidence
There is low quality evidence (RCT evidence: downgrade once for methodological limitations and once for 
imprecision) that stellate ganglion block via ultrasound is not effective for the treatment of pain or loss of hand 
function in people with CRPS I.
Ultrasound of the stellate ganglion versus TENS.
One trial with 30 participants compared ultrasound of the stellate ganglion to TENS in military recruits with 
acute (mean duration of symptoms: 44 days) CRPS I of the upper limb secondary to mixed aetiologies 
(Hazneci 2005). Both groups also received contrast baths and physiotherapist prescribed exercises. In this 
trial the ultrasound group demonstrated inferior post-treatment pain scores (0 to 10 VAS; MD 2.13, 95% CI 
1.47 to 2.79, P < 0.001) which equates to a potentially clinically important difference of 27% (95% CI 19 to 36) 
of the average baseline pain score. The trial authors measured pain severity at the end of the three-week 
intervention period only without longer-term follow-up. We rated the trial at 'unclear' risk of bias for random 
sequence generation and allocation concealment. They did not report any data concerning adverse events and 
did not measure other outcomes of interest, such as function, composite scoring of symptoms, HRQoL and 
PGIC.
Quality of the evidence
There is low quality evidence (RCT evidence: high, downgraded once for imprecision and once for 
inconsistency) that ultrasound to the stellate ganglion is inferior to TENS for the treatment of pain in people 
with CRPS I in the short-term.
Pulsed electromagnetic field therapy
One trial with 40 participants, Durmus 2004, compared pulsed electromagnetic field (PEMF) treatment (100 
Gauss, 50 Hz, five times weekly for six weeks) plus calcitonin and a stretching exercise routine to placebo 
EMF plus calcitonin and stretching in participants with acute (mean duration of symptoms: 52 days) CRPS I of 
the upper limb following Colles fracture. At the end of treatment, Durmus 2004 found no statistically significant 
between-group difference in pain at rest (VAS), pain on activity, or range of motion. We rated the trial at 'high' 
risk of bias for study size and duration of follow-up and at 'unclear' risk of bias for allocation concealment. The 
trial authors did not report any data concerning adverse events and did not measure other outcomes of 
interest, such as function, composite scoring of symptoms, HRQoL and PGIC.
Quality of the evidence
There is low quality evidence (RCT evidence: high, downgraded once for imprecision and once for 
inconsistency) that PEMF is not superior to placebo for the treatment of pain or range of motion in people with 
CRPS I.
Laser therapy versus Interferential therapy
One trial with 50 participants compared 20 sessions of low-level laser therapy with interferential current 
therapy in participants with post-traumatic CRPS I of the upper or lower limb (Dimitrijevic 2014). Both trial 
groups also received kinesitherapy that consisted of individualised active and active assisted exercises, strictly 
dosed up to pain threshold. We rated the trial at 'high' risk of bias for incomplete outcome data, trial size and 
duration of follow-up. Post-therapy the results demonstrated a statistically significant between-group mean 
difference for pain at rest (0 to 100 VAS) of − 8.6 (95% CI − 16.27 to − 0.93, P = 0.03) in favour of laser 
therapy. This equates to a difference of 14% (95% CI 1.5 to 26) from the mean baseline pain score of the two 
groups, which falls below our criteria for a minimal clinically important difference. There was no statistically 
significant post-treatment between-group difference with respect to pain with movement of the affected wrist or 
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ankle according to our analysis (P = 0.07). The trial authors reported that there were no negative effects of 
therapy recorded. The trial authors did not measure other outcomes of interest, such as function, composite 
scoring of symptoms, HRQoL and PGIC.
Quality of the evidence
There is very low quality evidence (RCT evidence: high, downgraded once for methodological limitations, once 
for imprecision and once for inconsistency) that low level laser therapy does not result in a clinically important 
reduction in pain when compared to interferential therapy when added to exercise therapy.
CO2 Bath therapy
One trial, Mucha 1992, with 40 participants compared carbon dioxide (CO2) baths in addition to exercise 
therapy with exercise therapy alone in participants with post-traumatic CRPS I of the hand. Neither intervention 
is clearly described in the paper though the baths were administered in 12-minute sessions five times a week 
for four weeks. Mucha 1992 reported that there was a statistically significant between-group difference in pain 
at rest, pain with movement and night pain in favour of the CO2 bath group. The trial authors did not report 
numerical data, and we have been unable to obtain these data from the trial authors. Consequently, we were 
unable to perform any further analyses of these measures and could not determine an effect size. We rated 
the study at 'high' risk of bias on five separate criteria. The trial authors did not report any data concerning 
adverse events and did not measure other outcomes of interest, such as function, composite scoring of 
symptoms, HRQoL and PGIC.
Quality of the evidence
There is very low quality evidence (RCT evidence: high, downgraded once for methodological limitations, once 
for imprecision and once for inconsistency) that CO2 baths combined with exercise therapy are more effective 
for relieving the pain associated with CRPS I than exercise alone.
Electro-acupuncture and massage versus rehabilitation
One trial, Li 2012, with 120 participants compared 30 sessions of electro-acupuncture combined with upper 
limb massage therapy to 30 sessions of rehabilitation in participants with post stroke shoulder-hand syndrome. 
Rehabilitation consisted of active-assisted scapular movements, Bobath exercises to clench the fist, functional 
transfer training and proprioceptive neuromuscular facilitation (PNF) exercise. It is unclear if the primary aim of 
the rehabilitation offered was to manage the shoulder-hand syndrome explicitly or if it was a general 
rehabilitation programme aimed at addressing the motor impairments related to the stroke. This trial measured 
pain in the shoulder when it was taken passively to 90° of elevation but did not include any other measure of 
upper limb or hand pain. We rated the trial at 'high' risk of bias for blinding of participants and at 'unclear' risk 
of bias for sample size. Li 2012 reported greater reductions on the outcome pain (in the shoulder when taken 
passively to 90º) in favour of the electro-acupuncture and massage group at the end of the six-week treatment 
period (MD − 1.70, 95% CI − 2.09 to − 1.31, P = 0.01) which were sustained at 12-weeks follow-up (MD − 1.40, 
95% CI − 1.78 to − 1.02, P < 0.001). The post-treatment and 12-week follow-up MD values equated to a 21% 
(95% CI 16 to 26%) and 18% (95% CI 13 to 22%) reduction in the average baseline pain level respectively. 
These were below the threshold for a moderately clinically important difference but exceeded the IMMPACT 
threshold (15%) for a minimally important benefit. Li 2012 reported no statistically significant difference in hand 
function between the two trial groups, but a statistically significant difference in upper limb function in favour of 
the electro-acupuncture and massage group at the end of treatment (MD 4.5, 95% CI 0.85 to 8.15, P = 0.05) 
which was no longer significant at 12-weeks follow-up. The trial authors reported that there were no adverse 
reactions to intervention in either trial group. They did not measure other outcomes of interest, such as 
composite scoring of symptoms, HRQoL and PGIC. Notably, we also have some concerns regarding the 
diagnostic equivalence of 'shoulder-hand syndrome' and CRPS I and whether the control intervention was 
directed towards the management of the shoulder-hand syndrome or the upper limb functional stroke problem, 
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both of which may have implications for the generalisability of this trial's findings.
Quality of the evidence
There is very low quality evidence (RCT evidence: high, downgraded once for methodological limitations, once 
for imprecision and once for indirectness) that a course of electro-acupuncture and massage is superior to 
rehabilitation therapy for pain on passive shoulder elevation in participants with post stroke shoulder-hand 
syndrome, but not hand-specific function. Also, the magnitude of effect on pain severity was clinically minimal.
Other interventions
Manual Lymphatic Drainage therapy
Two included trials, Duman 2009 and Uher 2000, investigated the effectiveness of adding MLD therapy to 
rehabilitation. Duman 2009 (N = 34) compared the addition of MLD massage to conventional care 
(nonsteroidal anti-inflammatory drugs and physical therapy) to conventional care alone in participants with 
CRPS I of the upper limb of mixed aetiology. Uher 2000 (N = 40) compared the addition of MLD in addition to 
exercise therapy to exercise therapy alone in participants with CRPS I of the lower limb of mixed aetiology. We 
rated both trials as being at 'high' risk of bias on multiple criteria. We were only able to extract data on relevant 
outcomes from Duman 2009, but both trials demonstrated no statistically significant effect of the addition of 
MLD on pain. The trial authors did not report any data on adverse events and did not measure other outcomes 
of interest, such as function, composite scoring of symptoms, HRQoL and PGIC.
Quality of the evidence
There is low quality evidence (RCT evidence: high, downgraded once for methodological limitations and once 
for imprecision) that the addition of MLD to rehabilitation does not improve pain in people with CRPS I.
Discussion
Summary of main results
Given the paucity of high quality of evidence derived from our analyses of the 18 included randomised 
controlled trials (RCTs) (739 participants), we cannot draw any firm conclusions regarding the effectiveness or 
harmfulness of a broad range of physiotherapy-based interventions for treating the pain and disability 
associated with complex regional pain syndrome (CRPS) I in adults.
The results of one included trial, Oerlemans 1999, provided very low quality evidence that a multimodal 
physiotherapy programme may provide a small, long-term improvement in impairment, as measured by a 
composite scoring method, compared to a minimal intervention of social work , but the magnitude of this effect 
is of questionable clinical significance. We could not determine its effect on a range of pain-related outcomes.
Evidence that supports the use of cortically-directed sensory-motor rehabilitation strategies was mixed. Our 
findings suggest that graded motor imagery (GMI) may provide clinically meaningful medium- and long-term 
improvements in both pain and disability in people with CRPS I, although the results from these trials were 
from very low quality studies and were inconsistent. While our meta-analysis of two trials, Moseley 2004 and 
Moseley 2006, provided evidence of such benefits, we were unable to obtain and include data from one, as yet 
unpublished, clinical trial with contradictory results (Schreuders 2014); these results should therefore be 
treated with caution.
Based on two included trials we found very low quality evidence that mirror therapy provides long-term 
clinically meaningful improvements in pain and function in people with CRPS I following stroke (Cacchio 
2009a; Cacchio 2009b). The effectiveness of mirror therapy in broader participant populations with CRPS I 
(e.g. post-trauma) is unknown. We also found very low quality evidence that the more novel interventions of 
virtual body swapping ± mental rehearsal (Jeon 2014) and tactile discrimination training (TDT) (Moseley 2009) 
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do not provide any short-term benefits for pain in people with CRPS I.
Evidence that supported the use of electrotherapy-based interventions was mixed. There was low to very low 
quality evidence that:
1. stellate ganglion block via ultrasound combined with a conventional treatment programme was not 
superior to placebo ultrasound for pain and hand function at medium-term follow-up (Askin 2014; 
Aydemir 2006);
2. stellate ganglion block via ultrasound combined with contrast baths and exercise was inferior to TENS 
combined with contrast baths and exercise for pain and short-term follow-up (Hazneci 2005);
3. PEMF therapy was not superior to placebo PEMF for pain at short-term follow-up (Durmus 2004);
4. laser therapy combined with exercise may provide a small, probably clinically insignificant, benefit in pain 
compared to interferential current therapy and exercise at short-term follow-up (Dimitrijevic 2014); and
5. CO2 bath therapy combined with exercise may improve pain compared to exercise therapy alone 
although the effect size could not be determined (Mucha 1992) and the interventions were inadequately 
described.
Two RCTs provided low quality evidence that manual lymphatic drainage (MLD) combined with and compared 
to either non-steroidal anti-inflammatories and physical therapy (Duman 2009) or exercise therapy (Uher 
2000) is not beneficial for pain in people with CRPS I.
We found very low quality evidence from one trial, Li 2012, that electro-acupuncture and massage were 
superior to a stroke rehabilitation programme for pain on passive shoulder movement in shoulder-hand 
syndrome post stroke at longer-term follow-up. However, the magnitude of this effect was unlikely to be 
clinically important and both the reliability and validity of the outcome measure used are questionable.
Only two trial reports, one related to laser and interferential therapies, Dimitrijevic 2014, and one to TDT, 
Moseley 2009, commented on the presence or absence of adverse events and reported no serious events.
We did not find any clinical trials that included participants with CRPS II that met the inclusion criteria of this 
Cochrane review.
Overall, we identified a lack of high or moderate quality evidence with which to inform or guide rehabilitation 
practice in people with CRPS I or II. Based on the current body of evidence, we cannot draw any accurate or 
firm conclusions regarding the effectiveness or safety of any of the specific physiotherapy-based interventions 
we identified in this Cochrane review.
Overall completeness and applicability of evidence
The evidence base for the use of physiotherapy interventions in CRPS is incomplete, although this reflects a 
broader problem for all intervention research in CRPS (O'Connell 2013). Most included trials (16/18) used 
established diagnostic criteria to identify participants with CRPS I. However, as might be expected given the 
development history of such criteria in CRPS, there was some variation in the criteria used between included 
trials. Beyond various issues relating to risk of bias and study size (see Quality of the evidence) there are very 
few instances where more than one included trial tested a specific intervention. Two trials, Duman 2009 and 
Hazneci 2005, specifically recruited participants from military populations. As such, it is possible that 
contextual factors specific to that participant group and environment may limit the applicability of those results 
to civilian clinical practice. Eight trials only measured outcomes immediately at the end of treatment with no 
longer-term follow-up. Such trials offer limited information about the genuine clinical utility of interventions for a 
condition that is commonly persistent. The broad heterogeneity of interventions assessed in the included trials 
afforded us limited opportunities to pool data. However, it is possible that advances in meta-analytical statistics 
may permit such analyses in the future (Melendez-Torres 2015).
The aim of this Cochrane review was to investIgate the effectiveness of physiotherapy interventions for people 
with CRPS I or II. We used a deliberately inclusive definition to attempt to include evidence on any intervention 
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that might reasonably be delivered within a physiotherapy context for people with CRPS. As a result the 
included trials varied considerably but most were designed to test the specific effectiveness of individual 
modalities either alone, when added to other treatments or compared to other treatments. While these trials 
offered information about the specific or additional clinical benefits of those modalities, they are less 
informative about the effectiveness of physiotherapy programmes that incorporate multiple treatment 
modalities, but are more likely to reflect physiotherapy as it is delivered in clinical practice. Only one included 
trial, Oerlemans 1999, took the pragmatic approach of testing a multimodal physiotherapy programme against 
a minimal treatment control group. Notably, this trial pre-dates substantial developments in the 
pathophysiological models of CRPS and it is possible that a modern multimodal physiotherapy programme 
might differ substantially. In addition, the included trials rarely reported on adverse events (two out of 18 trials) 
and it is unclear whether or not this represents an absence of adverse events or a failure to report them.
While we categorised these interventions under the label "physiotherapy" in this Cochrane review, we 
recognise that rehabilitation therapies may be delivered by a range of different professionals, including 
occupational therapists and nurses.
Quality of the evidence
As reflected by the Grading of Recommendations Assessment, Development and Evaluation (GRADE) ratings, 
the overall quality of the evidence in this Cochrane review was low or very low. This reflects the fact that most 
included trials were at unclear or high risk of bias for criteria included under the standard domains of the 
Cochrane 'Risk of bias' tool, and under the additional 'Risk of bias' criteria of study size and duration included 
in this review. The included trials studied a broad heterogeneity of interventions, which afforded us limited 
opportunity to pool data and that, coupled with study size, led to issues of imprecision and inconsistency.
It is likely that small study effects, wherein there is a propensity for negative studies to not be published, might 
lead to an overly positive picture for some interventions, particularly in a field with such a limited evidence 
base. Evidence from the wider literature indicates that this might lead to an overly positive picture for some 
interventions (Dechartres 2013; Moore 2012; Nüesch 2010). In a review of meta-analyses, Dechartres 2013 
demonstrated that trials with fewer than 50 participants, which reflects most trials (17/18) included in this 
Cochrane review, returned effect estimates that were on average 48% larger than the largest trials and 23% 
larger than estimates from studies with sample sizes of more than 50 participants. We did not downgrade any 
of the GRADE judgements on the basis of publication bias, as there can be no direct evidence with so few 
trials for any given intervention. Moreover, it is accepted that existing approaches to detecting publication bias 
are unsatisfactory. To an extent our GRADE judgements reflect this risk through the assessment of 
imprecision and the limitations of included trials. Conversely, the issue of small study size with few included 
trials available for any single comparison raises the possibility of false negatives through lack of statistical 
power (Button 2013). Many of the comparisons we included in this review did not demonstrate a statistically 
significant difference. However, it is possible that we may have missed real effects on this basis.
The quality of reporting in many included trials was problematic. There was a lack of detailed descriptions of 
some interventions and a number of included trials did not present key numerical outcome data for all 
time-points (9/18 trials) or insufficiently reported the scoring properties of their outcome measures for pain 
intensity (7/18 trials). The quality of reporting of pain-related outcomes measures in clinical trials and 
observational studies is frequently insufficient (Smith 2015). In a systematic review of the quality of pain 
intensity reporting in three prominent pain journals, Smith 2015 found that nearly one quarter of published 
studies inadequately reported the type of pain intensity measure employed.
Potential biases in the review process
We conducted extensive and sensitive literature searches and included trials regardless of the language of 
publication. As such this Cochrane review probably represents the totality of currently available evidence. The 
choice to use the IMMPACT thresholds to determine the clinical importance of effect sizes is potentially 
controversial. What exactly constitutes an important difference on any given outcome measure remains 
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contentious as the construct of a generic importance thresholds for a variety of interventions fails to reflect that 
patient satisfaction might differ substantially between interventions given their risks, costs and inconvenience, 
the point in the care pathway at which the participant arrives, and a range of other possible factors. Moreover, 
the IMMPACT thresholds are based on estimates of the degree of within-person change from baseline that 
participants might consider to be clinically important, whereas the effect sizes focused on in this review reflect 
the average change between intervention-groups following the interventions. For some pharmacological 
interventions the distribution of participant outcomes is bimodal (Moore 2013; Moore 2014a; Moore 2014b). 
That is, some participants experience a substantial reduction in symptoms, some minimal to no improvement 
and very few experience intermediate (moderate) improvements. In this instance, and if the distribution of 
participant outcomes reflects the distribution of treatment effects, then the average effect may be the effect 
that the fewest participants actually demonstrate (Moore 2013). It is therefore possible that a small average 
between-group effect size might reflect that a proportion of participants responded very well to the intervention 
tested. The common solution to this problem is to conduct a responder analysis , which compares the 
proportion of participants achieving a clinically important improvement from baseline in the treatment and 
control groups. However responder analysis is very rare in rehabilitation therapies and there is no evidence to 
date to establish whether outcomes are commonly bimodal in rehabilitation trials. It therefore remains equally 
possible that a very small average between-group effect might accurately represent the generally very small 
effects of an intervention for most or all individuals.
As such, the between-group change is our sole available estimate of the specific effectiveness of the 
interventions in the included trials. Since the publication of our protocol for this review, Smart 2013, the 
OMERACT 12 group reported recommendations for minimally important difference for pain outcomes (Busse 
2015). The group recommends a threshold of 10 mm on a 0 to 100 VAS as the threshold for minimal 
importance for average between-group change, though stress that this should be interpreted with caution as it 
remains possible that estimates which fall closely below this point may still reflect a treatment that benefits an 
appreciable number of participants. Using this largely more lenient threshold would not alter our conclusions 
regarding clinical importance. The OMERACT thresholds present similar problems to those associated with all 
generic thresholds and it seems likely that the discussion around what constitutes clinical importance will 
continue. Arguably, the thresholds used in this Cochrane review of a 15% or 30% improvement in baseline 
levels of pain that are specifically attributable to the interventions do not represent unreasonably high 
thresholds.
Agreements and disagreements with other studies or reviews
The results of this systematic review are largely consistent with the conclusions drawn in our recent overview 
of systematic reviews of all interventions for CRPS (O'Connell 2013). In O'Connell 2013 we drew our 
conclusions mainly based on two non-Cochrane reviews of physiotherapy interventions for CRPS (Daly 2009; 
Smith 2005) and we based the analysis of the evidence at the level of those included reviews. Our current 
review is more up-to-date, includes a number of additional studies and our conclusions are drawn from direct 
analysis of the original trials. Daly 2009 concluded that there was good to very good quality evidence to 
support the use of GMI for CRPS; and a review by Bowering 2013 (of which review author NEO was a 
co-author) concluded that there was limited evidence to suggest that GMI may be effective for CRPS. In 
O'Connell 2013 we concluded that there was low quality evidence for the effectiveness of GMI. In this 
Cochrane review we downgraded the GRADE rating for the evidence related to GMI to very low, largely due to 
the inconsistency introduced by the inclusion of Schreuders 2014. In Schreuders 2014 the trial authors 
adjusted the treatment schedule compared to the schedules delivered by Moseley 2004 and Moseley 2006, 
though it was based on the same theoretical model. Smith 2005 concluded that there was some evidence that 
exercise, acupuncture, TENS, relaxation techniques, mirror therapy, GMI and combined treatment 
programmes may be helpful and that it was not possible to determine the effectiveness of individual treatments 
for CRPS-I. Ten years on, that picture has not changed substantially. It is possible that future systematic 
reviews may provide further evaluations of the effectiveness of cortically-directed sensory-motor rehabilitation 
strategies (Plumbe 2013).
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Recent clinical guidelines from the USA (Harden 2013) and the UK (Goebel 2012) have placed rehabilitation 
therapies as first-line treatments for people with CRPS. Both guidelines describe and recommend an extensive 
range of possible physiotherapy modalities that might be employed. In making their recommendations, these 
guidelines (unlike this Cochrane review) draw on evidence from non-randomised studies, expert consensus 
and studies of neuropathic pain generally. This Cochrane review highlights the fragility of the evidence 
underpinning these recommendations. The optimal approach to physiotherapy for people with CRPS and the 
true extent of potential benefits and risks remain uncertain. Also, there may be substantial redundancy within 
the broad range of therapies described or recommended in the guidelines.
Authors' conclusions
Implications for practice
It is likely that, in line with contemporary clinical guidelines, physiotherapy and rehabilitation based 
interventions will continue to be first-line treatments for people with complex regional pain syndrome (CRPS). 
In this Cochrane review we have been unable to find compelling evidence of the effectiveness, or lack thereof, 
of physiotherapy interventions, or to inform an optimal approach to therapy, although very low quality evidence 
suggests a possible benefit of multimodal physiotherapy, graded motor imagery (GMI) and mirror therapy. The 
available evidence suggests that applying ultrasound to the stellate ganglion or manual lymphatic drainage 
(MLD) to the affected limb are unlikely to offer clinical benefit to people with CRPS type I.
Implications for research
Overall, given the existing limitations within the current body of evidence, there is a clear need for further 
research into physiotherapy interventions in people with CRPS but many challenges remain in addressing this 
problem. Given the relatively low incidence of CRPS, it is likely to be difficult to recruit adequate numbers of 
participants to clinical trials. It seems likely that the best chance of addressing this challenge is through 
multicentre, collaborative research projects aimed at recruiting participants from potentially larger pools of 
clinical populations. It seems unlikely that it will be possible to generate sufficient evidence to support the 
many individual modalities currently applied to people with CRPS. In this instance there is a case for taking a 
pragmatic approach to developing contemporary multi-modal, individually tailored "best practice" models of 
physiotherapy care and prioritising trials of these programmes against usual or minimal care. Such trials might 
provide pragmatic estimates of effectiveness which best reflect the value of guideline recommended practice. 
Larger replication trials of GMI and mirror therapy would also be useful in order to provide more accurate 
estimates of treatment effect for these interventions, which current evidence suggests may offer meaningful 
clinical benefit. Future trials should use established diagnostic criteria, clearly report the type of CRPS under 
investigation and their design should consider recent recommendations (Busse 2015; Dworkin 2008; Dworkin 
2009; Dworkin 2010; Turk 2008a; Turk 2008b) for the design and reporting of trials in chronic pain. This will 
help to ensure that outcomes, thresholds for clinical importance and study design are optimal and we also 
highlight the need to measure patient-focused outcomes over clinically relevant periods of time. Furthermore, 
future trials should adhere to CONSORT guidance, including that related to the reporting of the development 
and evaluation of complex interventions (Möhler 2015).
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Differences between protocol and review
With respect to Types of interventions, after the publication of Smart 2013 we decided to exclude studies that 
evaluated non-physiotherapy based interventions (e.g. pharmacological) in which all study arms received the 
same physiotherapy intervention (differing only in the application of the non-physiotherapy component) as they 
are unlikely to offer any insight into the value of physiotherapy management. In Smart 2013 we stated our 
intention to search the SciVerse SCOPUS electronic database. However we did not search this database as 
the primary review author (KMS) did not have institutional access. The Trials Search Co-ordinator of the 
Cochrane PaPaS group advised that its omission was unlikely to adversely influence our search results. We 
have described, in additional detail, our operational definitions upon which we based our 'Risk of bias' 
judgements (see the 'Assessment of risk of bias in included studies' section). In this Cochrane review we have 
specified the criteria upon which we based our GRADE judgements for rating the quality of evidence (see the 
'Data synthesis' section).
Published notes
Characteristics of studies
Characteristics of included studies
Askin 2014
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Methods Design: parallel group, 3-arm, single-blind RCT (Turkey; dates not reported).
Setting: outpatient hospital clinic.
Interventions: conventional care plus low dose high frequency ultrasound 
therapy (0.5 watts/cm²) for stellate ganglion blockade or conventional care plus 
low dose high frequency ultrasound therapy (3.0 watts/cm²) for stellate ganglion 
blockade or conventional care plus placebo ultrasound therapy.
Sample size calculation: not reported.
Participants Number of participants: 45 (15 per group).
Type of noxious initiating event: mixed (fracture of the distal radius (n = 17), 
tendon injury (n = 10), hand contusion (n = 5), postsurgery for carpal tunnel 
syndrome (n = 4), fracture of the elbow (n = 2), fracture of the humerus (n = 1), 
fracture of the finger (n = 1)) (upper limb).
Diagnostic criteria: Bruehl 1999 (CRPS I).
Baseline characteristics:
1. conventional care plus low dose high frequency ultrasound therapy (0.5 
watts/cm²) for stellate ganglion blockade:
a. Mean (range) age = 45 (23 to 69) years; female:male = 7:6;
b. Mean (range) duration of CRPS I 57 (38 to 156) days;
2. conventional care plus low dose high frequency ultrasound therapy (3.0 
watts/cm²) for stellate ganglion blockade:
a. Mean (range) age = 46 (23 to 69) years; female:male = 7:6;
b. Mean (range) duration of CRPS I 62 (26 to 161) days;
3. conventional care plus placebo ultrasound therapy
a. Mean (range) age = 44 (22 to 69) years; female:male = 5:9;
b. Mean (range) duration of CRPS I 70.5 (15 to 162) days.
Inclusion criteria:
1. upper limb CRPS I.
Exclusion criteria:
1. peripheral or central nerve lesions;
2. diabetes mellitus;
3. severe heart failure;
4. severe hypertension;
5. cardiac conduct disorders;
6. chronic obstructive pulmonary disease;
7. chronic alcoholism;
8. rheumatologic disease;
9. malignancy;
10. thyroid disease;
11. participants using anticholinergic or antihypertensive medication.
Interventions Participants in all 3 groups received conventional care including:
1. pharmacotherapy (including 500 mg/day vitamin C, Gabapentin (dose: 1800 
mg/day) and Prednisolone (dose: 30 mg/day-2 weeks, stopped within next 2 
weeks));
2. 20 sessions of transcutaneous electrical nerve stimulation ((Enraf Nonius 
brand Endomed 582ID) 100 hertz (Hz) frequency to the painful area of the 
affected extremity once a day, 20 minutes);
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3. contrast bath applications ((Ewac brand device) by immersing the affected 
upper extremity into hot (38°C) water for 4 minutes and then cold water 
(4°C) for 1 minute for a total 20 minutes); and
4. exercise (active, active assistive and passive range of motion exercises to 
the wrist and fingers, stretching exercises, progressive resistance 
exercises, performed as 2 sets of 15 repetitions for each exercise, once per 
day, plus mirror box exercises (details not reported) for 30 minutes).
Conventional care plus low dose high frequency ultrasound therapy (0.5 
watts/cm²) (N = 15)
Components of intervention: using a Enraf Nonius Sonopuls (590 model) 
therapeutic ultrasound of the stellate ganglion was applied by placing the 1 cm² 
ultrasound head at the level of transverse process of the 7th vertebra and 3 cm 
to 4 cm above the sternoclavicular joint, using a 1 MHz frequency and pulsed 
pattern of 1:4.
Dosage: 0.5 watts/cm², for 5 minutes.
Frequency of administration: not reported (5 times per week for 4 weeks (20 
sessions)) (Askin, personal communication).
Provider: not reported.
Conventional care plus low dose high frequency ultrasound therapy (3.0 
watts/cm²) (N = 15)
Components of intervention: ultrasound procedure as described above.
Dosage: 3.0 watts/cm², for 5 minutes.
Frequency of administration: 5 times per week for 4 weeks (20 sessions) .
Provider: not reported.
Conventional care plus placebo ultrasound therapy (N = 15)
Components of intervention: ultrasound procedure as described above, with the 
machine turned off.
Outcomes Time points at which outcomes were measured were not explicitly specified in 
the trial report. Outcomes were assessed at baseline and on completion of the 
intervention period (4 weeks post recruitment) (Askin, personal communication). 
The trial authors did not state any primary outcome.
1. Self-rated pain intensity at rest using a 10 cm VAS (0 = no pain, 10 = 
severe pain);
2. limitation of total finger flexion was assessed by measuring finger pulp-distal 
crease distance using a ruler;
3. grip strength was assessed using a hand dynamometer (average of 3 
measurements in kg);
4. self-reported upper extremity disability was assessed using the Disability of 
the Arm, Shoulder and Hand (DASH) questionnaire (Turkish version), with 
lower scores indicating better function (score range not reported).
Notes Source of funding: not reported.
Statement regarding declarations of interest: none declared.
Risk of bias table
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Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
High risk Quote: "Patients were randomly divided into 3 groups by 
picking cards in different colours. First, three groups of 
cards (each group consisted of 15 cards) in 3 different 
colours (blue for 3 watts/cm2, pink for 0.5 watts/cm2, yellow 
for placebo) were prepared. Participants were asked to 
choose a card before starting the treatment. The US dose 
was determined according to the colour of the selected card 
and it was recorded. The randomisation process was 
performed by another physician".
Comment: the trial authors used a non-random sequence 
generation process.
Allocation concealment (selection 
bias)
Low risk Quote: "The randomisation process was performed by 
another physician".
Comment: the trial authors probably used an acceptable 
method to conceal the allocation sequence.
Blinding of participants and 
personnel (performance bias)
Low risk Quote: "No information was given to patients and to the 
physician who will make assessments and US application 
about the randomisation process until the end of the study".
Comment: the participants were blinded to treatment 
allocation.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
Low risk Quote: "No information was given to patients and to the 
physician who will make assessments and US application 
about the randomisation process until the end of the study".
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Low risk Quote: "No information was given to patients and to the 
physician who will make assessments and US application 
about the randomisation process until the end of the study".
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Low risk Quote: "Thirteen patients from group I, 13 patients from 
group II and 14 patients from group III, a total of 40 patients 
completed the study".
Comment: an overall drop-out rate of 11% is unlikely to 
have biased the results.
Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
High risk Quote: "Two patients from group I, 2 patients from group II 
and 1 patient from group III who did not come to therapy 
sessions regularly were excluded".
Comment: the trial authors excluded 5 participants in 
violation of the ITT principle.
Selective reporting (reporting bias) Low risk Comment: outcome data were fully reported for all 
outcomes reported in the methods section of the publication.
Sample size High risk Quote: "Fourty-five patients with CRPS type I were 
randomly allocated into three groups".
Comment: the small sample size may have introduced bias 
in estimates of treatment effect
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Duration of follow-up High risk Quote: "Before and after the treatment the severity of the 
pain experienced at rest was assessed".
Comment: outcomes were re-measured on completion of 
the intervention period only and were not measured over a 
clinically relevant length of time.
Other bias Low risk Comment: we did not identify any other sources of bias 
were identified.
Aydemir 2006
Methods Design: parallel group, 3-arm double RCT (Turkey; dates not reported).
Setting: Department of Physical Medicine and Rehabilitation Clinic, Gulhane 
Military Medical Academy.
Interventions: stellate ganglion block (SGB) with lidocaine and sham SGB with 
ultrasound (US) or SGB with US and sham SGB with lidocaine or sham SGB 
with lidocaine and sham SGB with US.
Sample size calculation: not reported.
Participants Number of participants: 25 (SGB with lidocaine (N = 9); SGB with US (N = 9); 
sham SGB with lidocaine and sham SGB with US (N = 7)).
Type of noxious initiating event: mixed (trauma n = 12, fracture n = 11, 
idiopathic n = 2) (upper limb).
Diagnostic criteria: Bruehl 1999 (CRPS I).
Baseline characteristics:
1. SGB with lidocaine:
a. Mean (±) age = 21.9 (1.05) years; female:male = not reported 
(assumed to be all males as setting identical to (Hazneci 2005);
b. Mean (SD) duration of CRPS I = not reported;
2. Group receiving SGB with US:
a. Mean (±) age = 21.4 (0.73) years; female:male = not reported 
(assumed to be all males);
b. Mean (SD) duration of CRPS I = not reported;
3. Group receiving sham SGB with lidocaine and US:
a. Mean (±) age = 21.1 (0.38) years; female:male = not reported 
(assumed to be all males);
b. Mean (SD) duration of CRPS I = not reported.
Inclusion criteria:
1. CRPS I.
Exclusion criteria:
1. peripheral or central nervous system lesion affecting the upper limb;
2. participants using anti-hypertensive or anti-cholinergic medications;
3. lidocaine allergy;
4. cardiac arrhthymias;
5. history of stellate ganglion blockade within the last month.
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Interventions Participants in all 3 groups received 21 sessions of exercise (active, active 
assisted, passive exercises for the wrist and fingers, twice daily supervised by 
the same physiotherapist), contrast baths (extremities were put in 38 °C hot 
water, 4 °C cold water for 4 minutes hot and 1 minute cold, 4 minutes cold and 1 
minute hot and 4 minutes cold (total time 14 minutes)), transcutaneous electrical 
nerve stimulation (Enraf Nonius Endomed 582 instrument; for a period of 20 
minutes with a frequency of 100 Hz), external pneumatic compression (involved 
extremity was compressed by a pressure of 50 mmHg for a period of 60 seconds 
and then pressure was released for 20 seconds and this compression and 
release procedure was repeated for 15 minutes, for participants who could not 
tolerate the 50 mmHg pressure a lower level pressure was used) and 
paracetamol (500 mg orally every 4 hours, maximum dosage of 3 g/daily was 
given if it is needed).
Stellate ganglion block with lidocaine (N = 9)
Components of intervention:
1. 10 mL of 1% lidocaine was injected slowly into the stellate ganglion (on the 
line of 6th vertebra, 1.5 cm lateral of the median line, 4 cm to 5 cm under 
the skin);
2. (sham SGB with US) using a Enraf Nonius Sonopuls 590 and with the 
machine turned off the instrument was put on the ganglion for 5 minutes.
Dosage: 10 mL of 1% lidocaine.
Frequency of administration: not reported.
Provider: anaesthetist (other providers not reported).
Stellate ganglion block with ultrasound (N = 9) 
Components of intervention:
1. (sham SGB with lidocaine) 10 mL saline solution was used as placebo and 
injected slowly into the stellate ganglion;
2. SGB with US was applied by using Enraf Nonius Sonopuls 590 (further 
details regarding method of application not reported).
Dosage: 3 watt/cm² for 5 minutes.
Frequency of administration: not reported.
Provider: anaesthetist (other providers not reported).
Sham stellate ganglion block with lidocaine and ultrasound (N = 7)
Components of intervention:
1. (sham SGB with lidocaine) 10 mL saline solution was used as placebo and 
injected slowly into the stellate ganglion;
2. (sham SGB with US) using a Enraf Nonius Sonopuls 590 and with the 
machine turned off the instrument was put on the ganglion for 5 minutes.
Dosage: n/a.
Frequency of administration: not reported.
Provider: anaesthetist (other providers not reported).
Outcomes Outcomes assessed at baseline, after treatment and 1 month post-treatment:
1. self-reported spontaneous pain measured using a 10 cm VAS (0 to 10) 
(anchor points not reported);
2. self-reported provocative pain measured using a Likert-type scale (0 = no 
pain, 1 = mild pain with deep palpation, 2 = serious pain with deep 
palpation, 3 = serious pain with superficial palpation, 4 = hyperaesthesia) 
(further details not reported);
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3. oedema measured using a standard forearm volumeter (measured in mL, 
further details not reported);
4. finger pulp-distal palmer crease distance (measured in cm, further details 
not reported);
5. grip strength measured using a Jamar dynamometer, in a sitting position 
(measured in kg);
6. functional hand scale (score range 0 to 19 with lower scores indicating 
better function);
7. Keitel index score (score range 4 to 42; interpretation of scores not 
reported).
Notes Source of funding: not reported.
Statement regarding declarations of interest: not reported.
Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Low risk Quote: "Patients were randomised by envelope method and 
3 groups were established".
Comment: "Treatment orders were made online..."
Comment: it is likely that the trial authors used an 
acceptable method to generate the sequence allocation.
Allocation concealment (selection 
bias)
Low risk Quote: "Patients were randomised by envelope method and 
3 groups were established".
Comment: the trial authors probably used an acceptable 
method to conceal the allocation sequence.
Blinding of participants and 
personnel (performance bias)
Low risk Quote: "The study was designed as a double blind study. 
Treatment orders were made online and except the 
personnel who were involved in the therapy nobody even 
the doctor was aware of the selected method".
Comment: participants were likely to have been adequately 
blinded.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
Low risk Quote: "The study was designed as a double blind study. 
Treatment orders were made online and except the 
personnel who were involved in the therapy nobody even 
the doctor was aware of the selected method".
Comment: participants who completed self-reported 
outcome measures were blinded to treatment allocation.
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Low risk Quote: "Treatment orders were made online and except the 
personnel who were involved in the therapy nobody even 
the doctor was aware of the selected method".
Comment: the outcome assessor was blinded to the 
treatment allocation.
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Unclear risk
Comment: the drop-out rate was not reported.
Physiotherapy for pain and disability in adults with complex regional pain syndrome...26-Feb-2016
Review Manager 5.2 35
Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
Unclear risk
Comment: the method of analysis (ITT versus per protocol) 
was not reported.
Selective reporting (reporting bias) Low risk Comment: the trial authors fully reported outcome data for 
all outcomes reported in the methods section of the 
publication.
Sample size High risk Quote: "Twenty-five patients were divided into three groups".
Comment: the small sample size may have introduced bias 
in estimates of treatment effect.
Duration of follow-up Unclear risk Quote: "These evaluations were performed before and after 
treatment and one month later".
Comment: the clinical relevance of a 1 month follow-up of 
outcomes is uncertain.
Other bias Low risk Comment: we did not identify any other sources of bias.
Cacchio 2009a
Methods Design: parallel group, 2-arm, single-blind RCT (Italy; October 2000 to 
December 2006).
Setting: inpatient and outpatient rehabilitation centre.
Interventions: mirror therapy or placebo control (covered mirror).
Sample size calculation: 24 participants per group required to detect a 2 cm 
reduction in pain on a 10 cm VAS (SD 1.5) with 0 cm labelled as "no pain" and 
10 cm as "worst pain i have ever had" at 1 week after treatment at 1% level of 
statistical significance with 90% power, including a 30% rate of loss at follow-up.
Participants Number of participants: 48 (24 per group).
Type of noxious initiating event: stroke (upper limb).
Diagnostic criteria: Bruehl 1999 (CRPS I).
Baseline characteristics:
1. conventional stroke rehabilitation plus mirror therapy:
a. mean (SD) age = 57.9 (9.9) years; female:male = 13:11;
b. mean (SD) duration of CRPS I 2.8 (1.3) months;
2. conventional stroke rehabilitation plus placebo control:
a. mean (SD) age = 58.8 (9.4) years; female:male = 13:11;
b. mean (SD) duration of CRPS I 2.6 (1.5) months.
Inclusion criteria:
1. first episode of unilateral stroke with hemiparesis during the previous 6 
months;
2. VAS, 0 to 10 cm) pain score > 4 cm.
Exclusion criteria:
1. ipsilateral intra-articular shoulder injection within the last 6 months or use of 
systemic corticosteroids with the previous 4 months;
2. presence of another obvious explanation for the pain;
3. prior surgery to either shoulder or neck region;
4. serious uncontrolled medical conditions;
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5. global aphasia, cognitive or visual impairments interfering with testing or 
treatment;
6. visual impairment that might interfere with the trial aims;
7. evidence of recent drug or alcohol abuse or severe depression.
Interventions Participants in both groups received 4 weeks of conventional stroke rehabilitation 
comprising neuro-rehabilitation techniques, occupational therapy (OT) and 
speech therapy (if required), consisting of 5 1-hour sessions per week.
Conventional stroke rehabilitation plus mirror therapy (N = 24)
Components of intervention: mirror therapy programme: Whilst seated with a 
mirror board positioned between the upper limbs, perpendicular to the midline 
and with the unaffected limb facing the reflective surface and with their affected 
upper limb hidden from view, participants observed the reflection of their 
unaffected upper limb while performing flexion and extension at the shoulder, 
elbow and wrist and pronation and supination of the forearm.
Dosage: 30 minutes per session (for the first 2 weeks), 1 hour per session (for 
the second 2 weeks)
Frequency of administration: 5 times per week for 4 weeks (20 sessions)
Provider: physiotherapist.
Conventional stroke rehabilitation plus placebo control (N = 24)
Components of intervention: participants performed the same exercises, 
according to the same dosage and frequency, with the reflective mirror surface 
covered.
Outcomes Outcomes assessed at baseline and at 1 week and 6 months post-treatment.
Primary outcomes:
1. self-rated pain intensity at rest using a 10 cm horizontal VAS labelled "no 
pain" to "worst pain I have ever had" (pain location not reported);
2. self-rated pain intensity on shoulder movement (forward flexion) using a 10 
cm VAS labelled "no pain" to "worst pain I have ever had";
3. brush evoked tactile allodynia, assessed by means of 3 brush movements 
within the area of maximum pain, using a 10 cm VAS labelled "no pain" to 
"worst pain I have ever had".
Secondary outcomes:
1. functional ability value of the Wolf Motor Function Test (WMFT), to assess 
upper limb functional limitation (score range 0 to 5, higher scores indicate 
poorer performance);
2. performance time value of the WMFT, to assesses upper limb functional 
performance speed (measured in seconds, longer times indicate poorer 
performance);
3. Quality of Movement (QOM) item in the Motor Activity Log (MAL), to assess 
how well participants can use their affected upper limb in 30 activities of 
daily living (score range 0 to 5, lower scores indicate poorer performance).
Notes Source of funding: not reported
Statement regarding declarations of interest: not reported
Risk of bias table
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Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Unclear risk Quote: "...we undertook a randomized placebo-controlled 
study in which stroke patients with CRPSt I were randomly 
allocated..."
Comment: the trial authors did not report the method of 
sequence generation.
Allocation concealment (selection 
bias)
Unclear risk Comment: the trial authors did not report the method of 
concealment allocation.
Blinding of participants and 
personnel (performance bias)
Unclear risk Comment: given the nature of the intervention, participants 
were not blinded to treatment allocation but the extent to 
which the lack of blinding may have introduced bias is 
uncertain.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
Unclear risk Comment: unblinded participants self-reported some 
outcomes (e.g. pain intensity) but the extent to which the 
lack of blinding may have introduced bias is uncertain.
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Low risk Quote: "All the patients were examined 3 times by an 
investigator who was blinded to the nature of treatment 
performed".
Comment: the outcome assessor was blinded to treatment 
allocation.
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Unclear risk Quote: "Two patients (8%) in the mirror group and 7 patients 
(29%) in the control group dropped out of the study".
Quote: "One of the 2 patients in the mirror group dropped 
out because he moved to another city, while the other 
decided to perform corticosteroid injection therapy in 
another center. Three of the 7 patients in the control group 
refused to complete the study, while 4 decided to perform 
corticosteroid injection therapy in another center".
Comment: the extent to which an overall drop-out rate of 
19% and an unequal drop-out rate between groups may 
have introduced biased estimates of treatment effect is 
uncertain.
Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
Low risk Quote: "Both the primary and secondary outcome analyses 
were performed according to the intention-to-treat (ITT) 
principle. In this study, subjects that provided baseline and 
at least 1 post-treatment measurement constituted the ITT 
population, whereas those who completed all tests from 
baseline to the 6-month follow-up constituted the per 
protocol population.
Comment: the trial authors reported analyses according to 
the ITT principle.
Selective reporting (reporting bias) Low risk Comment: the trial authors fully reported outcome data for 
all outcomes reported in the methods section of the 
publication.
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Sample size High risk Quote: "48 patients with CRPSt1 of the affected upper limb 
were enrolled".
Comment: the small sample size may have introduced bias 
in estimates of treatment effect.
Duration of follow-up Low risk Quote: "The decision to set the follow-up at 6 months is 
based on the hypothesis that pain improves spontaneously 
over a long period of time".
Comment: the trial authors measured outcomes over a 
clinically relevant length of time.
Other bias High risk Quote: "For the ITT population, outcome measurements 
were analyzed using the last observation carried forward 
method".
Comment: the use of 'last observation carried forward' when 
accounting for missing data may have introduced bias in 
estimates of treatment effect.
Cacchio 2009b
Methods Design: parallel group, single-blind, 3-arm, sham-controlled RCT (Italy, dates 
not reported). (Whilst the trial authors reported that a number of participants from 
the 2 comparator groups crossed over into the experimental group, this was not 
undertaken in a randomised way and therefore we deemed that this trial did not 
employ a true crossover design. We analysed it as a 3-arm parallel group trial up 
to the endpoint just prior to crossover).
Setting: not reported.
Interventions: mirror therapy or placebo control (covered mirror) or mental 
imagery.
Sample size calculation: not reported.
Participants Number of participants: 24 (8 per group).
Type of noxious initiating event: stroke (upper limb).
Diagnostic criteria: Bruehl 1999 (CRPS I).
Baseline characteristics: not adequately reported.
Inclusion criteria: not explicitly reported.
Exclusion criteria: not reported.
Interventions Mirror therapy (N = 8)
Components of intervention: whilst viewing a reflected image of the unaffected 
arm in a mirror, participants performed all of the cardinal (proximal to distal) 
movements of the affected arm (reported as the 'affected' arm but assumed to be 
the 'unaffected' arm).
Dosage: 30 minutes per session.
Frequency of administration: daily for 4 weeks (28 sessions).
Provider: not reported.
Placebo control (N = 8)
Components of intervention: participants performed the same movements, 
according to the same dosage and frequency, with the reflective mirror surface 
covered.
Provider: not reported.
Mental imagery (N = 8)
Components of intervention: not reported.
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Dosage: not reported.
Frequency of administration: not reported.
Provider: not reported.
Outcomes The trial authors assessed outcomes at baseline and on completion of the 
intervention period (4 weeks post recruitment).
Primary outcomes:
1. self-rated pain intensity on movement using a 100 mm VAS (anchor point 
labels not reported) but with higher scores indicating more severe pain.
Secondary outcomes:
1. motor function as assessed by the Wolf Motor Function Test (WMFT) 
(scoring properties not reported);
2. brush-induced allodynia (method of assessment not reported);
3. oedema (method of assessment not reported).
Notes Source of funding: not reported.
Statement regarding declarations of interest: not reported.
Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Unclear risk Quote: "We conducted a randomised, sham-controlled study 
involving 24 patients with stroke".
Comment: the trial authors did not report the method of 
sequence.
Allocation concealment (selection 
bias)
Unclear risk Quote: "We randomly assigned the 24 patients to one of 
three groups".
Comment: the trial authors did not report the method of 
concealment allocation.
Blinding of participants and 
personnel (performance bias)
Unclear risk Comment: given the nature of the intervention, participants 
were not blinded to treatment allocation but the extent to 
which the lack of blinding may have introduced bias is 
uncertain.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
Unclear risk Comment: unblinded participants self-reported some 
outcomes (e.g. pain intensity) but the extent to which the 
lack of blinding may have introduced bias is uncertain.
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Low risk Quote: "The investigators were unaware of the study-group 
assignments".
Comment: outcome assessors were blinded to participants 
group allocation.
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Low risk Quote: "In the active-mirror group, seven of eight patients 
(88%) reported reduced pain".
Quote: "In the covered-mirror group, only one of eight 
patients (12%) reported reduced pain".
Quote: "In the mental-imagery group, two of eight patients 
(25%) reported reduced pain".
Comment: there were no apparent drop-outs.
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Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
Low risk Comment: the trial authors analysed participants in the 
group to which they were allocated but did not report the 
method of analysis (ITT versus per protocol).
Selective reporting (reporting bias) High risk Quote: "After 4 weeks of active mirror therapy, the pain 
intensity decreased (Fig. 1), and motor function, 
brush-induced allodynia, and edema improved (data not 
shown)".
Comment: the trial authors presented mean values for the 
primary outcome of pain severity in graphical format only; 
they did not report raw data in numerical form with 
measures of variation.
Comment: the trial authors did not report any outcome data 
for the 3 secondary outcome measures (motor function, 
brush-induced allodynia, oedema).
Sample size High risk Quote: "We conducted a randomised, sham-controlled study 
involving 24 patients..."
Comment: the small sample size may have introduced bias 
in estimates of treatment effect.
Duration of follow-up High risk Quote: "The primary end point was the score for the severity 
of pain after 4 weeks of therapy".
Comment: the trial authors re-measured outcomes on 
completion of the intervention period only and did not 
measure them over a clinically relevant length of time.
Other bias Unclear risk Comment: the trial was reported and published as a 'Letter 
to the Editor'. Full trial methodology and results have not 
been published elsewhere (Cacchio, personal 
communication).
Comment: the trial authors presented limited group-specific 
baseline data.
Comment: the trial authors did not report any 
inclusion/exclusion data.
Dimitrijevic 2014
Methods Design: parallel group, 2-arm, single-blind RCT (Serbia; December 2004 to 
January 2007).
Setting: outpatient clinic.
Interventions: low-level laser therapy and kinesitherapy or interferential current 
therapy and kinesitherapy.
Sample size calculation: not reported.
Participants Number of participants: 50 (25 per group).
Type of noxious initiating event: trauma (no further details reported) (upper 
and lower limb).
Diagnostic criteria: Harden 2005 (CRPS I).
Baseline characteristics:
1. laser therapy and kinesitherapy:
a. Mean (±) age = 53.9 (13.36) years; female:male = 12:8;
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b. Mean (±) duration of CRPS I 33.75 (8.44) days.
2. interferential current therapy and kinesitherapy:
a. Mean (±) age = 57.8 (10.75) years; female:male = 17:8;
b. Mean (±) duration of CRPS I = 31.64 (7.79) days.
Inclusion criteria:
1. CRPS I.
Exclusion criteria:
1. acute and subacute thrombophlebitis;
2. thrombosis;
3. neoplastic disease;
4. fever;
5. pregnancy.
Interventions Participants were instructed not to take any specific CRPS medication 
(corticosteroids, bisphosphonates, calcitonin, nifedipine, antiepileptic drugs, etc.) 
or analgesic medication. Participants in both groups received individual 
kinesitherapy (active and active assisted exercises, strictly dosed up to pain 
threshold) for 30 minutes, twice a day.
Low-level laser therapy and kinesitherapy (N = 20)
Components of intervention: using a GaAs laser diode, 8 points along the joint 
line and painful points in the affected area were treated using the following 
parameters: a low power of 70 mW, 810 nm wavelength, and 70 Hz, 640 Hz, and 
5000 Hz frequency, depending on the dominant findings.
Dosage: 1.5 J/cm2.
Frequency of administration: 5 days a week for 2 weeks (10 sessions), and then 
every other day (10 sessions) (20 sessions).
Provider: not reported.
Interferential current therapy and kinesitherapy (N = 25)
Components of intervention: bipolar IFC therapy was applied with electrodes 
positioned locally on the painful and swollen part using the following parameters: 
90 Hz frequency.
Dosage: 15 minutes.
Frequency of administration: 5 days a week for 2 weeks (10 sessions), and then 
every other day (10 sessions) (20 sessions).
Provider: not reported.
Outcomes The trial authors did not explicitly specify the time points at which outcomes were 
measured in the trial report. Outcomes assessed at baseline and on completion 
of the intervention period (6 weeks post recruitment) (Dimitrijevic, personal 
communication). The trial authors did not state any primary outcome.
1. Self-rated pain intensity at rest using a 100 mm horizontal VAS (0 = no 
pain, 100 = worst pain possible) with responses based on the average pain 
intensity over last few days;
2. self-rated pain intensity during active movements of the wrist/ankle using a 
100 mm horizontal VAS (0 = no pain, 100 = worst pain possible) with 
responses based on the average pain intensity over last few days;
3. oedema of the hand/foot using a figure-of-8 measurement (measurement 
tool and method not reported). Hand/foot oedema was expressed as the 
difference between hand/foot circumference of the affected and unaffected 
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sides;
4. total active range of motion of the wrist/ankle joint in the sagittal plane using 
a standard full-circle goniometer and recorded in degrees with the final 
value derived from mean of 3 measurements.
Notes Source of funding: the trial authors declared that this study received no 
financial support.
Statement regarding declarations of interest: none declared.
Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Low risk Quote: "...patients were randomly selected and classified 
into two groups using sequentially numbered, closed, 
opaque envelopes that had been prepared earlier using a 
computer-generated list of random numbers, and balanced 
to ensure equal numbers in each group".
Comment: the trial authors used an acceptable method to 
generate the sequence allocation.
Allocation concealment (selection 
bias)
Low risk Quote: "...patients were randomly selected and classified 
into two groups, using sequentially numbered, closed, 
opaque envelopes that had been prepared earlier".
Comment: the trial authors used an acceptable method to 
conceal the allocation sequence.
Blinding of participants and 
personnel (performance bias)
Low risk Comment: the participants were not blinded to treatment 
allocation but lack of blinding unlikely to have biased the 
results given that participants received interventions judged 
to have been of relatively equal credibility.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
Low risk Comment: the participants were not blinded to treatment 
allocation and self-reported some outcomes but lack of 
blinding unlikely to have biased the results given that 
participants received interventions judged to have been of 
relatively credibility.
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Unclear risk
Comment: the trial authors did not provide a statement of 
procedures regarding blinding of the outcome assessor.
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Unclear risk Quote: "During the study, 5 out of 50 patients dropped out. 
A total of 45 patients completed the study".
Comment: all 5 drop-outs came from the laser therapy 
group (lost to follow-up, n = 2; discontinued intervention, n = 
3). Whilst the overall drop-out rate was 10%, the extent to 
which an unequal drop-out rate between groups may have 
biased the results is uncertain.
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Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
High risk Comment: the trial authors excluded 3 participants from the 
laser therapy group from the analysis because they 
discontinued the intervention, in violation of the ITT principle.
Selective reporting (reporting bias) Low risk Comment: the trial authors fully reported outcome data for 
all outcomes reported in the methods section of the 
publication.
Sample size High risk Quote: "The prospective randomized study included 50 
patients with unilateral post-traumatic CRPS I".
Comment: the small sample size may have introduced bias 
in estimates of treatment effect.
Duration of follow-up High risk Quote: "All patients underwent evaluation of each separate 
parameter before treatment and after applying 20 
therapeutic procedures".
Comment: outcomes were re-measured on completion of 
the intervention period only and were not measured over a 
clinically relevant length of time.
Other bias Low risk Comment: we did not identify any other sources of bias.
Duman 2009
Methods Design: parallel group, 2-arm RCT (Turkey; dates not reported).
Setting: not reported.
Interventions: conventional care plus manual lymphatic drainage (MLD) or 
conventional care.
Sample size calculation: not reported.
Participants Number of participants: 34 (experimental group N = 18, control group N = 16).
Type of noxious initiating event: mixed (fracture n = 23, soft-tissue trauma n = 
7, incisive injury n = 3, non-traumatic n = 1) (upper limb).
Diagnostic criteria: Bruehl 1999 (RSD i.e. CRPS I).
Baseline characteristics:
Total sample (separate intervention and control group data not reported but no 
statistically significant between-group differences).
Mean (±) age = 20.6 (0.8) years; female:male = not reported.
Mean (±) duration of Reflex sympathetic dystrophy (RSD) 5.1 (1.3) months.
Inclusion criteria:
1. fulfilled IASP criteria for RSD;
2. minimum 50 cc volumetric difference between 2 upper limbs.
Exclusion criteria:
1. infection;
2. thrombosis;
3. cardiac, pulmonary or renal problems.
Interventions Participants in both groups received conventional care including non-steroidal 
anti-inflammatory drugs (NSAIDs) (type, dosage, frequency of administration not 
reported) and physical therapy (once per day, 5 days per week for 3 weeks), 
comprising therapeutic ultrasound of the affected limb and stellate ganglions 
(treatment parameters not reported) and therapeutic exercises for all joints of the 
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affected limb (10 repetitions, twice per day; type of exercises performed not 
reported) followed by a 2-month programme of home maintenance therapeutic 
exercises.
MLD (N = 18)
Components of intervention: MLD. Light massage for superficial abdominal, 
axillary and upper limb lymphatic stimulation of the affected upper limb followed 
by light upper limb massage in a distal to proximal direction up to the axillary 
region.
Dosage: 1 session per day for approximately 45 minutes administered by a 
therapist plus 1 session per day of participant self-administered MLD (duration 
not reported).
Frequency of administration: 5 times per week for 3 weeks (15 sessions), 
followed by a home maintenance. programme of self-administered MLD for 2 
months
Provider: not reported.
Conventional care (N = 16).
Outcomes Outcomes assessed at baseline, at the end of the 3-week treatment period and 2 
months post-treatment. The trial authors did not state any primary outcome.
1. Self-rated pain intensity during gentle passive finger flexion using a 10-cm 
VAS labelled "no pain" to "worst possible pain";
2. upper limb oedema using volumetric measurements of water displacement;
3. functional range of motion measuring the third finger pulp-distal palmer 
crease distance.
Notes Source of funding: not reported
Statement regarding declarations of interest: not reported.
Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Unclear risk Quote: "The patients were allocated randomly into two 
groups".
Comment: the trial authors did not report the method of 
sequence generation.
Allocation concealment (selection 
bias)
Unclear risk Comment: the trial authors did not report the method of 
concealment allocation.
Blinding of participants and 
personnel (performance bias)
High risk Comment: given the nature of the intervention, participants 
were not blinded to treatment and may have had different 
expectations about the benefits of each intervention.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
High risk Comment: unblinded participants, who may have had 
different expectations about the benefits of the intervention 
they received, self-reported some outcomes (e.g. pain 
intensity).
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Unclear risk Quote: "All of the parameters were obtained before the 
treatment (baseline), after treatment and 2 months after 
treatment (follow-up) by a different physician".
Comment: the trial authors did not report a statement of 
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procedures regarding blinding of the outcome assessor.
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Low risk Quote: "After 2 months, all of the patients were 
re-evaluated".
Comment: there were no apparent drop-outs.
Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
Low risk Quote: "After 2 months, all of the patients were 
re-evaluated".
Comment: trial authors analysed participants analysed in 
the group to which they were allocated but did not report the 
method of analysis (ITT versus per protocol).
Selective reporting (reporting bias) Low risk Comment: the trial authors fully reported outcome data for 
all outcomes reported in the methods section of the 
publication.
Sample size High risk Quote: "A total of 34 patients who fulfilled the modified 
International Association for the Study of Pain (IASP) 
criteria and diagnosed as RSD were enrolled".
Comment: the small sample size may have introduced bias 
in estimates of treatment effect.
Duration of follow-up Low risk Quote: "After 2 months, all of the patients were 
re-evaluated".
Comment: the trial authors measured outcomes over a 
clinically relevant length of time.
Other bias Low risk Comment: we did not identify any other other sources of 
bias.
Durmus 2004
Methods Design: parallel group, 2-arm, double-blind placebo-controlled RCT (Turkey; 
1999 to 2001).
Setting: out-patient rehabilitation clinic.
Interventions: usual care plus pulsed electromagnetic field treatment or usual 
care plus placebo pulsed electromagnetic field treatment.
Sample size calculation: not reported.
Participants Number of participants: 40 (number of participants per group not reported).
Type of noxious initiating event: Colles fracture (upper limb).
Diagnostic criteria: Merskey 1994 (CRPS I).
Baseline characteristics:
1. pulsed electromagnetic field treatment:
a. mean (SD) age = 37.65 (12.33) years; female:male = 50%:50%;
b. mean (SD) duration of CRPS I: 48.80 (28.63) days;
2. placebo:
a. mean (SD) age = 40.60 (11.05) years; female:male = 45%:55%;
b. mean (SD) duration of CRPS I: 54.55 (36.24) days.
Inclusion criteria:
1. aged 18 to 55 years;
2. development of pathology after trauma;
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3. presence of phase I CRPS I based on 3 phase bone scintigraphy;
4. absence of any known hypersensitivities to calcitonin.
Exclusion criteria:
1. previous treatment for CRPS I;
2. pacemaker;
3. presence of an infectious or malignant disease;
4. being either pregnant or in a menopausal state.
Interventions Participants in both groups received 100 units of calcitonin via intramuscular 
injection for 6 weeks; once per day for the first 3 weeks then once every other 
day for the second 3 weeks, and performed active and active assisted range of 
motion exercises and a stretching programme for 30 minutes, 3 times per day.
Electromagnetic field treatment (N = not reported)
Components of intervention: pulsed electric magnetic field treatment. Treatment 
was administered using a Magnetic-Therapy Mg Port Cosgamma® device. The 
trial authors did not report participant and equipment positioning.
Dosage: 100 Gauss intensity and 50 Hz frequency for 60 minutes per session.
Frequency of administration: 5 times per week for 6 weeks (30 sessions).
Provider: not reported.
Placebo (N = not reported)
Components of intervention: participants were placed in the same device without 
it being switched on.
Outcomes The trial authors assessed outcomes at baseline and on completion of the 
intervention period (6 weeks post recruitment). The trial authors did not state any 
primary outcome.
1. Self-rated pain at rest using a 10 cm VAS graded between 0 and 10 (anchor 
point descriptors not reported);
2. self-rated pain with activity (details not reported) using a 10 cm VAS graded 
between 0 and 10 (anchor point descriptors not reported);
3. 4-point verbal pain scale (measurement properties not described);
4. pain on palpation using 5-point grading scale (0 = no pain, 4 = 
hyperesthesia) (further measurement properties not reported);
5. ratings of stiffness and change of colour (measurement properties not 
reported);
6. change in oedema using volumetric displacement;
7. range of motion using a goniometer (joints not specified);
8. 3-phase bone scintigraphy (bone to soft-tissue ratios) (measurement 
properties not reported);
9. biochemical markers of bone formation (bone alkaline phosphatase, 
osteocalcin, procollagen 1) and bone resorption (pyridinoline, 
deoxypyridinoline, hydroxyproline) (measurement properties not reported).
Notes Source of funding: not reported.
Statement regarding declarations of interest: not reported.
Risk of bias table
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Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Low risk Quote: "The patients were divided into two groups with the 
random numbers table".
Comment: the trial authors used an acceptable method was 
used to generate the sequence allocation.
Allocation concealment (selection 
bias)
Unclear risk Comment: the trial authors did not report the method of 
concealment allocation.
Blinding of participants and 
personnel (performance bias)
Low risk Quote: "In this randomized double-blind, placebo-controlled 
study".
Quote: "the second group of patients received placebo 
treatment by being placed in the same device without it 
being switched on".
Comment: participants were likely to have been adequately 
blinded but the trial authors did not explicitly report the 
extent to which the placebo intervention controls for the 
auditory and sensory characteristics of the intervention.
Comment: the trial authors did not report the procedure for 
blinding of care providers.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
Low risk Quote: "the second group of patients received placebo 
treatment by being placed in the same device without it 
being switched on".
Comment: the participants who completed self-reported 
outcome measures were blinded to treatment allocation.
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Low risk Quote: "The patients were assessed at the beginning of a 6 
week course of treatment and on the final week of treatment 
by a physician who did not know which group received the 
applied magnetic field treatment".
Comment: the outcome assessor was blinded to treatment 
allocation.
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Low risk Quote: "There were no refusals or drop-outs from the study".
Comment: all randomly assigned participants completed the 
study.
Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
Low risk Quote: "There were no refusals or drop-outs from the study".
Comment: the trial authors did not report the method of 
analysis (ITT versus per protocol).
Selective reporting (reporting bias) Low risk Comment: the trial authors fully reported outcome data for 
the 2 main pain outcomes but did not report any outcome 
data for the 4-point verbal pain scale or any other outcomes 
(pain on palpation, ratings of stiffness and change of colour, 
range of motion and 3-phase bone scintigraphy), as 
reported in the methods section of the publication.
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Sample size High risk Quote: "Forty patients diagnosed as having Type I CRPS 
subsequent to trauma (Colles Fracture), who consulted the 
Physical Medicine and Rehabilitation Department of Istanbul 
University, Istanbul Medical Faculty between 1999 and 2001 
were included in the study".
Comment: the small sample size may have introduced bias 
in estimates of treatment effect.
Duration of follow-up High risk Quote: "Patients were assessed at the beginning of a 6 
week course of treatment and on the final week of 
treatment".
Comment: the trial authors re-evaluated participants at the 
end of the treatment period only.
Other bias Low risk Comment: we did not identify any other sources of bias.
Hazneci 2005
Methods Design: parallel group, 2-arm RCT (Turkey; 2001 to 2002).
Setting: Department of Physical Medicine and Rehabilitation Clinic, Gulhane 
Military Medical Academy.
Interventions: transcutaneous electrical nerve stimulation (TENS) or pulsed 
ultrasound of the stellate ganglion.
Sample size calculation: not reported
Participants Number of participants: 30 (TENS N = 16; pulsed ultrasound N = 14).
Type of noxious initiating event: mixed (trauma n = 20, sports injury n = 5, 
post finger amputation n = 1, post injection n = 1, idiopathic n = 3) (upper limb).
Diagnostic criteria: Kozin 1992 (stage I and II) (Reflex sympathetic dystrophy 
syndrome).
Baseline characteristics
1. TENS:
a. mean (SD) age = 20.75 (0.58) years; female:male = 0:16;
b. mean (SD) duration of CRPS I 45.31 (26.68) days;
2. pulsed ultrasound of the stellate ganglion:
a. mean (SD) age = 20.6 (0.76) years; female:male = 0:14;
b. mean (SD) duration of CRPS I 43.21 (17.72) days.
Inclusion criteria: CRPS I.
Exclusion criteria: not reported.
Interventions Participants in both groups received contrast bathing (the upper extremity was 
put in hot water for 4 minutes and then in cold water for 1 minute and this 
procedure was repeated for 20 minutes) and an exercise programme 
(undertaken with the assistance of a physiotherapist and comprising active, 
assisted active and passive exercise within the pain limits; including extension, 
flexion, ulnar and radial deviation for the wrist, abduction and flexion for the 
thumb, flexion and extension for the metacarpophalangeal, proximal and distal 
interphalangeal joints).
TENS (N = 16)
Components of intervention: TENS was applied, using a Myomed 932 Enraf 
model, to the painful area of the involved upper extremity.
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Dosage: frequency 100 Hz, mono-rec wave module.
Frequency of administration: once per day, for 20 minutes, for 3 weeks (total 
number of sessions not reported).
Provider: not reported.
Pulsed ultrasound of the stellate ganglion (N = 14) 
Components of intervention: using a BTL 07p model ultrasound device pulsed 
ultrasound was applied with a 1 cm² probe to the stellate ganglion on the 
involved side of the upper extremity.
Dosage: 3 watt/cm² (pulsed).
Frequency of administration: once per day, for 5 minutes, for 3 weeks (total 
number of sessions not reported).
Provider: not reported.
Outcomes The trial authors assessed outcomes at baseline and on completion of the 
intervention period (3 weeks post recruitment):
1. self-reported spontaneous pain measured using a VAS (0 = no pain to 10 = 
worst pain);
2. self-reported provocative pain (pain on palpation) measured using a 
Likert-type scale (0 = no pain, 1 = mild pain with deep palpation, 2 = severe 
pain with deep palpation, 3 = severe pain with superficial palpation, 4 = 
hyperaesthesia);
3. grip strength measured using a hand dynamometer device with the score 
(in kg) determined by the mean of 3 attempts;
4. joint mobility (extension, flexion, ulnar and radial deviation of the wrist; 
flexion and extension for the fingers). Active joint movement distance was 
measured by standard goniometer. Mobility loss was calculated by the 
formula: 100 −  (measured value/normal joint movement distance) x 100. 
The mean value for the joint movement distance for all directions was 
calculated and compared with the values of the normal extremity. The scale 
was as follows: 0 = total mobility; 1 = 1% to 25% mobility loss; 2 = 26% to 
50% mobility loss; 4 = mobility loss of more than 76%;
5. oedema measured using standard volumetric measurements. Firstly the 
participant s uninvolved upper extremity was placed in a container filled with 
water. The volume (in mL) of displaced water was measured and compared 
to the volume displaced when he involved upper extremity was placed in 
the same container with the value taken as the difference between the 
volumes displaced by the affected and normal extremities.
Notes Source of funding: not reported.
Statement regarding declarations of interest: not reported.
Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Unclear risk Quote: "Patients were divided into two groups randomly".
Comment: the trial authors did not report the method of 
sequence generation.
Allocation concealment (selection 
bias)
Unclear risk Comment: the trial authors did not report the method of 
concealment allocation.
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Blinding of participants and 
personnel (performance bias)
Low risk Comment: the participants appear not to have been blinded 
to treatment allocation but lack of blinding is unlikely to have 
biased the results given that participants received 
interventions judged to have been of relatively equal 
credibility.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
Low risk Comment: participants appear not to have been blinded to 
treatment allocation and self-reported some outcomes, but 
lack of blinding is unlikely to have biased the results given 
that participants received interventions judged to have been 
of relatively equal credibility.
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Unclear risk
Comment: the trial authors did not give a statement of 
procedures regarding blinding of the outcome assessor.
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Unclear risk
Comment: the trial authors did not report the drop-out rate.
Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
Unclear risk
Comment: the trial authors did not report the method of 
analysis (ITT versus per protocol).
Selective reporting (reporting bias) Low risk Comment: the trial authors fully reported outcome data for 
all outcomes reported in the methods section of the 
publication.
Sample size High risk Quote: "30 patients diagnosed with Reflex Sympathetic 
Dystrophy Syndrome at the upper extremities were included 
into the study".
Comment: the small sample size may have introduced bias 
in estimates of treatment effect.
Duration of follow-up High risk Quote: "All patients evaluated before treatment and 3rd 
week following the treatment"
Comment: the trial authors re-measured outcomes on 
completion of the intervention period only and were not 
measured over a clinically relevant length of time.
Other bias Low risk Comment: we did not identify any other sources of bias.
Jeon 2014
Methods Design: parallel group, 2-arm, placebo-controlled pilot RCT (South Korea; dates 
not reported).
Setting: tertiary university pain centre.
Interventions: virtual body swapping with mental rehearsal or virtual body 
swapping alone.
Sample size calculation: pilot RCT with bootstrapping method to increase the 
robustness of small-sample analyses.
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Participants Number of participants: 10 (number per group not reported).
Type of noxious initiating event: not reported (upper limb only n = 1, lower 
limb only n = 1, multiple limbs n = 4, and whole body n = 4).
Diagnostic criteria: Harden 2007 (CRPS I).
Baseline characteristics:
Total sample (separate intervention and control group data not reported but no 
statistically significant between-group differences).
Mean (SD) age: 39.30 (10.99) years; female:male = 0:10.
Median (range) duration of CRPS I: 52 (33 to 120) months.
Inclusion criteria: CRPS I
Exclusion criteria: not reported
Interventions The trial authors did not report any co-interventions.
Virtual body swapping with mental rehearsal (N = not reported)
Components of intervention:
1. whilst lying down and wearing a head mounted display (VR2000; Virtual 
Realities, Ltd.) participants watched a virtual body swapping training video 
in order to evoke a virtual body swapping illusion. The 3 minute 20 second 
long video clip was filmed from the first person perspective and consisted of 
4 physical movements (making fists and opening up the fingers, bending 
and unbending the elbows, bending the ankles forward and backward, and 
bending and unbending the legs). The first person perspective would help 
participants to feel as if they observed their body when they watch the video;
2. participants were additionally asked to assume a posture similar to that of 
the body on the screen and rehearse the movements mentally, as if the 
body presented on the display was their own body.
Dosage: 1 training session.
Frequency of administration: the experimental video clip was played twice with a 
1-minute break given between viewing's.
Provider: 1 specialist in pain and 2 assistants (trained graduate students); 
professional discipline not reported.
Virtual body swapping alone (N = not reported)
Components of intervention: participants watched the same video but did not 
perform mental rehearsal of the 4 physical movements.
Dosage: 1 training session.
Frequency of administration: the experimental video clip was played twice with a 
1-minute break given between viewings.
Provider: 1 specialist in pain and 2 assistants (trained graduate students); 
professional discipline not reported.
Outcomes The trial authors did not explicitly specify the time points at which they measured 
outcomes in the trial report. The outcomes were assessed immediately 
pre-intervention and postintervention. The trial authors did not state any primary 
outcome.
1. Self-rated pain intensity measured on an 11-point Likert scale ranging from 
0 (no pain) to 10 (severe pain);
2. the modified Body Perception Disturbance Questionnaire (BPDQ) 
consisting of 9 items with each item rated on an 11-point scale ranging from 
0 (not at all) to 10 (very likely). Scores range from 0 to 90 with higher scores 
indicating greater body perception disturbance.
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Notes Source of funding: Basic Science Research Program through the National 
Research Foundation of Korea (NRF) funded by the Ministry of Education, 
Science and Technology (2012R1A1A2008624) and the Chung-Ang University 
Excellent Student Scholarship in 2014.
Statement regarding declarations of interest: none declared.
Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Unclear risk "Ten patients who met the diagnostic criterion for CRPS 
type 1 were randomly assigned to either the treatment or 
control group".
Comment: the trial authors did not report the method of 
sequence generation.
Allocation concealment (selection 
bias)
Unclear risk Comment: the trial authors did not report the method of 
concealment allocation.
Blinding of participants and 
personnel (performance bias)
Unclear risk Comment: given the nature of the intervention, participants 
were not blinded to treatment allocation but the extent to 
which the lack of blinding may have introduced bias is 
uncertain.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
Unclear risk Comment: given the nature of the intervention, participants 
were not blinded to treatment allocation but the extent to 
which the lack of blinding may have introduced bias is 
uncertain.
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Low risk
Not applicable.
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Low risk Comment: the trial authors did not report the drop-out rate 
but, given the methodology, it is likely there were no 
drop-outs.
Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
Low risk Comment: the trial authors did not report the method of 
analysis but, given the methodology, it is likely that they 
analysed all participants in the group to which they were 
allocated.
Selective reporting (reporting bias) High risk Quote: "There was no significant difference between the 
groups in pain intensity, F(1, 7) = 0.05, p = 0.81".
Comment: the trial authors did not report any 
pre-intervention or postintervention outcome data for 
self-reported pain intensity.
Sample size High risk "Ten patients with CRPS type 1 were recruited from a 
tertiary university pain center in Seoul, Korea".
Comment: the small sample size may have introduced bias 
in estimates of treatment effect.
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Duration of follow-up High risk Quote: "The experimental video clip was played twice with a 
1-minute break given between viewing's. The participants 
were then asked to respond to the pain intensity 
question...and to complete the BPDQ".
Comment: the trial authors re-measured outcomes on 
immediate completion of the intervention period only and did 
not measure them over a clinically relevant length of time.
Other bias Unclear risk Comment: the trial authors did not report baseline pain data.
Li 2012
Methods Design: parallel group, 2-arm RCT (China; July 2008 to July 2010).
Setting: hospital.
Interventions: acupuncture and massage or rehabilitation therapy.
Sample size calculation: not reported.
Participants Number of participants: 120 (60 per group).
Type of noxious initiating event: stroke (upper limb).
Diagnostic criteria: Steinbrocker 1948 (stage 1).
Baseline characteristics:
1. acupuncture and massage:
a. mean (±) age = 62 (12) years; female:male = 20:40;
b. mean (±) duration of shoulder-hand syndrome = 28 (6) days.
2. rehabilitation:
a. mean (±) age = 61 (13) years; female:male = 19:41;
b. mean (±) duration of shoulder-hand syndrome 27 (5) days.
Inclusion criteria:
1. ischemic stroke;
2. age 18 to 75 years;
3. clinical symptoms of shoulder-hand syndrome conforming to stage I of the 
Steinbrocker criteria;
4. fixed address and agreement to long-term follow-up visits;
5. sufficient cognitive ability to consent.
Exclusion criteria:
1. shoulder-hand syndrome caused by a second stroke, cerebral 
haemorrhage, cerebral tumour or trauma;
2. shoulder-hand syndrome at stage II or III;
3. pain or restricted shoulder motion secondary to dislocation or subluxation, 
fracture or brachial plexus injury;
4. severe heart, liver or kidney disease;
5. severe cognitive dysfunction, mental disorder, malnutrition or poor general 
condition;
6. unable to consent.
Interventions Acupuncture and massage (N = 60)
Components of intervention:
1. acupuncture: electric and non-electric acupuncture involving the following 
points: Sanjian (LI 3), Houxi (SI 3), Zhongzhu (SJ 3), Jianzhongshu (SI 15), 
Jianliao (SJ 14), Shousanli (LI 10), Waiguan (SJ 5) and Tianzong (SI 11);
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2. massage: massage of the affected upper limb, passive shoulder 
movements without pain.
Dosage: acupuncture = 25 minutes, massage = 25 minutes.
Frequency of administration: once per day for 6 therapeutic courses; each course 
comprised 5 sessions, with a 2-day interval between courses (30 sessions).
Provider: doctors.
Rehabilitation therapy (n = 60)
Components of intervention: active-assisted scapular movements; Bobath 
exercises to clench the fist, functional transfers (e.g. changing position from 
prone to sitting, sitting to standing); proprioceptive neuromuscular facilitation 
(PNF).
Dosage: active-assisted scapular movements = 15 minutes, Bobath exercises 
and functional transfers = 15 minutes, PNF = 10 minutes.
Frequency of administration: once per day for 6 therapeutic courses; each course 
comprised 5 sessions, with a 2-day interval between courses (30 sessions).
Provider: doctors.
Outcomes The trial authors assessed outcomes at baseline, at the end of the 6-week 
treatment period and at 12 weeks post-treatment.
Primary outcomes:
1. self-rated pain on passive shoulder motion [direction of motion not 
described] to 90° with the participant in a seated position using a numeric 
pain rating scale (scale characteristics not reported);
2. number of participants with shoulder-hand syndrome at Steinbrocker stage 
II or III after treatment.
Secondary outcomes
1. Fugl-Meyer evaluation of functional movement of the upper limb (33 items, 
maximum possible score = 66; higher scores indicating more normal 
movement);
2. Fugl-Meyer evaluation of functional movement of the hand (7 items, 
maximum possible score = 14; higher scores indicating more normal 
movement);
3. Modified Rankin scale (scale properties and scoring method not reported);
4. adverse events (incidence of shoulder dislocation, fainting during 
acupuncture, haematoma, other).
Notes Source of funding: not reported.
Statement regarding declarations of interest: not reported.
Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Low risk Quote: "A random encoding plan was designed using SPSS 
software".
Comment: the trial authors used an acceptable method to 
generate the sequence allocation.
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Allocation concealment (selection 
bias)
Low risk Quote: "A random encoding plan was designed using SPSS 
software and concealed in an envelope
Comment: the trial authors used an adequate method to 
conceal the allocation sequence.
Blinding of participants and 
personnel (performance bias)
High risk Comment: given the nature of the intervention, participants 
were not blinded to treatment and may have had different 
expectations about the benefits of each intervention.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
High risk Comment: unblinded participants who may have had 
different expectations about the benefits of the intervention 
they received self-reported some outcomes (e.g. pain 
intensity).
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Unclear risk
Comment: the trial authors did not give a statement of 
procedures regarding blinding of the outcome assessor.
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Low risk Quote: "All patients finished the treatment and had a 
follow-up visit".
Comment: all randomly assigned participants completed the 
study.
Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
Low risk Quote: "All patients finished the treatment and had a 
follow-up visit".
Comment: the trial authors did not report the method of 
analysis (ITT versus per protocol).
Selective reporting (reporting bias) Low risk Comment: the trial authors fully reported outcome data for 
all outcomes reported in the methods section of the 
publication.
Sample size Unclear risk Quote: "The 120 subjects in this series...were selected from 
202 stroke patients...They were randomly divided into an 
acupuncture-massage group and a rehabilitation group, with 
60 cases in each".
Comment: the extent to which the small to moderate sample 
size may have introduced bias into estimates of treatment 
effect is uncertain.
Duration of follow-up Low risk Quote: "Each of the above indices was recorded before 
treatment, at the end of the 6-week treatment period and at 
the 12th-week follow-up visit".
Comment: the trial authors measured outcomes over a 
clinically relevant length of time.
Other bias Low risk Comment: we did not identify any other sources of bias.
Moseley 2004
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Methods Design: single-blind, 2-arm RCT (Australia; dates not reported). (The trial author 
reported that participants in the control group crossed over into the experimental 
group. However, we deemed that this trial had not employed a true crossover 
design and we analysed it as a 2-arm parallel group trial up to the endpoint just 
prior to crossover).
Setting: hospital physiotherapy department.
Interventions: graded motor imagery (GMI) or ongoing medical management.
Sample size calculation: not reported.
Participants Number of participants: 13 (experimental group n = 7; control group n = 6).
Type of noxious initiating event: wrist fracture (upper limb).
Diagnostic criteria: Bruehl 1999 (CRPS I).
Baseline characteristics:
1. GMI:
a. Mean (SD) age = 35 (15) years; female:male = 5:2;
b. Mean (SD) duration of CRPS I: 51 (18) weeks;
2. ongoing medical management:
a. Mean (SD) age = 38 (14) years; female:male = 4:2;
b. Mean (SD) duration of CRPS I : 65 (19) weeks.
Inclusion criteria: > 6 months post non-complicated wrist fracture.
Exclusion criteria:
1. previously benefited from an intravenous regional sympathetic blockade;
2. any other upper limb pathology or pain;
3. any neurological or motor disorder including dyslexia or difficulty performing 
a rapid naming task;
4. visually impaired;
5. a diagnosed psychopathology;
6. any invasive analgesic strategy (e.g. spinal cord stimulator);
7. lived beyond the immediate metropolitan area of the host department.
Interventions GMI (N = 7)
Components of intervention:
1. recognition of hand laterality stage (2 weeks): whilst seated at a computer 
monitor, participants viewed a random sequence of 56 photographic images 
of either a right or left hand in a variety of postures. Participants were 
instructed to identify whether the displayed image was of a right or left hand 
by pressing an appropriate button on the computer keyboard. participants 
borrowed a notebook computer to repeat the task at home;
2. imagined hand movements stage (2 weeks): whilst viewing a random 
sequence of 28 images of the affected hand participants were advised to 
deliberately imagine moving their hand to adopt the posture shown in the 
picture, 3 times
3. Mirror therapy stage (2 weeks): using a mirror box which concealed the 
affected limb from view but allowed participants to view a mirror image of 
their unaffected limb, participants viewed a sequence of 20 pictures of the 
unaffected hand and were instructed to slowly and smoothly adopt the 
posture shown in each picture with both hands. Emphasis was placed on 
watching the reflection of their unaffected hand in the mirror.
Dosage: hand laterality and imagined movements tasks - 3 times; mirror therapy 
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task - 10 times.
Frequency of administration: each waking hour, daily for 2 weeks (6 weeks in 
total).
Provider: not reported.
Ongoing medical management (N = 6)
Components of intervention:
1. no limitations placed on treatment;
2. participants were requested not to change medication type or dosage and 
to record any new treatments received;
3. predominantly physical therapy (2 to 3 sessions per week) comprising 
active and passive limb mobilisation, systemic desensitisation and 
hydrotherapy;
4. chiropractic manipulation and acupuncture (1 participant); psychological 
counselling (1 participant).
Outcomes Trial authors assessed outcomes at baseline, at 2 and 4 weeks after 
commencement of treatment, at the end of the 6-week treatment period (week 6) 
and 6 weeks post-treatment (week 12). The trial authors did not state a primary 
outcome.
1. Neuropathic pain scale (NPS), with responses regarding the 2 previous 
days (scoring properties not reported);
2. swelling, using the average of measure of the circumference of the base of 
the 2nd and 3rd digits, as measured with a hand measuring tape.
Notes Source of funding: Clinical Research Fellowship from the National Health and 
Medical Research Council of Australia ID 210348.
Statement regarding declarations of interest: not reported.
Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Low risk Quote: "Patients were randomised by an independent 
investigator to the 6-week MIP treatment group or to 
ongoing medical management (control) using a random 
number table".
Comment: the trial authors used an acceptable method to 
generate the sequence allocation.
Allocation concealment (selection 
bias)
Low risk Quote: "Patients were randomised by an independent 
investigator..."
Comment: the trial authors used an acceptable method to 
conceal the allocation sequence.
Blinding of participants and 
personnel (performance bias)
High risk Comment: given the nature of the intervention, participants 
were not blinded to treatment and may have had different 
expectations about the benefits of each intervention.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
High risk Comment: unblinded participants, who may have had 
different expectations about the benefits of the intervention 
they received, self-reported some outcomes (e.g. NPS).
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Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Low risk Quote: "All assessments were made by a separate 
investigator who was blind to experimental group and 
measurement occasion".
Comment: the outcome assessor of objective outcomes was 
blinded to treatment allocation.
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Low risk Comment: all randomly assigned participants completed the 
study (as displayed in the published report's 'Experimental 
plan').
Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
Low risk
Comment: the trial authors analysed participants in the 
group to which they were allocated.
Selective reporting (reporting bias) High risk Comment: the trial authors fully reported outcome data 
graphically for all outcomes; but did not report raw data in 
numerical form with measures of variation.
Sample size High risk Quote: "Written informed consent was obtained from the 
remaining 13 subjects".
Comment: the small sample size may have introduced bias 
in estimates of treatment effect.
Duration of follow-up Unclear risk Quote: "Post hoc analyses showed...a significant reduction 
in all three variables during the MIP with the effect 
maintained for at least 6 weeks after the completion of 
treatment". 
Comment: the clinical relevance of a 6-week follow-up of 
outcomes is uncertain.
Other bias Unclear risk Comment: we did not identify any other sources of bias.
Moseley 2005
Methods Design: parallel group, 3-arm, single-blind RCT (Australia; dates not reported).
Setting: not reported.
Interventions: hand laterality recognition followed by imagined movements 
followed by mirror movements (RecImMir, MIP) or imagined movements followed 
by laterality recognition followed by imagined movements (ImRecIm) or laterality 
recognition followed by mirror movements followed by recognition (RecMirRec).
Sample size calculation: not reported.
Participants Number of participants: 20 (RecImMir, MIP group (1) N = 7; ImRecIm group (2) 
N = 6; RecMirRec group (3) N = 7).
Type of noxious initiating event: wrist fracture (upper limb).
Diagnostic criteria: Bruehl 1999 (CRPS I)
Baseline characteristics:
1. RecImMir, MIP:
a. mean (SD) age = 36 (8) years; female:male = 5:2;
b. mean (SD) duration of CRPS I: 12 (6) months;
2. ImRecIm:
a. mean (SD) age = 27 (7) years; female:male = 4:2;
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b. mean (SD) duration of CRPS I : 16 (5) months;
3. RecMirRec:
a. mean (SD) age = 39 (8) years; female:male = 5:2;
b. mean (SD) duration of CRPS I : 14 (5) months.
Inclusion criteria: onset of CRPS I post non-complicated wrist fracture > 6 
months prior to enrolment.
Exclusion criteria:
1. previously obtained relief from an intravenous regional sympathetic 
blockade;
2. any invasive analgesic strategy (e.g. spinal cord stimulator, 
sympathectomy);
3. any other neurological, psychopathology or motor disorder or dyslexia;
4. difficulty performing a rapid naming task;
5. visually impaired;
6. any other upper limb pathology or pain;
7. lived outside the immediate metropolitan area of the host department.
Interventions Participants were advised to avoid changing medication or seeking alternative 
treatment during the course of the trial up to and including the 12-week follow-up. 
Participants were permitted to attend physiotherapy during the 12-week 
follow-up, but no criteria about physiotherapy were set.
RecImMir, group 1 (N = 7)
Components of intervention:
1. hand laterality recognition (2 weeks): whilst seated at a computer monitor, 
participants viewed a random sequence of 56 photographic images of either 
a right or left hand in a variety of postures. Participants were instructed to 
identify whether the displayed image was of a right or left hand by pressing 
an appropriate button on the computer keyboard. Participants borrowed a 
notebook computer to repeat the task at home;
2. imagined hand movements (2 weeks): whilst viewing a random sequence of 
28 images of the affected hand participants were advised to imagine 
moving their own hand to adopt the posture shown in the picture then 
returning it to its resting position, and to repeat the process twice for each 
picture;
3. mirror therapy (2 weeks): using a mirror box which concealed the affected 
limb from view but allowed participants to view a mirror image of their 
unaffected limb, participants viewed a sequence of 20 pictures of the 
unaffected hand and were instructed to slowly and smoothly adopt the 
posture shown in each picture with both hands. Emphasis was placed on 
watching the reflection of their unaffected hand in the mirror.
Dosage: hand laterality task - 3 times, imagined movements task - twice; mirror 
therapy task - 5 times.
Frequency of administration: each waking hour, daily for 2 weeks (6 weeks in 
total).
Provider: not reported.
ImRecIm, group 2 (N = 6)
Components of intervention: 2 weeks imagined movements, 2 weeks hand 
laterality recognition, 2 weeks imagined movements (components described 
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above).
Dosage and frequency of administration: as described above.
RecMirRec, group 3 (N = 7)
Components of intervention: 2 weeks hand laterality recognition, 2 weeks mirror 
therapy, 2 weeks hand laterality recognition (components described above).
Dosage and frequency of administration: as described above.
Outcomes The trial authors assessed outcomes at baseline, at 2 and 4 weeks after 
commencement of treatment, at the end of the 6-week treatment period (week 6) 
and 12 weeks post-treatment (week 18). The trial authors did not state a primary 
outcome.
1. NPS, with responses regarding the 2 previous days (possible range 0 to 
100);
2. self-rated function with respect to 5 self-selected activities or tasks using an 
11-point numerical rating scale (NRS) anchored with "0, completely unable 
to perform" and "10, able to perform normally" (final score average of 5 
tasks, possible range 0 to 10 higher number indicates less severe limitation).
Notes Source of funding: Australian Clinical Research Fellowship from the National 
Health and Medical Research Council of Australia ID 210348.
Statement regarding declarations of interest: not reported.
Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Low risk Quote: "Using a random numbers table, an independent 
investigator allocated consenting patients into one of three 
treatment groups".
Comment: the trial authors used an acceptable method to 
generate the sequence allocation.
Allocation concealment (selection 
bias)
Low risk Quote: "Using a random numbers table, an independent 
investigator allocated consenting patients..."
Comment: the trial authors used an acceptable method to 
conceal the allocation sequence.
Blinding of participants and 
personnel (performance bias)
Low risk Comment: participants were not blinded to treatment 
allocation but a lack of blinding is unlikely to have biased the 
results given that participants received interventions judged 
to have been of relatively equal credibility.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
Low risk Comment: participants were not blinded to treatment 
allocation and self-reported their outcomes but lack of 
blinding unlikely to have biased the results given that 
participants received interventions judged to have been of 
relatively equal credibility.
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Unclear risk
Not applicable.
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Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Low risk Comment: all but 1 randomly assigned participant 
completed the study, and the 1 participant appeared to have 
dropped out from group 3 (as displayed in the published 
report's 'Treatment plan').
Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
High risk Comment: the trial author did not report the method of 
analysis (ITT versus per protocol). The trial authors appear 
to have excluded 1 participant from group 3 from the 
analysis in an apparent violation of the principle of ITT.
Selective reporting (reporting bias) High risk Comment: the trial authors fully reported outcome data 
graphically for all outcomes; but did not report raw data in 
numerical form with measures of variation.
Sample size High risk Quote: "Twenty subjects with chronic CRPS1 initiated by 
wrist fracture and who satisfied stringent inclusion criteria, 
were randomly allocated to one of three groups".
Comment: the small sample size may have introduced bias 
in estimates of treatment effect.
Duration of follow-up Low risk Quote: "Single blind randomised trial with 12-week 
follow-up".
Comment: the trial authors measured outcomes over a 
clinically relevant length of time.
Other bias Unclear risk Comment: we did not identify any other sources of bias.
Moseley 2006
Methods Design: parallel group, 2-arm, single-blind RCT (Australia; dates not reported). 
NB: this trial recruited participants with CRPS I and phantom limb pain. However 
we only included information and data from participants with CRPS for the 
purpose of this systematic review.
Setting: not reported.
Interventions: GMI or physiotherapy and ongoing medical care.
Sample size calculation: a total sample size of 51 participants would detect an 
effect size of 0.80 (equivalent to a reduction in pain of 29 mm on a 100 mm 
VAS), with a probability of 80%, assuming an alpha level of 0.05.
Participants Number of participants: 37 (experimental group N = 17; control group N = 20).
Type of noxious initiating event: mixed (fractures n = 14, soft-tissue injury n = 
15, post carpal tunnel release n = 2, venepuncture site n = 2, post finger/toe 
amputation n = 2, carpal tunnel syndrome n = 1, nail infection n = 1) (upper and 
lower limb).
Diagnostic criteria: Bruehl 1999 (CRPS I).
Baseline characteristics:
1. GMI:
a. mean (SD) age = 45 (14) years; female:male = 11:6;
b. mean (SD) duration of CRPS I: 14 (10) months;
2. physical therapy and ongoing medical care:
a. mean (SD) age = 41 (14) years; female:male = 15:5;
b. mean (SD) duration of CRPS I: 12 (8) months.
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Inclusion criteria: CRPS I of an upper or lower limb.
Exclusion criteria:
1. any other neurologic, psychopathology or motor disorder;
2. dyslexia;
3. difficulty performing a rapid naming task;
4. visually impaired;
5. any other limb pathology or pain;
6. lived outside the immediate metropolitan area of the host department.
Interventions GMI (N = 17)
Components of intervention
1. limb laterality recognition phase (2 weeks): whilst seated at a computer, 
participants viewed a random sequence of photographic images (matched 
to gender) of either a right or left hand (participants with an affected upper 
limb) or foot (participants with an affected lower limb) in a variety of 
positions and alignments. Participants indicated whether the displayed 
image was of a right or left limb by pressing an appropriate key on the 
computer keyboard;
2. imagined movements phase (2 weeks): whilst viewing a random sequence 
of images of both limbs participants were required to imagine twice adopting 
the posture shown with a smooth and pain-free movement;
3. mirror movements phase (2 weeks): using a mirror box which concealed the 
affected limb from view but allowed participants to view a mirror image of 
their unaffected limb, participants viewed a sequence of images and were 
instructed to twice adopt the posture shown with both limbs, using smooth 
and pain-free movements.
Dosage: participants were prescribed a training protocol of gradually increased 
training load according to task difficulty during each of the 3 GMI phases, as 
detailed by the trial authors.
Frequency of administration: hourly training (further details not reported).
Provider: physiotherapist.
Physiotherapy and ongoing medical care (N = 20)
Components of intervention: not reported.
Dosage: not reported.
Frequency of administration: minimum of once per week together with a hourly 
home programme.
Provider: physiotherapists.
Outcomes Outcomes assessed at baseline, at the end of the 6-week treatment period and 6 
months post-treatment.
Primary outcomes:
1. self-rated function with respect to 5 self-selected activities or tasks using an 
11-point NRS anchored with "0, completely unable to perform" and "10, able 
to perform normally";
2. self-rated pain severity using a 0 to 100mm VAS (anchor points not 
described) to rate average level of pain over the last 2 days;
3. McGill Pain Questionnaire (MPQ).
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Notes Original trial publication reported data for participants with CRPS I and phantom 
limb pain (N = 51). Details reported above refer to only those participants with 
CRPS I (N = 37).
Source of funding: not reported
Statement regarding declarations of interest: the authors declared no 
conflicts of interest.
Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Low risk Quote: "Patients were randomized via random number 
generation by an independent investigator...using a random 
numbers table".
Comment: the trial authors used an acceptable method to 
generate the sequence allocation.
Allocation concealment (selection 
bias)
Low risk Quote: "Patients were randomized via random number 
generation by an independent investigator..."
Comment: the trial authors used an acceptable method to 
conceal the allocation sequence.
Blinding of participants and 
personnel (performance bias)
High risk Comment: given the nature of the intervention, participants 
were not blinded to treatment and may have had different 
expectations about the benefits of each intervention.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
High risk Comment: unblinded participants, who may have had 
different expectations about the benefits of the intervention 
they received, self-reported some outcomes (e.g. pain 
intensity).
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Low risk
Not applicable.
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Low risk Quote: "One female subject in the control group withdrew 
from the study because she sustained an unrelated injury. 
There were no other dropouts or withdrawals".
Comment: the minimal drop-out rate (5% from 1 trial arm) is 
unlikely to have biased the results.
Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
Low risk
Comment: the trial authors performed an available case 
analysis.
Selective reporting (reporting bias) Low risk Comment: the trial authors fully reported outcome data for 
self-reported function and pain severity outcomes for 
participants with CRPS and phantom limb pain combined as 
conceived in the original trial design. They presented 
outcome data for participants with CRPS graphically only.
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Sample size High risk Quote: "Fifty-one patients [37 with CRPS] with phantom limb 
pain or CRPS1 were randomly allocated".
Comment: the small sample size may have introduced bias 
in estimates of treatment effect. (We acknowledge that our 
judgement regarding the risk of bias linked to sample size 
for this study is based on the purposeful exclusion of a 
number of participants with phantom limb pain (N = 14) that 
the original design did not intend).
Duration of follow-up Low risk Quote: "All assessments were undertaken at 
prerandomization and at 6 weeks (completion of the 
treatment period). Pain VAS and function NRS were also 
undertaken at 6 months follow-up".
Comment: the trial authors measured outcomes over a 
clinically relevant length of time.
Other bias Unclear risk Comment: we did not identify any other sources of bias.
Moseley 2009
Methods Design: within-subject randomised crossover design (Australia; dates not 
reported).
Setting: not reported.
Interventions: tactile discrimination training (TDT) under 4 separate conditions.
Sample size calculation: not reported.
Participants Number of participants: 10.
Type of noxious initiating event: mixed (fractures of the hand or wrist n = 4, 
sprains n = 2, carpal tunnel syndrome n = 2, post hand cannulation n = 1, thumb 
dislocation n = 1) (upper limb).
Diagnostic criteria: Bruehl 1999 (CRPS I).
Baseline characteristics:
1. mean (SD) age = 43 (11) years; female:male = 6:4;
2. mean (SD) duration of CRPS I: 20 (5) months.
Inclusion criteria: CRPS of 1 wrist of hand.
Exclusion criteria: not reported.
Interventions TDT (N = 10)
Components of intervention:
1. two probes (2 mm and 12 mm in diameter) were applied to 1 of 5 
stimulation sites on the affected limb in a random order, with an 
interstimulus interval of 15 seconds;
2. TDT was performed under 4 different conditions:
a. facing + skin: involved participants watching the reflected image of their 
unaffected, non-stimulated arm in a mirror placed between the upper 
limbs while facing the stimulated arm;
b. skin only: involved participants watching their unaffected, 
non-stimulated arm directly
c. facing only: involved participants looking in the direction of their 
affected, stimulated arm but with no mirror and the unaffected limb 
hidden;
d. control condition: involved participants looking away from their 
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stimulated limb with the unaffected limb hidden.
Dosage: three 6-minute blocks of 24 stimuli were undertaken with a 3-minute rest 
period between blocks. Each treatment session involved 72 stimuli and lasted for 
24 minutes.
Frequency of administration: each participant received 4 sessions of each 
experimental condition in varying order (total of 16 sessions), with 3 to 4 days 
between sessions.
Provider: not reported.
Outcomes The trial authors assessed outcomes at baseline, immediately and 2 days 
post-treatment.
Primary outcomes: 2-point discrimination threshold, measured in mm, using a 
mechanical calliper.
Secondary outcomes: self-rated current pain (at rest) severity using a 100 mm 
VAS anchored with "no pain" and "worst possible pain".
Notes Source of funding: Nuffield Oxford Medical Fellowship, NHMRC Senior 
Research Fellowship, Templeton Foundation.
Statement regarding declarations of interest: the authors declared no 
conflicts of interest.
Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Unclear risk Quote: "The conditions were randomised and 
counterbalanced so that each participant had four sessions 
of each condition, but in varying order".
Comment: the trial authors did not report the method of 
sequence generation.
Allocation concealment (selection 
bias)
Low risk Comment: this was not applicable (when crossover design 
employed).
Blinding of participants and 
personnel (performance bias)
Unclear risk Comment: given the nature of the intervention, participants 
were not blinded to treatment allocation but the extent to 
which the lack of blinding may have introduced bias is 
uncertain.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
Unclear risk Comment: unblinded participants self-reported some 
outcomes (e.g. pain intensity) but the extent to which the 
lack of blinding may have introduced bias is uncertain.
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Unclear risk
Comment: we do not known whether or not the outcome 
assessors were blinded to the treatment condition.
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Low risk Comment: the trial authors did not report any drop-outs; 
they presented results based on the total number of 
included participants.
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Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
Low risk
Comment: not applicable (when crossover design 
employed).
Selective reporting (reporting bias) High risk Comment: the trial authors fully reported outcome data 
graphically for all outcomes; they did not report raw data in 
numerical form with measures of variation.
Sample size High risk Quote: "Ten patients with chronic CRPS of one hand or 
wrist (diagnosed according to Bruehl et al.) were recruited".
Comment: the small sample size may have introduced bias 
in estimates of treatment effect.
Duration of follow-up High risk Quote: "The TPD for the three sites was averaged to 
provide a measure at pre-training, post-training and 2 days 
later".
Comment: the trial authors did not measure outcomes over 
a clinically relevant length of time.
Other bias Unclear risk Quote: "...there were 1 2 days between the follow-up 
assessment and the next training session. Participants were 
advised not to undertake tactile training in between 
sessions".
Comment: the extent to which an interval of 1 to 2 days 
between outcome assessment and training sessions 
represented an adequate wash-out period, and therefore 
the extent to which a carry-over effect may have introduced 
bias in estimates of treatment effect, is not known.
Mucha 1992
Methods Design: parallel group, 2-arm RCT (Germany; dates not reported). (The trial 
authors reported that participants in the control group crossed over into the 
experimental group. However, we deemed that this trial did not employ a true 
crossover design and we analysed it as a 2-arm parallel group trial up to the 
endpoint just prior to crossover).
Setting: not reported.
Interventions: CO2 baths plus exercise therapy or exercise therapy alone.
Sample size calculation: not reported.
Participants Number of participants: 40 (20 per group).
Type of noxious initiating event: post-trauma (no further details reported) 
(upper limb).
Diagnostic criteria: acute algodystrophy of the hand (diagnostic criteria not 
reported).
Baseline characteristics:
Total sample (separate intervention and control group data not reported).
Age range 47 to 56 years (group data not reported).
Duration of CRPS (range) 2 to 6 weeks (group data not reported).
1. CO2 baths plus exercise therapy
a. Female:male = 13:7
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2. exercise alone
a. Female:male = 11:9
Inclusion criteria:
1. CRPS I of the hand;
2. post-traumatic onset;
3. 'high active stage of condition';
4. minimum of 2 weeks duration of symptoms.
Exclusion criteria: more than 6 weeks duration of symptoms.
Interventions Those participants on medication prior to the trial were instructed to cease their 
medication at the start of the trial.
CO2 baths plus exercise (N = 20)
Components of intervention
1. CO2 bath;
2. after the bath, 30 to 45 minutes rest in an anti-swelling functional position;
3. exercise therapy (as below).
Dosage: 12 minute CO2 bath with water temperature of 32 to 33 °C and a CO2 
concentration of 800 to 1000 mg/L.
Frequency of administration: 5 times a week for 4 weeks (20 sessions).
Provider: not reported.
Exercise (N = 20) 
Components of intervention: progressive exercise therapy. The intensity was 
dependent on pain level and symptom behaviour.
Dosage: not reported.
Frequency of administration: 5 times a week for 4 weeks (20 sessions).
Provider: not reported.
Outcomes The trial authors assessed outcomes at baseline and twice weekly until 
completion of the intervention period (4 weeks post recruitment). The trial authors 
did not state any primary outcomes.
1. self-rated pain intensity at rest; measured using a graphic analogue scale 
(no scale reported);
2. self-rated pain intensity at night; measured using a graphic analogue scale 
(no scale reported);
3. self-rated pain intensity with movement; measured using a graphic 
analogue scale (no scale points reported);
4. hand circumference: measured over the wrist, MCPs and DIPs, recorded in 
cm. Probably difference between sides. Only MCP data provided;
5. range of motion: neutral 0 method of forearm, hand and fingers, recorded in 
degrees, only wrist data reported;
6. grip strength: hand held dynamometer, relative to other side;
7. temperature: difference between sides; more than 0.8 degrees difference 
was recorded as positive.
Notes Source of funding: not reported
Statement regarding declarations of interest: not reported
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Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Unclear risk Quote: " Patients were randomised into two groups".
Comment: the trial authors did not report the method of 
sequence generation.
Allocation concealment (selection 
bias)
Unclear risk Comment: the trial authors did not report the method of 
concealment allocation.
Blinding of participants and 
personnel (performance bias)
High risk Comment: given the nature of the intervention, participants 
were not blinded to treatment and may have had different 
expectations about the benefits of each intervention.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
High risk Comment: unblinded participants, who may have had 
different expectations about the benefits of the intervention 
they received, self-reported some outcomes (e.g. pain 
intensity).
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Unclear risk
Comment: the trial authors did not report the statement of 
procedures regarding blinding of the outcome assessor.
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Low risk
Comment: there were no apparent drop-outs.
Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
Low risk Comment: the trial authors analysed participants in the 
group to which they were allocated but did not report the 
method of analysis (ITT versus per protocol).
Selective reporting (reporting bias) High risk Comment: the trial authors fully reported outcome data 
graphically for all outcomes; but did not report raw data in 
numerical form with measures of variation.
Sample size High risk Quote: "20 participants per group".
Comment: the small sample size may have introduced bias 
in estimates of treatment effect.
Duration of follow-up High risk Comment: comparison was only possible immediately at the 
end of the 4-week therapy session as the control group 
crossed over to the treatment arm at this point.
Other bias Low risk Quote: "Statistical testing showed homogeneity across both 
groups".
Comment: there were no apparent baseline differences 
between groups.
Comment: we did not identify any other sources of bias.
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Oerlemans 1999
Methods Design: parallel group, 3-arm, single-blind RCT (The Netherlands; June 1994 to 
February 1998).
Setting: outpatient clinics of 2 university hospitals.
Interventions: physical therapy (PT) plus medical treatment or occupational 
therapy (OT) plus medical treatment or social work (SW) plus medical treatment 
(control).
Sample size calculation: the study planned to recruit 150 participants (50 per 
group) in order to be able to detect between-group differences of 6 to 7 points in 
the impairment level sumscore (ISS) with 80% power.
Participants Number of participants: 135 (physical therapy group N = 44; OT group N = 44; 
SW (control) group N = 47).
Type of noxious initiating event: mixed (fracture (53%), spontaneous onset 
(13%), contusion (11%), mallet finger, carpal tunnel syndrome, postoperative 
interventions, sprains (proportions not reported) (upper limb).
Diagnostic criteria: Veldman 1993 (CRPS I).
Baseline characteristics:
1. PT:
a. mean (SD) age = 50.4 (15.6) years; female:male = 29:15;
b. mean (SD) duration of CRPS I: 3.1 (3.4) months;
2. OT:
a. mean (SD) age = 56.3 (17) years; female:male = 31:13;
b. mean (SD) duration of CRPS I: 2.9 (2.5) months;
3. SW:
a. mean (SD) age = 51.5 (16.9) years; female:male = 35:12;
b. mean (SD) duration of CRPS I: 2.9 (3.1) months.
Inclusion criteria:
1. CRPS I of 1 upper limb of less than 1 year duration;
2. participants could complete treatment at 1 of 2 study sites;
3. aged 18 years or older.
Exclusion criteria:
1. impairment of contralateral extremity;
2. relapse of CRPS I;
3. pregnancy or lactation;
4. prior sympathectomy of the affected extremity.
Interventions All participants received medical treatment according to a fixed pre-established 
protocol, consisting of free-radical scavengers (dimethylsulfoxide (DMSO) 50% 
applied locally 5 times a day at the affected location or if DMSO-intolerant, 
N-acetylcysteine (600 mg 3 times a day), peripheral vasodilators in the case of 
primarily cold CRPS I (calcium entry blocker verapamil, sustained-release 240 
mg once per day or ketanserine 20 mg twice per day eventually increased to 40 
mg or pentoxifylline 400 mg twice per day) and treatment of trigger points. 
Participants also received general information regarding CRPS I; including 
advice to rest the extremity and not provoke pain.
PT (N = 44)
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Components of intervention:
1. intensity and form of treatment adjusted to the needs of each individual 
participant;
2. pain management advice/counselling directed towards helping participants 
gain control of the pain and optimise coping by offering insight, practical 
advice, and support and/or by relaxation exercises;
3. connective tissue massage, transcutaneous electric nerve stimulation 
(TENS), exercises for reducing the pain (details not reported);
4. instruction, training and practicing of skills by addressing compensatory 
activities and body positioning (details not reported).
Dosage: 30 minutes per session (details for individual components not reported).
Frequency of administration: adjusted to the needs of each individual participant 
(details not reported).
Provider: physical therapists.
OT (N = 44)
Components of intervention:
1. intensity and form of treatment adjusted to the needs of each individual 
participant;
2. splinting;
3. desensitisation (tactile and proprioceptive) programme (details not reported);
4. improving functional abilities of the arm/hand by executing various activities, 
while moving as normally as possible;
5. training to improve performance of activities of daily living (e.g. learning how 
to perform activities differently, advice regarding assistive devices).
Dosage: 30 minutes per session (details for individual components not reported).
Frequency of administration: adjusted to the needs of each individual participant 
(details not reported).
Provider: occupational therapists.
SW (N = 47)
Components of intervention:
1. participants were given attention in the form of listening and insight into the 
social problems accompanying CRPS I;
2. advice regarding how not to evoke pain, rest and asking for help with 
performing activities perceived as excessively demanding.
Dosage: 45 minutes per session.
Frequency of administration: adjusted to needs of each individual participant 
(details not reported).
Provider: social workers.
Outcomes Outcomes, as reported across trial reports, variously assessed at baseline and at 
6 weeks, 3 months, 6 months and 12 months post recruitment. The primary 
endpoint was the difference in impairment level sum score between baseline and 
12 months post recruitment.
1. Self-rated pain intensity (present) using a VAS (0 to 100 scale, anchor 
points not reported);
2. self-rated pain intensity (resulting from effort with the affected extremity) 
using a VAS (0 to 100 scale, anchor points not reported);
3. self-rated pain intensity (least pain experienced in the preceding week) 
using a VAS (0 to 100 scale, anchor points not reported);
4. self-rated pain intensity (worst pain experienced in the preceding week) 
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using a VAS (0 to 100 scale, anchor points not reported);
5. McGill Pain Questionnaire (Dutch language version), including the: a. total 
pain rating index (PRI-T), b. total number of words chosen (NWC-T), c. 
number of 'sensory' words chosen (NWT-S), d. number of 'affective' words 
chosen (NWT-A), e. number of 'evaluative' words chosen (NWT-E);
6. percentage of reduced normal mobility, measured by dividing the difference 
in active range of motion, as measured with a plastic transparent 
goniometer, between the joints (shoulder, elbow, wrist, digits) of the 
affected and unaffected upper limbs;
7. impairment rating (according to the Guides to the Evaluation of Permanent 
Impairment (GEPI): a composite score derived from a. measures of loss of 
active range of motion assessed using goniometry, b. sensory loss in the 
fingers and thumb assessed via 2-point discrimination testing and c. grip 
strength assessed by a dynamometer; with a maximum possible score of 
60%, with higher scores indicating greater impairment (only measured at 12 
months post-treatment; not measured at baseline);
8. impairment level sumscore (ISS): constructed to map alterations in 
impairment in RSD participants; formed by outcomes obtained with 4 
measurement parameters and 5 instruments. The outcomes for each 
instrument are converted into a score, from which the compounded ISS is 
derived, including a. VAS pain/effort; b. McGill Pain Qr (NWC-T); c. active 
ROM (from 5 joints (wrist/fingers); d. temperature difference between 
hands; e. volume difference between hands. Score range was from 5 to50, 
with higher scores indicating more severe impairment;
9. the Radboud Skills Questionnaire; used to determine the perceived degree 
of deviation from normal use of both hands in activities of daily living (details 
regarding scoring and interpretation not reported);
10. the modified Greentest; used to measure differences in the degree to which 
both hands could move light objects (e.g. small pins, discs) within 15 
seconds using different grips (details regarding scoring and interpretation 
not reported);
11. the Radboud Dexterity Test; used to make qualitative assessments of 7 
skills associated with daily activities (e.g. closing a zip fastener, washing 
hands) (details regarding scoring and interpretation not reported);
12. Sickness Impact Profile (SIP) 36. The total score was computed (score 
range of 0 to 100) as well as the sub-scores for the degree of physical 
dysfunction and the degree of psychosocial dysfunction (details regarding 
scoring and interpretation not reported).
Notes Source of funding: research grant from the National Health Insurance Board 
(Ziekenfondsraad), The Netherlands.
Statement regarding declarations of interest: not reported.
Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Low risk Quote: "Patients were randomly assigned to one of three 
groups".
Quote: "Randomisation was restricted to blocks of six".
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Quote: "Assigmnent to groups was performed according to 
allocation lists established by the Department of Medical 
Statistics of the University of Nijmegen".
Comment: the trial authors used an acceptable method to 
generate the sequence allocation.
Allocation concealment (selection 
bias)
Unclear risk Quote: "Assigmnent to groups was performed according to 
allocation lists established by the Department of Medical 
Statistics of the University of Nijmegen".
Comment: the trial authors did not adequately report the 
method of concealment allocation.
Blinding of participants and 
personnel (performance bias)
High risk Comment: given the nature of the intervention, participants 
were not blinded to treatment and may have had different 
expectations about the benefits of each intervention.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
High risk Comment: unblinded participants, who may have had 
different expectations about the benefits of the intervention 
they received, self-reported some outcomes (e.g. pain 
intensity).
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Unclear risk Comment: we do not know if outcome assessors were 
blinded to treatment allocation when measuring percentage 
loss of joint mobility, impairment ratings, impairment level 
sumscore and disability-based measures.
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Unclear risk Quote: "After inclusion in the study, 44 patients were 
assigned to PT, 44 patients to OT and 47 patients to CT. In 
the course of the 1-year study period, seven, four and four 
patients abandoned the trial, respectively".
Comment: whilst the overall drop-out rate was acceptable 
(11%), there was an unequal drop-out rate between groups 
(PT: 16%, OT: 9%, CT: 9%) and the trial authors did not 
report the reasons for dropping out.
Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
Low risk Quote: "Two analyses were done: an intention-to-treat 
analysis (ITT) and a per-protocol analysis (PP). In the ITT 
analysis, outcomes of all the participants were used for the 
group they were originally assigned to. In the PP analysis, 
outcomes of protocol violators were ignored".
Quote: "Three patients from the PT group could not 
complete the treatment protocol (so were protocol violators) 
but had test continuity".
Comment: the trial authors presented limited data from both 
ITT and per protocol analyses for selected outcomes.
Selective reporting (reporting bias) High risk Comment: the trial authors reported limited and incomplete 
outcome data across 4 separate trial reports for 
self-reported pain and disability outcomes and for 
investigator-administered outcomes.
Comment: no numerical data presented for 3 out of the 4 
measures of self-rated pain intensity or percentage of 
reduced normal mobility outcomes.
Comment: no numerical data reported for impairment rating.
Comment: limited numerical data presented for ISS.
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Comment: no numerical data presented for the Radboud 
Skills Questionnaire, modified Greentest or Radboud 
Dexterity Test.
Sample size High risk Quote: "After inclusion in the study, 44 patients were 
assigned to PT, 44 patients to OT and 47 patients to CT".
Comment: the small sample size may have introduced bias 
in estimates of treatment effect.
Duration of follow-up Low risk Quote: "Re-assessment was performed 6 weeks (t1), 3 
months (t2), 6 months (t3) and 12 months (t4) after inclusion 
in the study".
Comment: the trial authors measured outcomes over a 
clinically relevant length of time.
Other bias High risk Quote: "If, during the period of the trial, the patient explicitly 
indicated that he or she wanted to switch to another 
adjuvant therapy, this was allowed. Using a coin, with heads 
or tails it was decided which adjuvant therapy was next".
Quote: "Fourteen patients switched therapies: 12 from CT to 
PT (nine patients) or OT (three patients) and two from OT to 
PT".
Comment: violations of the random sequence generation 
were permitted.
Quote: "Thus, with the inclusion of 135 patients, the power 
to recognize significant differences was somewhat smaller: 
the power to detect a significant treatment effect within each 
group was 72%, whereas differences between the 3 groups 
could be established with a power of 79%".
Comment: the trial was slightly underpowered, which may 
have introduced bias in estimates of treatment effect and/or 
contributed to a lack of precision regarding estimates of 
treatment effect.
Schreuders 2014
Methods Design: parallel group, 2-arm, single-blind RCT (The Netherlands; dates not 
reported).
Setting: not reported.
Interventions: GMI programme plus conventional treatment or conventional 
treatment alone.
Sample size calculation: not reported.
Participants Number of participants: 18 (experimental group N = 11, control group N = 7).
Type of noxious initiating event: not reported (upper limb).
Diagnostic criteria: Bruehl 1999 (CRPS I).
Baseline characteristics:
1. GMI programme (and included in the analysis N = 10):
a. mean (SD) age = 42.4 (16.8) years; female:male = 8:2;
b. mean (SD) duration of CRPS I: 50.3 (53.7) months;
2. standard care (and included in the analysis N = 5):
a. mean (SD) age = 52.8 (12.7) years; female:male = 4:1;
b. mean (SD) duration of CRPS I: 127.4 (87.5) months.
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Inclusion criteria:
1. aged between 18 and 75 years;
2. symptoms > 6 months.
Exclusion criteria: not reported
Interventions All participants received conventional treatment including a 6-week OT and 
physiotherapy programme, including training of grip function, muscle 
strengthening and joint mobility interventions, writing exercises and advice to 
reduce the use of splints. Participants were asked not to participate in other 
treatment programmes during the 12-week period and not to change the type or 
dosage medication of their medication unless instructed to do so by their 
physician.
GMI programme (N = 11)
Components of intervention:
1. adapted from Moseley 2004;
2. hand laterality recognition (1 week);
3. visual movement imagery exercises (1 week);
4. mirror therapy (4 weeks).
Dosage: 10 minutes.
Frequency of administration: every hour (3 times per day minimum) for a total of 
6 weeks.
Provider: therapists (distinction between physio- and occupational therapist not 
reported).
Standard care (N = 7)
Components of intervention:
1. supervised exercise (first 3 weeks);
2. feedback regarding home exercises (second 3 weeks);
3. training of grip functions (details not reported);
4. muscle strengthening exercises (details not reported);
5. joint mobility (details not reported);
6. housekeeping and other daily activities (details not reported);
7. writing exercises;
8. coaching to reduce the use of splints.
Dosage: 60 minutes per week (over 1 or 2 sessions).
Frequency of administration: 1 or 2 sessions per week, for 6 weeks.
Provider: physical therapists and occupational therapists.
Outcomes Outcomes were assessed at baseline and after 3, 6 (immediately post-treatment) 
and 12 weeks (6 weeks post-treatment) post enrolment.
Primary outcomes:
1. self-rated current pain intensity using a VAS ranging from 0 (no pain) to 100 
(unbearable pain);
2. self-rated minimum pain intensity (last 3 days) using a VAS ranging from 0 
(no pain) to 100 (unbearable pain);
3. self-rated maximum pain intensity (last 3 days) using a VAS ranging from 0 
(no pain) to 100 (unbearable pain);
4. activities of daily living using the Radboud Skills Questionnaire (RASQ) 
total score and 3 sub-scales:
a. clothing, washing, eating;
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b. household activities;
c. recreation, social activities.
Secondary outcomes: fine hand coordination of both hands by using the Nine 
Hole Peg Test (recorded in seconds).
Notes Source of funding: ErasmusMC Mrace Project Zorg 2004-20, grant number 
2004-20.
Statement regarding declarations of interest: the trial authors declared no 
conflicts of interest.
Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Low risk Quote: "Based on a computerized random schedule..."
Comment: the trial authors used an acceptable method to 
generate the sequence allocation.
Allocation concealment (selection 
bias)
Low risk Quote: "Based on a computerized random schedule, a 
researcher not involved in the execution of the trial, made a 
sequence of numbered opaque envelopes. These 
envelopes were prepared with equality being achieved after 
every ten subjects (block size 10)".
Quote: "Envelopes were given in sequence of entry to the 
patient and were opened by the patient".
Comment: the trial authors used an acceptable method to 
conceal the allocation sequence.
Blinding of participants and 
personnel (performance bias)
High risk Quote: "Patients were not blinded to the treatment as they 
were aware of the treatment content".
Comment: given the nature of the intervention, participants 
were not blinded to treatment and may have had different 
expectations about the benefits of each intervention.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
High risk Comment: unblinded participants, who may have had 
different expectations about the benefits of the intervention 
they received, self-reported some outcomes (e.g. pain 
intensity).
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Low risk Quote: "The assessor was blinded for the allocation to the 
experimental or control group".
Quote: "The measurements were performed by trained 
blinded assessors".
Comment: the trial authors blinded outcome assessors to 
participant group allocation
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
High risk Comment: the trial authors did not adequately report 
drop-out rate in the 'Results' section of the manuscript.
Comment: according to 'Figure 2' of the manuscript, 1 
participant was lost to follow-up and 2 discontinued the 
intervention from the experimental group, 1 participant 
withdrew after randomisation, 1 participant was lost to 
follow-up and 3 discontinued the intervention from the 
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conventional treatment group, giving drop-out rates of 27% 
and 71% respectively, and an overall drop-out rate of 44%.
Comment: the high drop-out rate may have introduced bias 
in estimates of treatment effect.
Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
High risk Comment: the trial authors reported analysis as ITT in 
Figure 2 of the unpublished manuscript.
Quote: "Three patients (one in the experimental group, two 
in the control group) could not be included in the analysis 
due to insufficient compliance in filling out the VAS and 
RASQ questionnaires or because of immediate withdrawal 
from the control therapy because the participants only 
wanted the graded MIP".
Comment: violation of the principle of ITT analysis may 
have introduced bias in estimates of treatment effect.
Quote: "From seven of the remaining fifteen patients (five in 
the experimental group and two in the control group) there 
were missing end-tests" (i.e. at 12 weeks post enrolment/6 
weeks postintervention).
Quote: "Differences in changes in both groups over times 
were tested using a generalized estimating equations (GEE) 
approach. Under the assumption that missing data were 
random and not due to group allocation or treatment effect, 
this model estimates missing data values, thereby allowing 
the use of data from all participants, irrespective of whether 
they were measured at all time points".
Comment: use of GEE may have introduced bias in 
estimates of treatment effect.
Selective reporting (reporting bias) High risk Comment: the trial authors reported outcome data 
graphically for all self-reported pain outcomes; and did not 
report raw data in numerical form with measures of 
variation. The trial authors presented effect sizes with 
measures of variation for the Radboud Skills Questionnaire 
and Nine Hole Peg Test; and did not report numerical data 
with measures of variation.
Sample size High risk Quote: "For this trial eighteen patients were included".
Quote: "For this study only 18 patients were assessed for 
eligibility and only 15 of them could be included in the 
analysis. The number of patients in the study was therefore 
too small to detect possible effects with the intended power 
for which 52 patients were needed".
Comment: the small sample size may have introduced bias 
in estimates of treatment effect.
Duration of follow-up Unclear risk Quote: "Outcome was assessed at baseline, after 3, 6 and 
12 [i.e. 6 weeks post-treatment] weeks".
Comment: the clinical relevance of a 6-week follow-up of 
outcomes is uncertain.
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Other bias High risk Comment: baseline data for 3 participants excluded from 
the analysis not reported.
Comment: likely highly significant baseline imbalance in 
duration of symptoms between groups.
Uher 2000
Methods Design: parallel group, 2-arm, RCT (Germany, dates not reported).
Setting: not reported.
Interventions: manual lymph drainage (MLD) plus exercise or exercise alone.
Sample size calculation: not reported.
Participants Number of participants: 40 (15 in the manual lymph drainage group, 25 in the 
exercise alone group).
Type of noxious initiating event: mixed (postfracture n = 27, post dislocation n 
= 9, postsurgery n = 4) (lower limb).
Diagnostic criteria: CRPS I (diagnostic criteria not reported).
Baseline characteristics:
Total sample: female:male 31:4.
1. Group receiving manual lymph drainage plus exercise:
a. mean (SD) age = not reported; female:male = not reported;
b. mean (SD) duration of CRPS I = not reported.
2. Group receiving exercise:
a. mean (SD) age = not reported; female:male = not reported;
b. mean (SD) duration of CRPS I = not reported.
Inclusion criteria:
1. clinical, radiographic and scintigraphic signs of CRPS 1;
2. < 6 months post-trauma/surgery.
Exclusion criteria:
1. venous insufficiency;
2. recurrent thrombophlebitis;
3. peripheral vascular disease;
4. blood disorders;
5. currently receiving physical treatment.
Interventions Participants were given a brochure providing general advice (details not 
reported), no analgesic or anti-inflammatory medication prescribed, participants 
were asked to inform the clinician if they took analgesia or anti-inflammatory 
medication for more than 3 days.
Manual lymph drainage plus exercise (N = 15)
Components of intervention:
1. manual lymph drainage (further details not reported);
2. exercise (as below).
Dosage: 30 minutes
Frequency of administration: 3 times per week for 6 weeks (18 sessions)
Provider: physiotherapists
Exercise (N = 25)
Components of intervention:
1. goal to improve range of motion and reduce pain;
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2. rhythmic stabilisation techniques of Klein Vogelbach and passive 
movements as tolerated of the affected ankle.
Dosage: 30 minutes.
Frequency of administration: 3 times per week for 6 weeks (18 sessions).
Provider: physiotherapists.
Outcomes Outcomes assessed at baseline and immediately on completion of the 
intervention period (6 weeks post recruitment). The trial authors did not state any 
primary outcome.
1. Self-rated pain intensity measured using a 6-point verbal rating scale (0 = 
no pain, 5 = maximum pain);
2. range of motion (dorsiflexion and plantarflexion) at the talocrural joint 
measured using a goniometer;
3. temperature measured using a surface thermometer, between the malleoli, 
with the value recorded as the difference between 2 sides;
4. swelling measured as the difference in ankle circumference (in cm), at level 
of malleoli, between 2 sides;
5. radiological assessment (details not reported);
6. scintigraphic assessment (details not reported).
Notes Source of funding: not reported.
Statement regarding declarations of interest: not reported.
Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence generation 
(selection bias)
Unclear risk Comment: the trial authors did not report the method of 
sequence generation.
Allocation concealment (selection 
bias)
Low risk Quote: "Randomisation was done using the sealed 
envelope method, by a doctor not involved in the study".
Comment: the trial authors used an acceptable method to 
conceal the allocation sequence.
Blinding of participants and 
personnel (performance bias)
High risk Comment: given the nature of the intervention, participants 
were not blinded to treatment and may have had different 
expectations about the benefits of each intervention.
Blinding of outcome assessment 
(detection bias) 
Self-reported outcomes
High risk Comment: unblinded participants, who may have had 
different expectations about the benefits of the intervention 
they received, self-reported some outcomes (e.g. pain 
intensity).
Blinding of outcome assessment 
(detection bias) 
Investigator-administered 
outcomes
Low risk Quote: "Tested by a doctor who did not know group 
assignment".
Comment: the outcome assessor was blinded to treatment 
allocation.
Incomplete outcome data (attrition 
bias) 
Drop-out rate described and 
acceptable
Low risk
Comment: an overall, and balanced, drop-out rate of 12% is 
unlikely to have biased the results.
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Incomplete outcome data (attrition 
bias) 
Participants analysed in the group 
to which they were allocated
High risk Comment: the trial authors excluded 3 participants (2 from 
the MLD group and 1 from the exercise group) were 
excluded from the analysis because they did not regularly 
attend for therapy, in violation of the ITT principle. Two 
participants from the exercise group were excluded after 
randomisation secondary to wrongful inclusion despite 
fulfilment of exclusion criteria
Selective reporting (reporting bias) High risk Comment: the trial authors did not report outcome data for 
pain intensity.
Sample size High risk Comment: the small sample size may have introduced bias 
in estimates of treatment effect.
Duration of follow-up High risk Quote: "Assessment after six weeks of therapy".
Comment: outcomes were re-measured on immediate 
completion of the intervention period only and were not 
measured over a clinically relevant length of time.
Other bias Low risk Comment: we did not identify any other sources of bias.
Footnotes
Abbreviations: CRPS I: complex regional pain syndrome type 1; CT: control therapy; GMI: graded motor 
imagery; IFC: interferential current; ITT: intention to treat; MIP: motor imagery programme; MLD: manual 
lymphatic drainage; NRS: numerical rating scale; OT: occupational therapy; PT: physiotherapy/physical 
therapy; RCT: randomised controlled trial; RSD: reflex sympathetic dystrophy; SD: standard deviation; SGB: 
stellate ganglion block; SPSS: Statistical Package for the Social Sciences; SW: social work; TDT: tactile 
discrimination training; TENS: transcutaneous electrical nerve stimulation; TPD: two-point discrimination; US: 
ultrasound; VAS: visual analogue scale.
Characteristics of excluded studies
Bolel 2006
Reason for exclusion This study only evaluated the outcome measure of 'sympathetic skin response' 
and fell outside the inclusion criteria of this review.
Fialka 1992
Reason for exclusion Not a RCT.
Fialka 1996
Reason for exclusion Autogenic training does not fall within the scope of practice of physiotherapy.
Field 1993
Reason for exclusion Not a RCT.
Gromo 1974
Reason for exclusion Not a RCT.
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Jasmina 2012
Reason for exclusion Not a RCT.
Karabegovi  2009
Reason for exclusion Not a RCT.
Koci  2010
Reason for exclusion The study authors only evaluated 'infrared thermovision' as the only outcome 
measure and fell outside the inclusion criteria of this review.
Perrigot 1982
Reason for exclusion Not a RCT.
Toth 2014
Reason for exclusion The trial included participants (N = 54) with mixed aetiologies but only 2 
participants with complex regional pain syndrome (CRPS) with 1 randomised to 
each trial arm. We could not make any meaningful comparison.
Tulgar 1991
Reason for exclusion Not a RCT.
Wu 1999
Reason for exclusion Qigong does not fall within the scope of practice of physiotherapy.
Zyluk 1994
Reason for exclusion Not a RCT.
Footnotes
Abbreviations: RCT: randomised controlled trial.
Characteristics of studies awaiting classification
ISRCTN39729827
Methods Unavailable.
Participants Unavailable.
Interventions Unavailable.
Outcomes Unavailable.
Notes We are awaiting submission for publication.
Physiotherapy for pain and disability in adults with complex regional pain syndrome...26-Feb-2016
Review Manager 5.2 81
Mete-Topcuoglu 2010
Methods Not yet assessed.
Participants Not yet assessed.
Interventions Not yet assessed.
Outcomes Not yet assessed.
Notes This is currently only available as a conference abstract.
NCT00625976
Methods Unavailable.
Participants Unavailable.
Interventions Unavailable.
Outcomes Unavailable.
Notes We were unable to contact the study authors.
Footnotes
Characteristics of ongoing studies
Barnhoorn 2012
Study name The effectiveness and cost evaluation of pain exposure physical therapy and 
conventional therapy in patients with complex regional pain syndrome type 1. 
Rationale and design of randomized controlled trial.
Methods Parallel-group, 2-arm randomised controlled trial (RCT) (The Netherlands)
Participants Inclusion criteria:
1. diagnosis of CRPS I; of upper or lower extremity; and of between 3 and 24 
months duration;
2. age 18 to 80 years.
Exclusion criteria:
1. alternative diagnoses that may explain the pain syndrome;
2. impairments of the contra-lateral extremity;
3. relapse of CRPS I;
4. prior sympathectomy of the affected extremity;
5. pregnancy; lactation.
Interventions Experimental group: 'pain exposure physical therapy', consisting of a 
progressive-loading exercise programme, de-sensitising massage and 
management of pain-avoidance behaviour.
Conventional group: conventional treatment according to Dutch guidelines; 
comprising pharmacological and physical therapy exercise interventions.
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Outcomes Primary outcome measures:
1. impairment level SumScore (ISS) (restricted version).
Secondary outcome measures:
1. Disability of Arm, Shoulder and Hand questionnaire;
2. Lower Limb Tasks Questionnaire;
3. Fear-Avoidance Beliefs Questionnaire;
4. SF-36;
5. muscle force measurements, as measured by a hand-held dynamometer;
6. 10 metre walking test;
7. Timed Up and Go test;
8. compliance and adherence, as measured by interview, questionnaires (the 
Seven Days Physical Activity Recall, International Physical Activity 
Questionnaire, Pain Catastrophising Scale, Pain Disability Index) and 
accelerometry.
Starting date January 2009
Contact information Jan Paul Frölke MD, PhD; J.Frolke@chir.umcn.nl
Notes http://clinicaltrials.gov/show/NCT00817128
ISRCTN48768534
Study name Transcutaneous electrical nerve stimulation (TENS) for patients with upper limb 
complex regional pain syndrome: a feasibility study
Methods Parallel-group, 2-arm RCT (UK)
Participants Inclusion criteria:
1. 18 years of age or older;
2. have had CRPS for ≥  6 months;
3. can speak English to a good standard;
4. no neurological conditions;
5. capable of making an informed decision to take part or not.
Exclusion criteria:
1. individuals with a pacemaker, heart disease or epilepsy;
2. individuals who are pregnant;
3. abnormal skin sensation in the area below the electrodes.
Interventions Intervention group: transcutaneous electrical nerve stimulation
Placebo group: sham transcutaneous electrical nerve stimulation
Outcomes Primary outcome measures:
1. pain intensity using a VAS;
2. medication use;
3. Disability of Arm, Shoulder and Hand questionnaire;
4. Hand Laterality Recognition Task;
5. Bath CRPS Body Perception Disturbances questionnaire.
Secondary outcome measures:
1. placebo blinding credibility;
2. adverse reactions;
3. qualitative interviews.
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Starting date November 2013
Contact information Dr Cormac Ryan PhD, c.ryan@tees.ac.uk
Notes http://controlled-trials.com/ISRCTN48768534
NCT01915329
Study name Effects of repetitive electrical sensory stimulation (RSS) as intervention in 
complex regional pain syndrome type I (CRPS)
Methods Parallel-group, 2-arm RCT (Germany)
Participants Inclusion criteria:
1. age 18 to 75 years;
2. diagnosed with CRPS.
Exclusion criteria:
1. intolerable hyperalgesia;
2. lesions at the finger tips;
3. high grade digit contracture;
4. central neurological disorders;
5. psychiatric disorders;
Interventions Experimental group: repetitive electrical sensory stimulation
Sham comparator: sham repetitive electrical sensory stimulation
Outcomes Primary outcome measures:
1. static tactile 2-point discrimination threshold.
Secondary outcome measures:
1. pain intensity using an 11-point NRS;
2. somatosensory evoked potentials.
Starting date February 2012
Contact information Christoph Maier MD, PhD; christopp.maier@rub.de
Notes http://clinicaltrials.gov/show/NCT01915329
NCT01944150
Study name Association of transcutaneous electrical nerve stimulation and hypnosis 
(HYPTENS)
Methods Parallel-group, 2-arm RCT (France)
Participants Inclusion criteria:
1. age 18 to 80 years suffering from chronic non-cancer pain of mixed 
aetiologies (either nociceptive or neuropathic) including osteoarthritic limb 
arthralgia, chronic lumbo radiculalgia, chronic back pain, cervical 
radiculopathy, postherpetic neuralgia, postsurgical peripheral neuropathic 
pain, post-trauma neuropathic pain, CRPS I or II, tendinopathy;
2. uninjured skin;
3. ability to comply with requirements of the trial.
Exclusion criteria:
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1. participants with fibromyalgia;
2. participants receiving relaxation therapy, acupuncture or 
cognitive/behavioural therapies;
3. participants with cognitive disorders, unaided hearing loss, a major hearing 
impairment, a pace maker, allodynia or complete anaesthesia of the painful 
territory or already been treated by TENS or hypnosis, or both;
4. pregnancy.
Interventions Experimental group: transcutaneous electrical nerve stimulation and hypnosis.
Active comparator group: transcutaneous electrical nerve stimulation.
Outcomes Primary outcome measures:
1. pain intensity using a VAS (0 to 100 mm).
Secondary outcome measures:
1. analgesic consumption;
2. SF36;
3. patient global impression of change (PGIC).
Starting date September 2013
Contact information Louise Geoffroy, ide.emdsp@sat.aphp.fr
Notes http://clinicaltrials.gov/show/NCT01944150
UKCRN ID 12602
Study name Development of an Electrical Sensory Discrimination Therapies device (ESDT) 
for the relief of chronic pain in Complex Regional Pain Syndrome. A proof of 
concept study.
Methods Parallel-group, 2-arm RCT (UK)
Participants Inclusion criteria:
1. diagnosed with CRPS type I.
Exclusion criteria:
1. diagnosed with any other neurological, psychopathologic, motor disorder or 
major nerve damage (CRPS II);
2. the presence of any other limb pathology or pain on the affected CRPS limb;
3. cutaneous damage on the area to be stimulated;
4. receiving intensive CRPS-specific MDT rehabilitation in an inpatient setting 
during the time course of the study or within the previous month;
5. unable to understand written or verbal English and give informed consent.
Interventions Intervention group: ESDT and de-sensitisation tasks.
Control group: routine care, including de-sensitisation tasks.
Outcomes 1. Short form McGill Pain Questionnaire;
2. Brief Pain Inventory questionnaire;
3. Disability of Arm, Shoulder and Hand questionnaire (upper limb CRPS);
4. Lower Extremity Functional Scale questionnaire (lower limb CRPS);
5. Hospital Anxiety and Depression Scale;
6. adverse events.
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Starting date 2012
Contact information Prof CS McCabe PhD, Candy; Mccabe@uwe.ac.uk
Notes
Footnotes
Abbreviations: ESDT: electrical sensory discrimination therapies; PGIC: patient global impression of change; 
RCT: randomised controlled trial; RSS: repetitive electrical sensory discrimination; TENS: transcutaneous 
electrical nerve stimulation; UK: United Kingdom; VAS: visual analogue scale.
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Data and analyses
1 Graded motor imagery versus usual care
Outcome or Subgroup Studies Participa
nts
Statistical Method Effect Estimate
1.1 Pain intensity 
(post-treatment)
2 49 Mean Difference (IV, Random, 
95% CI)
-14.45 [-23.02, -5.87]
1.2 Function (0 to 11 patient 
specific functional scale) 
(post-treatment)
2 49 Mean Difference (IV, Random, 
95% CI)
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Study flow diagram.
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Figure 2
'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages 
across all included trials.
Figure 3
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'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included trial.
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1 Search strategies
CENTRAL, DARE and HTA search strategies
#1 MeSH descriptor: [Complex Regional Pain Syndromes] explode all trees
#2 "complex regional pain syndrome*":ti,ab,kw (Word variations have been searched)
#3 crps:ti,ab,kw (Word variations have been searched)
#4 (Post traumatic near/1 (algodystrophy or dystrophy or neurodystrophy or osteoporosis or pain 
syndrome)):ti,ab,kw (Word variations have been searched)
#5 "Minor causalgia":ti,ab,kw (Word variations have been searched)
#6 "Transient migratory osteoporosis":ti,ab,kw (Word variations have been searched)
#7 "Peripheral trophneurosis":ti,ab,kw (Word variations have been searched)
#8 ((Major or mitchell*) near/1 causalgia):ti,ab,kw (Word variations have been searched)
#9 "Neurovascular dystrophy":ti,ab,kw (Word variations have been searched)
#10 "Sudecks Osteodystrophy":ti,ab,kw (Word variations have been searched)
#11 Sympathalgia:ti,ab,kw (Word variations have been searched)
#12 Chronic traumatic oedema:ti,ab,kw (Word variations have been searched)
#13 Sympathetic dystrophy syndrome:ti,ab,kw (Word variations have been searched)
#14 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13
#15 MeSH descriptor: [Physical Therapy Modalities] explode all trees
#16 physiotherap*:ti,ab,kw (Word variations have been searched)
#17 "physical therap*":ti,ab,kw (Word variations have been searched)
#18 manual therapy:ti,ab,kw (Word variations have been searched)
#19 manipulative therapy:ti,ab,kw (Word variations have been searched)
#20 ((therapeutic or therapy) near/2 exercise):ti,ab,kw (Word variations have been searched)
#21 MeSH descriptor: [Electric Stimulation Therapy] explode all trees
#22 (electrotherapy or TENS or "transcutaneous electrical nerve stimulation" or "therapeutic ultrasound" or 
interferential or "shortwave diathermy" or "laser therapy " or "heat therapy" or cryotherapy):ti,ab,kw (Word 
variations have been searched)
#23 graded motor imagery:ti,ab,kw (Word variations have been searched)
#24 mirror therapy:ti,ab,kw (Word variations have been searched)
#25 MeSH descriptor: [Musculoskeletal Manipulations] explode all trees
#26 tactile sensory discriminatory training:ti,ab,kw (Word variations have been searched)
#27 sensory-motor integration:ti,ab,kw (Word variations have been searched)
#28 sensory-motor re-tuning:ti,ab,kw (Word variations have been searched)
#29 hydrotherapy:ti,ab,kw (Word variations have been searched)
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#30 (pain near/3 (advice or education)):ti,ab,kw (Word variations have been searched)
#31 (manipulation or massage or de-sensiti?ation or mobili?ation):ti,ab,kw (Word variations have been 
searched)
#32 #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or 
#30 or #31
#33 #14 and #32
MEDLINE search strategy
1. exp Complex Regional Pain Syndromes/
2. "complex regional pain syndrome*".tw.
3. crps.tw.
4. (Post traumatic adj1 (algodystrophy or dystrophy or neurodystrophy or osteoporosis or pain syndrome)).tw.
5. "Minor causalgia".tw.
6. "Transient migratory osteoporosis".tw.
7. "Peripheral trophneurosis".tw.
8. "Sudeck s Osteodystrophy".tw.
9. "Neurovascular dystrophy".tw.
10. ((Major or mitchell*) adj1 causalgia).tw.
11. Sympathalgia.tw.
12. Chronic traumatic oedema.tw.
13. Sympathetic dystrophy syndrome.tw.
14. or/1-13
15. exp Physical Therapy Modalities/
16. physiotherap*.tw.
17. "physical therap*".tw.
18. manual therapy.tw.
19. manipulative therapy.tw.
20. ((therapeutic or therapy) adj2 exercise).tw.
21. exp Electric Stimulation Therapy/
22. (electrotherapy or TENS or "transcutaneous electrical nerve stimulation" or "therapeutic ultrasound" or 
interferential or "shortwave diathermy" or "laser therapy " or "heat therapy" or cryotherapy).tw.
23. graded motor imagery.tw.
24. mirror therapy.tw.
25. exp Musculoskeletal Manipulations/
26. tactile sensory discriminatory training.tw.
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27. sensory-motor integration.tw.
28. sensory-motor re-tuning.tw.
29. hydrotherapy.tw.
30. (pain adj3 (advice or education)).tw.
31. (manipulation or massage or de-sensiti#ation or mobili#ation).tw.
32. or/15-31
33. 14 and 32
34. randomized controlled trial.pt.
35. controlled clinical trial.pt.
36. randomized.ab.
37. placebo.ab.
38. drug therapy.fs.
39. randomly.ab.
40. trial.ab.
41. or/34-40
42. exp animals/ not humans.sh.
43. 41 not 42
44. 33 and 43
EMBASE search strategy
1. exp Complex Regional Pain Syndromes/
2. "complex regional pain syndrome*".tw.
3. crps.tw.
4. (Post traumatic adj1 (algodystrophy or dystrophy or neurodystrophy or osteoporosis or pain syndrome)).tw.
5. "Minor causalgia".tw.
6. "Transient migratory osteoporosis".tw.
7. "Peripheral trophneurosis".tw.
8. "Sudeck s Osteodystrophy".tw.
9. "Neurovascular dystrophy".tw.
10. ((Major or mitchell*) adj1 causalgia).tw.
11. Sympathalgia.tw.
12. Chronic traumatic oedema.tw.
13. Sympathetic dystrophy syndrome.tw.
14. or/1-13
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15. exp Physical Therapy Modalities/
16. physiotherap*.tw.
17. "physical therap*".tw.
18. manual therapy.tw.
19. manipulative therapy.tw.
20. ((therapeutic or therapy) adj2 exercise).tw.
21. exp Electric Stimulation Therapy/
22. (electrotherapy or TENS or "transcutaneous electrical nerve stimulation" or "therapeutic ultrasound" or 
interferential or "shortwave diathermy" or "laser therapy " or "heat therapy" or cryotherapy).tw.
23. graded motor imagery.tw.
24. mirror therapy.tw.
25. exp Musculoskeletal Manipulations/
26. tactile sensory discriminatory training.tw.
27. sensory-motor integration.tw.
28. sensory-motor re-tuning.tw.
29. hydrotherapy.tw.
30. (pain adj3 (advice or education)).tw.
31. (manipulation or massage or de-sensiti#ation or mobili#ation).tw.
32. or/15-31
33. 14 and 32
34 random$.tw.
35 factorial$.tw.
36 crossover$.tw.
37 cross over$.tw.
38 cross-over$.tw.
39 placebo$.tw.
40 (doubl$ adj blind$).tw.
41 (singl$ adj blind$).tw.
42 assign$.tw.
43 allocat$.tw.
44 volunteer$.tw.
45 Crossover Procedure/
46 double-blind procedure.tw.
47 Randomized Controlled Trial/
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48 Single Blind Procedure/
49 or/34-48 (1433702)
50 (animal/ or nonhuman/) not human/
51 49 not 50
52 33 and 51
PsycINFO search strategy
1. exp "Complex Regional Pain Syndrome (Type I)"/
2. "complex regional pain syndrome*".tw.
3. crps.tw.
4. (Post traumatic adj1 (algodystrophy or dystrophy or neurodystrophy or osteoporosis or pain syndrome)).tw.
5. "Minor causalgia".tw.
6. "Transient migratory osteoporosis".tw.
7. "Peripheral trophneurosis".tw.
8. "Sudeck s Osteodystrophy".tw.
9. "Neurovascular dystrophy".tw.
10. ((Major or mitchell*) adj1 causalgia).tw.
11. Sympathalgia.tw.
12. Chronic traumatic oedema.tw.
13. Sympathetic dystrophy syndrome.tw.
14. or/1-13
15. exp Physical Therapy/
16. physiotherap*.tw.
17. "physical therap*".tw.
18. manual therapy.tw.
19. manipulative therapy.tw.
20. ((therapeutic or therapy) adj2 exercise).tw.
21. exp Electrical Stimulation/
22. (electrotherapy or TENS or "transcutaneous electrical nerve stimulation" or "therapeutic ultrasound" or 
interferential or "shortwave diathermy" or "laser therapy " or "heat therapy" or cryotherapy).tw.
23. graded motor imagery.tw.
24. mirror therapy.tw.
25. tactile sensory discriminatory training.tw.
26. sensory-motor integration.tw.
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27. sensory-motor re-tuning.tw.
28. hydrotherapy.tw.
29. (pain adj3 (advice or education)).tw.
30. (manipulation or massage or de-sensiti#ation or mobili#ation).tw.
31. or/15-30
32. 14 and 31
33. clinical trials/
34. (randomis* or randomiz*).tw.
35. (random$ adj3 (allocat$ or assign$)).tw.
36. ((clinic$ or control$) adj trial$).tw.
37. ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw.
38. (crossover$ or "cross over$").tw.
39. random sampling/
40. Experiment Controls/
41. Placebo/
42. placebo$.tw.
43. exp program evaluation/
44. treatment effectiveness evaluation/
45. ((effectiveness or evaluat$) adj3 (stud$ or research$)).tw.
46. or/33-45
47. 32 and 46
CINAHL search strategy
S43 S33 AND S42
S42 S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41
S41 (allocat* random*)
S40 (MH "Quantitative Studies")
S39 (MH "Placebos")
S38 placebo*
S37 (random* allocat*)
S36 (MH "Random Assignment")
S35 (Randomi?ed control* trial*)
S34 (singl* blind* ) or (doubl* blind* ) or (tripl* blind* ) or (trebl* blind* ) or (trebl* mask* ) or (tripl* mask* ) or
(doubl* mask* ) or (singl* mask* )
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S33 S14 AND S32
S32 S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR 
S27 OR S28 OR S29 OR S30 OR S31
S31 (manipulation or massage or de-sensiti?ation or mobili?ation)
S30 (pain N3 (advice or education))
S29 hydrotherapy
S28 sensory-motor re-tuning
S27 sensory-motor integration
S26 tactile sensory discriminatory training
S25 (MH "Manual Therapy+")
S24 mirror therapy
S23 graded motor imagery
S22 (electrotherapy or TENS or "transcutaneous electrical nerve stimulation" or "therapeutic ultrasound" or 
interferential or "shortwave diathermy" or "laser therapy " or "heat therapy" or cryotherapy)
S21 (MH "Transcutaneous Electrical Nerve Stimulation (Iowa NIC)")
S20 ((therapeutic or therapy) N2 exercise)
S19 manipulative therapy
S18 manual therapy
S17 "physical therap*"
S16 physiotherap*
S15 (MH "Physical Therapy+")
S14 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13
S13 Sympathetic dystrophy syndrome
S12 Chronic traumatic oedema
S11 Sympathalgia
S10 ((Major or mitchell*) N1 causalgia)
S9 "Neurovascular dystrophy"
S8 "Sudeck s Osteodystrophy"
S7 "Peripheral trophneurosis"
S6 "Transient migratory osteoporosis"
S5 "Minor causalgia"
S4 (Post traumatic N1 (algodystrophy or dystrophy or neurodystrophy or osteoporosis or pain syndrome))
S3 crps
S2 "complex regional pain syndrome*"
Physiotherapy for pain and disability in adults with complex regional pain syndrome...26-Feb-2016
Review Manager 5.2 107
S1 (MH "Complex Regional Pain Syndromes+")
LILACS search strategy
1. "crps"
2. "physiotherapy"
3. "clinical trial"
PEDro search strategy
1. "complex regional pain syndrome"
2. "reflex sympathetic dystrophy"
3. "causalgia"
4. "sudeks'"
5. "sympathetic pain"
6. "clinical trial"
Web of Science search strategy
1. "crps"
2. "physiotherapy"
3. "orthopaedic rehabilitation"
4. "articles" 
